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ABSTRACT 
Many neural networks are required to function at particular frequencies. These 
processes are often driven by rhythmic, intrinsically generated electrical activity that is 
produced by cells described as pacemaker neurons. Two disease-relevant in-vitro 
models were investigated that display poorly understood pacemaker activity; AtT20 
anterior pituitary corticotrophs and human induced pluripotent stem cell (hiPSC)-
derived dopaminergic (DA) neurons. Using electrophysiology and Ca2+ imaging, gaps in 
our understanding of pacemaking in these cell types were investigated. For AtT20s, it 
was revealed that hormone secretion in this cell type is uncoupled from its electrical 
activity. Novel roles were found for T-type voltage-gated calcium channels (VGCCs) in 
pacemaking and for L-type VGCCs in maintaining intracellular Ca2+ concentrations. 
hiPSC-derived DA neurons were found to produce apparently spontaneous electrical 
activity in culture that was dependent upon L-type VGCCs. This pacemaking was not 
found to be intrinsic, instead being driven by and developing in parallel with synaptic 
input in culture. These DA neurons immunostained for the L-type VGCC subtype 
CaV1.3, which is involved in the death of DA neurons in Parkinson's disease. Using a 
novel cell death assay these neurons were found to be selectively susceptible to the 
DA toxin 6-hydroxydopamine but displayed a resistance to glutamate-induced 
excitotoxicity. Data here provides valuable information on the similarities and 
differences between these in-vitro models and their in-vivo counterparts. This allowed 
for an in-depth assessment of their suitability as models for their respective diseases, 
hopefully leading to the targeted, efficient design of studies that use these cell types. 
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Chapter 1 
 
Introduction 
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Many neural networks are required to function at particular frequencies. These 
processes are often driven by rhythmic, intrinsically generated electrical activity that is 
produced by cells described as pacemaker neurons. This activity is known to drive 
processes such as motor control, release of hormones/neurotransmitters and synaptic 
plasticity (Pike et al., 1999). This pacemaking is also implicated in diseases such as 
epileptic seizures and Parkinson’s disease (PD) (Brozoski et al., 1979; Ludwig et al., 
2003). Understanding the biophysical mechanisms of how pacemaking is generated, 
maintained and impaired is therefore critical to the understanding of such diseases. 
The research in this thesis focusses on two disease-relevant in-vitro models that exhibit 
poorly understood pacemaker activity. AtT20 D16v-F2 is a mouse tumour cell line 
derived from corticotrophs in the anterior pituitary. Corticotrophs are involved in the 
regulation of the stress hormone cortisol in-vivo. Dysregulation of corticotroph activity 
can lead to Cushing’s disease (Bornstein et al., 2008). The role of voltage-gated calcium 
channel (VGCC) subtypes in AtT20 pacemaking is relatively underexplored. Human 
induced pluripotent stem cell (hiPSC) derived dopaminergic (DA) neurons have 
recently come to the foreground as a human model for Parkinson's disease (PD). In-
vivo, DA neurons tonically release the neurotransmitter dopamine to control fine motor 
processes. Their death is associated with the main motor symptoms of PD (Burns et al., 
1983). Cultured DA neurons from rats have been shown to fire rhythmically in culture 
(Grace & Onn, 1989) though the electrical properties of hiPSC-derived DA neurons are 
relatively underexplored. Given that the majority of research into PD has been 
performed on animal models, these neurons provide an opportunity to learn more about 
human forms of the disease. 
This introduction will give a review of the literature so as to allow the reader to 
understand the background and aims of the following research. Later chapters will focus 
on my research into understanding the role of VGCC subtypes in pacemaking in AtT20s 
and how pacemaking develops in hiPSC-derived DA neurons. It is possible to define 
pacemaking as being either endogenously or exogenously generated. The data obtained 
from these chapters allows for a comparison between the mechanisms of pacemaking in 
these models and their in-vivo counterparts to be performed in greater depth than has 
previously been documented in the literature. This allows for the answering of one 
simple question in the discussion: Are these cell types suitable for modelling the role of 
excitability in their respective in-vivo diseases? 
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1.1       Pacemaker Activity in the Nervous System 
 
1.1.1     Excitable Cells, their Roles & their Discovery 
It has long been known that the brain is a critical organ for the centralised control of the 
body. In the 4th century BC the Greek philosopher Hippocrates believed the brain to be 
the seat of intelligence, a notion that has been proven correct by anatomical lesion 
studies. In 1550 the first link between the visual system and the brain was established 
by the discovery that the optic nerve originates in the brain (reviewed in Shampo & 
Kyle, 1981). In 1855 Bartolomeo Panizzas’ treatise “Observations of the Optic Nerve” 
presented evidence for the occipital lobe being critical to the visual system (Colombo et 
al., 2002). In 1760 it was shown that compression of the cerebellum can produce sleep 
and that a puncture of the spinal cord between the second and third vertebrae causes 
immediate cessation of breathing (Lorry, 1760). Lesion studies in frogs soon localised 
this respiratory centre to the medulla oblongata within the hindbrain (Fye, 1995). This 
idea of separate brain regions for separate functions was backed up by Jean Pierre 
Flourens in 1822. His layer by layer lesioning of brain regions in pigeons showed the 
role of the brain in cognition, motor control and autonomic processes (reviewed in 
Dennis, 1948).  
This ability of the brain to control processes peripheral to itself gives rise to several 
important questions: 
1. How are signals reaching different parts of the body? 
2. How are these signals propagated? 
3. Do signals originate from external or internal sources? 
Early theories centred on the idea that the tissue as a whole was the source of the signal 
(Harris & Almerigi, 2009) though with the invention of silver nitrate staining (Golgi, 
1873) and pioneering work by Jan Evangelista Purkyně and Santiago Ramón y Cajal it 
was discovered that the nervous system is composed of discrete individual cells known 
as neurons (reviewed in López-Muñoz et al., 2006). Before this, in 1852, it had been 
definitively shown that motor nerves originated in the anterior horn of the spinal cord. 
This proved for the first time that neuronal processes directly interact with tissues 
throughout the body to send and receive signals (in JAMA, 1968). 
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The nature of the signal was a more complicated question to answer, with incremental 
advances in its understanding having occurred since the 1700’s. Luigi Galvani’s 
observations on frogs were the first to suggest the existence of electrical potentials in 
animals. He discovered that when two different metals came into contact with a frog’s 
leg the muscle would twitch (Bresadola, 1998). This was later confirmed to be an 
electrical signal passing through the muscle and was theorised to be caused by “electric 
molecules” on either side of the muscle fibre membrane (Pearce, 2001). In 1928, 
experiments by Edgar Adrian on the optic nerve of frogs led to the conclusion of an all-
or-nothing response of electrical firing. This was later termed an ‘action potential’ 
(Hodgkin et al., 1979). The carriers of the action potential in neurons were identified 
and described in detail by Alan Hodgkin and Andrew Huxley in 1952. By performing 
voltage clamp experiments they were able to deduce that the selective flow of sodium 
and potassium ions across the membrane were responsible for the initiation and 
propagation of the squid giant axon action potential (Hodgkin & Huxley, 1952). 
Throughout the 1980’s work primarily by William Catterall identified and functionally 
reconstituted the voltage-gated sodium channel, the first known membrane protein 
responsible for the selective permeability of ions across the membrane (Hartshorne & 
Catterall, 1981, 1985). Later, channels were discovered for the other constituent ions. 
This, coupled with the invention of the patch clamp technique allowing the recording of 
single channel currents (Neher & Sakmann, 1976), has led to the characterisation of the 
action potential and to a modern definition of an excitable cell: that which can be 
electrically excited in response to a stimulus, resulting in the generation of action 
potentials. 
 
1.1.2     Spontaneous Excitability in the Nervous System 
There is a great deal of evidence to suggest that much of the electrical activity within 
the nervous system is generated by external stimuli, with action potential firing often 
being driven by synaptic input from other neurons (Magee, 2000). However, not all 
activity in the nervous system occurs in response to an identifiable external stimulus. 
Firing has been identified that is driven solely by intrinsic factors. This is known as 
‘spontaneous excitability.’ Activity of this nature has been seen in a vast number of 
neuronal cell types during embryonic development and is believed to be a property 
shared by all developing neural networks (Donovan, 1999). Spontaneous, periodic 
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activity has been identified in the developing networks of the spinal cord, hippocampus 
and neocortex in the absence of synaptic connections (Yuste et al., 1995; Chub & 
O'Donovan, 1998; Feller, 1999). Increasing the rate of spontaneous firing in maturing 
cortical neurons by raising intracellular Ca2+ may halt their migration and promote 
dendrite formation (Bando et al., 2016). Depression of spontaneous excitability is 
associated with a lower number of synaptic connections but increased synaptic strength 
to those already formed (Burrone et al., 2002). It is therefore apparent that spontaneous 
activity is required for the formation and modulation of synaptic networks during 
development and possibly has an important role to play in synaptic plasticity. 
Spontaneous firing has also been detected in the adult nervous system in cells such as 
cerebellar Purkinje, retinal dopaminergic, amacrine and reticular thalamic neurons 
(Avanzini et al., 1989; Häusser & Clark, 1997; Feigenspan et al., 1998). Changes in 
neuronal spontaneity have also been linked to disease states such as spinal muscular 
atrophy and epilepsy (Benardete et al., 2002; Jablonka et al., 2007). 
Given how energetically demanding the firing of action potentials is, spontaneous 
activity must serve an important purpose. Several possible roles have been suggested 
(Häusser & Clark, 1997). Firstly, changes in firing rate could provide a mechanism of 
plasticity independent of synaptic input. Secondly, it could cause cells to become more 
sensitive to excitatory input. Thirdly, if the activity is regular in nature, it could act as a 
pacemaking controller for other systems. Evidence for it fulfilling all of these roles has 
been identified: intrinsic excitability has been shown to be mediated by changes in the 
levels of particular of proteins such as CaMKII, providing a mechanism for non-
synaptic plasticity (Nelson et al., 2005). Neurons that normally receive a large number 
of inputs, such as reticular thalamic neurons, have been seen to show spontaneous 
activity in the absence of synaptic connections, suggesting that spontaneous activity 
increases their sensitivity to synaptic input (Steriade et al., 1987). Pacemaker neurons 
have been identified in numerous autonomic processes and will be discussed in detail in 
the next section.  
 
1.1.3     Pacemaker Neurons 
Systems in the nervous system that are required to perform at set frequencies often have 
associated sets of neurons that act as controllers to ensure their correct functioning. 
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Rhythmic Tonic Firing Rhythmic Bursting Rhythmic Bursting (Plateau)
A
B
Non-Rhythmic Bursting Non-Rhythmic Bursting (Plateau)Non-Rhythmic Tonic Firing
These neurons, termed pacemaker neurons, fire spontaneous action potentials at regular 
intervals to entrain the system to the rate of pacemaking (Ramirez et al., 2004). 
Neurons possessing pacemaker properties have been identified in the neocortex, basal 
ganglia, thalamus, hypothalamus, ventral tegmentum area, hippocampus, substantia 
nigra and amygdala among others. These areas of the brain have been associated with 
the sleep/wake cycle, motivation, addiction, memory consolidation, cognition, fear and 
motor control (Ramirez et al., 2004). 
Pacemakers of this sort have benefits over other mechanisms of synchronised control. 
First, functional states can be quickly modulated by changes in excitability at the 
cellular level, such as the observed changes in firing patterns during sleep-wake 
transition (Henn et al., 1984). Second, groups of cells can be synchronised to fire in an 
ensemble, as is the case for cardiac pacemaker cells in the sinoatrial node (Rekling et 
al., 1996). 
Pacemaking is tightly controlled either by the firing of single action potentials at a 
particular frequency (tonic firing) or by firing in rhythmic bursts or plateaus followed 
by periods of quiescence  (Figure 1.1). An interplay of different voltage-sensitive ionic 
conductances allows pacemaker cells to produce rhythmic changes in membrane 
potential, on-top of which action potentials are generated. This allows for the retention 
of a set firing rate independent of synaptic input (Schweitzer et al., 2003). In contrast, 
non-pacemaking neurons gradually change their firing pattern to correspond to their 
synaptic input (Ramirez et al., 2004). The mechanisms that control pacemaking can 
roughly be broken down into two categories: intrinsic and agonist-induced. 
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Figure 1.1 - Rhythmic vs Non-rhythmic activity. (A) 3 rhythmic firing patterns that can be present in 
pacemaker cell types. (B) This is contrasted against the arrhythmic activity of non-pacemaker cell types. 
Rhythmic and arrhythmic activity isn't always so clear cut, with cells being rhythmic at times and 
arrhythmic at others depending on their intracellular dynamics and synaptic input. Pacemakers are 
therefore defined by their ability to produce rhythmic activity in synaptic isolation. 
 
1.1.3.1     Intrinsic drivers of excitability 
The innate properties of the action potential typically act to prevent spontaneous or 
repetitive action potential firing. The squid giant axon for example, when stimulated, 
produces a single action potential at the other end of the fibre (Curtis & Cole, 1942). 
This acts to prevent the loss of signal integrity and spontaneous firing, resulting in high 
fidelity, 1:1 propagation of action potentials. It is obvious why this high-fidelity 
signalling has developed, as unwanted activation of critical systems could have 
potentially disastrous effects. This lack of spontaneous firing is due to there being a 
refractory period between action potentials (Figure 1.2).  
 
 
 
 
 
 
 
 
 
 
Figure 1.2 - Action potential properties in excitable cells. Diagram of a typical action potential where a 
change in resting membrane potential (VRest) up to threshold (VThreshold) produces an all-or-nothing 
response followed by hyperpolarisation and repolarisation. The absolute (green) and relative (blue) 
refractory periods are highlighted. Diagram by M. Euston, with information from Lodish et al., 2000. 
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This can be broken down into two constituent parts: The absolute refractory period 
(where no stimulus no matter how strong can cause a repeat firing) which is dependent 
upon Na+ channel inactivation and the relative refractory period (where a strong enough 
stimulus can still induce firing) which is the result of slow inactivation of K+ channels 
after the membrane hyperpolarisation (Lodish et al., 2000). In ureter smooth muscle, for 
example, the refractory period is over 10 seconds long (Burdyga & Wray, 2005). How 
then does repetitive or burst firing occur in pacemaker cell types despite these 
limitations? 
The answer appears to lie in the unique combination of ion channels expressed within 
spontaneously active neurons. A range of voltage gated ion channels have been seen in 
the cell bodies and dendrites of various pacemaker cell types, ranging from voltage-
gated ion channels such as L-type VGCCs, voltage-gated sodium (NaV) and voltage-
gated potassium (KV) channels, Ca
2+ activated SK, BK and Cl- channels, 
hyperpolarization-activated cyclic nucleotide–gated (HCN) channels and rectifiers such 
as the Ca2+-ATPase pump and the K+ inwardly rectifying channels. The balance of these 
different channel conductances appears to be critically important, as the modelling of 
eight different voltage-sensitive currents with varying conductances can produce 
excitatory states ranging from single action potentials to rhythmic burst firing in 
neurons (Prinz et al., 2003). VGCCs appear to be of particular importance, with internal 
changes in the cytoplasmic Ca2+ concentration being present in numerous pacemaker 
systems including thalamic neurons and DA neurons of the substantia nigra (Coulon et 
al., 2009; Ferrari et al., 2012). 
The line between pacemaking and non-pacemaking neurons can be difficult to 
distinguish, with the same neurons displaying pacemaker activity at certain times and 
non-pacemaker activity at others. Respiratory neurons show variation between cells 
with arrhythmic bursting, tonic firing and rhythmic bursting seen within the same 
population (Peña et al., 2004). Electrically coupled pacemaker neurons in lobsters have 
different reactions to the same electrical stimulus (Marder & Eisen, 1984). This 
heterogeneity can be partially explained by the fact that neurons of the same phenotype 
may not express the same combinations of ion channels (Amaya et al., 2000).  
Differences in ion channel expression can result in several changes in excitability. The 
refractory period in neurons varies between cell types and is believed to be dependent 
upon the expression of Ca2+ and K+ channels. Alteration of these conductances has been 
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observed to reduce or elongate the time between action potential firing in ureter smooth 
muscle cells by affecting the relative refractory period (Burdyga & Wray, 2005).  
Action potentials also require the reaching of a threshold potential in order for firing to 
occur (Hodgkin & Huxley, 1952). This threshold can vary between cell types and can 
even vary between regions of a cell with dendrites typically showing lower thresholds 
than cell bodies (Kole & Stuart, 2008). Increases in external [K+] can shift the threshold 
for firing, suggesting that ionic concentration gradients and therefore ion channel 
expression are critical in setting the potential at which cells fire (Chen & Gettes, 1976). 
The rate of change of membrane potential (dV/dt) is also of critical importance. Due to 
the capacitive properties of neuronal cell membranes any changes in potential do not 
occur instantaneously, instead occurring in a ramp-like fashion that takes into account 
the charging time of the membrane (Martin, 1976). Modelling studies in cortical 
neurons show that changes in dV/dt have drastic effects on action potential firing, 
controlling whether or not they occur as well as their amplitude and duration (Naundorf 
et al., 2006). dV/dt is dependent upon both the capacitive properties (which are 
dependent upon cell size) and the resistive properties of the membrane, which are 
dependent upon ion channel expression (Kandel et al., 1997). This provides a 
mechanism whereby small differences in ion channel expression can have much larger 
influences on cell excitability, explaining the diversity seen within and between 
pacemaker cell types. 
The importance of dV/dt is related to the gating properties of voltage-gated ion 
channels, with particular emphasis on NaV channels (Figure 1.2). NaV channels can 
exist in one of 3 conformations. When at resting membrane potentials NaV channels are 
typically closed. Upon reaching the required potential threshold for channel opening, 
these channels rapidly open to allow Na+ conductance. These channels cannot return 
directly to a closed state however. First they are required to cycle through an 
inactivation state before recovering to the closed state. When the rate of membrane 
potential change to threshold is slow (low dV/dt), these channels can inactivate without 
fully reaching an open state (Armstrong, 2006). Computer modelling has shown that 
this inactivation can directly affect the firing threshold and prevent action potential 
firing (Platkiewicz & Brette, 2011) (Figure 1.3).  
Pacemaker activity can therefore be intrinsically driven in these cell types by careful 
balancing of the various ion channel conductances that control their action potential 
properties. This results in underlying fast changes in membrane potential and changes in 
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Figure 1.3 - NaV channel activation and inactivation. Diagrams showing the activation properties of 
NaV channels in response to fast (high dV/dt) and slow (low dV/dt) changes in membrane potential up to 
threshold. Diagram by M. Euston, with information from Armstrong, 2006. 
 
1.1.3.2     Agonist-Induced Excitability 
Heterogeneity is not only explained by ion channel expression however, as internal 
mechanisms such as phosphorylation, intracellular Ca2+ dynamics and receptor 
activation can alter ion channel conductances (Pape et al., 2004). Pacemaker currents 
can be altered by cAMP synthesis in response to G-protein coupled receptor activation 
(Frère & Lüthi, 2004). Activation-dependent firing is seen in pacemakers in the 
hypothalamic arcuate nucleus in response to orexigens and in pancreatic islets in 
response to glucose (Atwater et al., 1978; van den Top et al., 2004). 
Although pacemaker cells are characterised by their ability to fire without input, 
synaptic inputs are often able to alter their activity patterns. Changing the frequency of 
regularly spaced synaptic inputs in computer-based models of Aplysia pacemaker 
neurons results in frequency-dependent changes in excitability (Perkel et al., 1964). 
This proposed effect of neurotransmitter-dependent changes in activity has been 
experimentally confirmed. For example, inhibition of DA transmission in lobster 
pyloric neurons causes irregular and infrequent burst firing (Johnson et al., 2003).  
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It is clear then that pacemaking in the nervous system is a complicated process, with 
intrinsic drivers of excitability being regulated by activity-dependent processes such as 
intracellular signalling and synaptic activity.  
Two disease relevant examples of pacemakers in the nervous system are anterior 
pituitary corticotrophs and DA neurons of the substantia nigra pars compacta (SNc). As 
neuroendocrine cells the principle role of corticotrophs is to release adrenocorticotropic 
hormone (ACTH). Disturbance of ACTH release can lead to Cushing’s disease 
(Bornstein et al., 2008). DA neurons are involved in the control of fine motor control 
and their intrinsic excitability is believed to lie behind their specific cell death in PD 
(Surmeier & Schumaker, 2013). Both cell types have in-vitro models that present an 
opportunity to study how pacemaking develops as these cell types mature into 
electrically active cells. The following review sections will focus on the literature 
surrounding these models, focusing on their roles in-vivo and what is and isn’t known 
about their excitability. 
  
 
1.2    Pacemaking in Anterior Pituitary Corticotrophs 
1.2.1     The Role of Corticotrophs In-Vivo 
The anterior pituitary is a gland, located in the midbrain, whose function is the release 
of hormones to regulate homeostatic processes such as stress, development and 
reproduction. A subpopulation of cells within this region, when identified using electron 
microscopy, have been found to contain numerous large (~0.5 µM in diameter), dense 
core vesicles that contain ACTH (Kurosumi et al., 1966). ACTH is a key regulator of 
stress responses through its induction of cortisol secretion from the adrenal cortex, as 
well as indirect roles in the release of adrenaline and noradrenaline. This hormonal 
response chain is termed the hypothalamic–pituitary–adrenal (HPA)-axis (Fulkerson & 
Pamela, 1982; Valenta et al., 1986). ACTH causes a time-dependent increase in plasma 
cortisol levels following exposure to a stressor (Fulkerson & Pamela, 1982). 
Optogenetic release of ACTH in zebrafish promotes avoidance behaviour, indicating its 
importance in immediate responses to stress (De Marco et al., 2016). ACTH is also 
critical for long term responses to stress and the control of circadian rhythms such as 
those involved in sleep and alertness. Corticotrophs display pacemaker activity in-vivo 
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and the release of ACTH is linked to action potential firing (Guérineau et al., 1991; Lee 
& Tse, 1997). This provides a link between pacemaking and diseases of ACTH 
secretion, such as Cushing's disease. 
 
1.2.1.1     Cushing's Disease: A Case Study of HPA-Axis Function 
Cushing’s disease is a form of ACTH-dependent Cushing’s syndrome that is caused by 
pituitary corticotroph tumours. Over-production of ACTH in these tumours leads to 
excessive release of cortisol and subsequent dysfunction of cortisol-related processes 
(Nelson et al., 1960). It is also associated with reduced regularity, orderliness and 
synchrony of hormone release, indicating that abnormal pacemaking may be involved 
(van den Berg et al., 1997). 
Cushing’s disease and increased cortisol levels are associated with weight gain and 
obesity (Greening et al., 2006). Intravenous injection of cortisol in rats causes sustained 
increases in the appetite promoter Neuropeptide Y in the hypothalamus and, 
paradoxically, increases in the appetite suppressant leptin (Zakrzewska et al., 1999). 
Weight gain in Cushing’s therefore appears to be caused by complex changes in levels 
of proteins with contradictory effects, resulting in an overall trend towards weight gain.  
Stunted growth and osteoporosis have been seen in Cushing's disease patients (Raff et 
al., 2014). Elevating cortisol levels in rats causes an increase in the number of 
osteoblasts and osteoclasts seen undergoing apoptosis (Weinstein et al., 1998). ACTH 
can also interact with osteoblasts through the MC2R receptor to directly regulate bone 
mass. In-vitro, ACTH stimulates osteoblast proliferation while inhibiting proliferation at 
high concentrations (Isales et al., 2010). ACTH aids in the regulation of bone density 
through direct, concentration-dependent effects on osteoblast proliferation and 
indirectly by promoting apoptosis through the release of cortisol.  
A study looking at the psychiatric condition of patients with Cushing’s disease found 
high levels of association with depression, decreased concentration, decreased libido 
and insomnia. The severity of the disability, although found to be reduced, was still 
present in patients with high cortisol but low ACTH levels, indicating that effects of 
ACTH independent of cortisol are involved in many of the symptoms (Starkman & 
Schteingart, 1981). The predominant theory for the mechanism of ACTH induction of 
psychiatric illnesses centres on increased net glucocorticoid signalling in affected brain 
regions. Indeed, regions such as the neocortex and hippocampus that are associated with 
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memory formation have been seen to express high numbers of glucocorticoid receptors 
(Hansson et al., 2000).  
Diabetes and insulin resistance are seen in a proportion of patients (Raff et al., 2014). 
Patients infused with high doses of cortisol showed increased gluconeogenesis in the 
pancreas (Khani & Tayek, 2001). Cortisol also promotes glucagon and catecholamine 
action, contributing to insulin resistance and increased blood glucose levels (Gerich et 
al., 1980).  
 
1.2.1.2     Mechanisms of ACTH Secretion 
Secretion of adrenal hormones is caused by ACTH binding to melanocyte type-2 
receptor, a G-protein coupled receptor on cells of the zona fasciculata and zona 
reticularis in the adrenal cortex (Cone & Mountjoy, 1993). This causes induction of 
cAMP synthesis (Gallo-Payet & Payet, 2003) and the translocation of cholesterol to the 
inner cell membrane by the action of steroidogenic acute regulatory protein, the 
proposed rate-limiting step in steroid hormone synthesis (Lin et al., 1995). Increased 
expression of the mitochondrial genes cytochrome P450, cytochrome oxidase and 
ATPase have been detected following ACTH binding (Hanukoglu et al., 1990). 
Upregulation of these genes increases energy-producing capacity and in turn steroid 
hormone production. This provides a mechanism for long-term changes in hormone 
release through the regulation of gene expression (Raikhinstein & Hanukoglu, 1993).  
ACTH secretion is regulated through interaction with other brain regions, most notably 
the posterior pituitary, the suprachiasmatic nucleus (SCN) and the hypothalamus. 
Corticotropin releasing hormone (CRH), a 41 amino acid peptide released from 
periventricular neurons in the hypothalamus, is the primary stimulator of ACTH release 
by interaction with the CRH-R1 receptor on corticotroph cells. Upon binding to its 
receptor it stimulates synthesis of ACTH from its precursor, pro-opiomelanocortin, 
through the activation of cAMP pathways (Kageyama & Suda, 2009). Different 
isoforms of this receptor have been found which could explain why only a proportion of 
ACTH-containing vesicles go through exocytosis at any one time, giving a mechanism 
for pulsatile release (Pisarchik & Slominski, 2001). Arginine vasopressin (AVP), either 
released from the posterior pituitary or synthesised by corticotrophs, also stimulates 
ACTH secretion (Aguilera & Rabadan-Diehl, 2000). It acts through the V1b receptor to  
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Figure 1.4 - The principle components of the HPA-axis. (A) The regions involved in the HPA-axis. 
Hypothalamic stimulation of the anterior pituitary, located at the base of the hypothalamus, causes 
stimulation of the adrenal glands located at the top of the kidneys. (B) Release of CRH from the 
hypothalamus or AVP from the posterior pituitary stimulates ACTH secretion from corticotrophs within 
the anterior pituitary. This leads to release of cortisol from the adrenal cortex. Cortisol, aside from its 
physiological effects, acts as part of a negative feedback loop by binding to receptors on corticotrophs to 
inhibit its own release. In Cushing's disease, excessive ACTH secretion results in excessive release of 
cortisol (Diagram by M. Euston). 
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increase the responsiveness of cells to CRH (Spiga et al., 2009) and has been found to 
rescue the stress response in CRH-R1 knockout mice (Turnbull et al., 1999).  
Various other receptors have been implicated in ACTH release from corticotrophs. 
Lesioning of the suprachiasmatic nucleus causes the release of ACTH to become less 
rhythmic, an effect that can be replicated by blockade of serotonin receptors (Spinedi & 
Negro-Vilar, 1983; Sage et al., 2001). Lastly, glucocorticoid receptors on corticotrophs 
provide evidence for a cortisol-dependent feedback loop (Yokote et al., 1991). 
Corticotrophs show reduced secretion of ACTH in high concentrations of cortisol, 
perhaps through the attenuation of Ca2+-dependent voltage-gated potassium currents 
(Duncan et al., 2016). 
It is clear then that secretion of ACTH is involved in a large number of physiological 
processes, either directly or indirectly through the release of cortisol, and is controlled 
by several pacemaker systems or feedback loops. The components of the HPA-axis are 
outlined in Figure 1.4. Due to the finding that ACTH secretion is coupled to membrane 
depolarisation (Lee & Tse, 1997), a vast body of research has been performed on the 
mechanisms of corticotroph pacemaking to determine the role of electrical activity in 
diseases of ACTH secretion. 
 
1.2.2     Corticotroph Pacemaking In-Vivo 
ACTH release from corticotrophs is highly dependent upon changes in membrane 
potential, with secretion being associated with membrane depolarisation and an 
increased intracellular Ca2+ concentration (Lee & Tse, 1997). Their firing activity 
consists of two modalities: low frequency tonic firing or plateau-like bursts of action 
potentials. Activity is rhythmic in nature, acting as a pacemaker for ACTH release 
(Zemkova et al., 2016). This pacemaker is controlled by two complementary systems: 
intrinsic and agonist-induced excitability (Figure 1.5).  
 
1.2.2.1     Intrinsic Excitability in Corticotrophs 
Various voltage-gated currents have been implicated in the regulation of intrinsic 
excitability in corticotrophs. Inactive corticotrophs have a more depolarised resting 
membrane potential compared to active cells, an effect likely caused by the membrane 
potential being depolarised past the threshold for firing (Zemkova et al., 2016). This 
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indicates that maintenance of this potential is important in progressing corticotrophs to 
an excitable state. Patch clamp recording and channel knockout experiments have 
reported that inwardly-rectifying potassium channels and TREK-1, a potassium channel 
activated by polyunsaturated fats and lysophospholipids, all  maintain this 
hyperpolarised resting membrane potential (Kuryshev et al., 1995; Liang et al., 2011). 
RT-PCR has revealed the presence of HCN channels (Kretschmannova et al., 2012). 
These channels are commonly found in pacemaking cells and act at hyperpolarised 
potentials to drive membrane repolarisation (Zolles et al., 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5 - Excitability in corticotrophs in-vivo. Pacemaking is controlled by intrinsic and agonist-
induced factors. The resting membrane potential is maintained by K+ channels such as KV, BK, SK and 
TREK-1. Action potentials are generated by NaV channels with underlying Ca2+ waves produced by L-
type VGCCs. Inwardly rectifying K+ channels, Ca2+-ATPase pumps and Na+/Ca2+ transporters maintain 
ionic concentrations following an action potential. HCN channels act as pacemaker channels to help 
return the cell to its resting potential following an action potential, aided by K+ channels. CRH and AVP, 
act on receptors to induce increases in Ca2+ concentration and cAMP synthesis. This causes changes in 
the activity of TREK-1, BK/SK and inwardly rectifying K+ channels. V1b activation also affects TRPC6 
channels via an as-of-yet unknown mechanism (Diagram by M Euston). 
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Block of NaV channels or L-type VGCCs abolishes pacemaking. Block of L-type 
channels reveals single Na+-dependent action potential firing upon current injection, 
while block of NaV channels alone reveals underlying, subthreshold Ca
2+-dependent 
changes in membrane potential (Zemkova et al., 2016). It would seem then that both of 
these channels are involved in pacemaking, with VGCCs producing a fast, rhythmic 
dV/dt that brings the membrane potential past a threshold that induces firing of Na+ 
dependent action potentials. Modelling of ion channel properties in corticotrophs has 
shown that the relative balance of these different ion channel conductances can explain 
the spiking patterns seen in-vivo, as well as a possible role for BK channels. When Na+ 
conductances are low, changes in BK conductance decide whether a fire tonically or 
burst fire. For inactive cells however, changes in BK conductance do not cause them to 
become active (Fletcher et al., 2017). A further modelling study suggested that raising 
or lowering K+ and Ca2+ conductances was able to shift the threshold for firing and 
cause faster, more exaggerated shifts in dV/dt. This resulted in rhythmic spiking within 
the model and explains the effects seen in the previous study (LeBeau et al., 1997). The 
Ca2+ dependence of BK channels also implicates VGCCs in the regulation of spike 
duration and could help explain how rhythmic firing is generated. A Ca2+ transient 
during depolarisation could promote the activation of BK channels in a concentration-
dependent manner, providing a feedback mechanism to limit spike duration to within a 
set range. BK channels are present in corticotrophs (Duncan et al., 2015) and VGCCs 
have been seen to regulate BK channel activity in other pacemaker systems (Marcantoni 
et al., 2010). Experimental evidence for their involvement in intrinsic excitability is 
sparse, however there is evidence for BK channels affecting spike frequency in subsets 
of mouse corticotroph knockouts (Liang, 2012).  
 
1.2.2.2     Agonist-Induced Excitability in Corticotrophs 
The main hormonal regulators of ACTH secretion, CRH and AVP, have been reported 
to induce firing in corticotrophs (Kuryshev et al., 1995; Lee et al., 2015). Both agonists 
can switch non-active cells to a burst firing modality and increase the firing rate of 
active cells. 
CRH, upon binding to CRH-R1, causes an initial membrane depolarisation followed by 
an increase in the intracellular [Ca2+] and cAMP concentrations caused by activation of 
the PKA signalling pathway (Lee & Tse, 1997). This in turn has been proposed to 
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modulate certain ionic currents within the cell.For example, inwardly rectifying K+ 
channel currents were reduced by the addition of CRH, an effect that was mimicked by 
the addition of extracellular cAMP (Kuryshev et al., 1997). A similar reduction has 
been seen in TREK-1 currents, which are partially responsible for maintaining a 
depolarised resting membrane potential (Lee et al., 2015). CRH-induced burst firing is 
reduced in BK knockout mice, an effect that is also suspected to be cAMP-dependent 
(Liang, 2012). L-type VGCCs are critical for pacemaking in AtT20 pituitary tumour 
cells and produce predictions in line with experimental data when incorporated into 
models of CRH-dependent corticotroph excitability, however there is as of yet no 
experimental evidence for their role in-vivo (Luini et al., 1985; Duncan et al., 2016). 
The relative degree to which each of these channels are involved in CRH-induced 
excitability is unknown at this stage and remains a complex matter. 
AVP acts on the G-coupled V1b receptor to cause opening of L-type VGCCs via an 
IP3-dependent release of Ca2+ from stores in the endoplasmic reticulum. This causes a 
membrane hyperpolarisation followed by a sustained depolarisation that increases tonic 
firing and bursting activity. This effect is blocked by the Ca2+-dependent potassium 
channel blocker apamin and is likely due to block of TREK-1 channel currents (Lee et 
al., 2015). AVP was also shown to stimulate the non-specific cation channel TRPC6 
though its role in excitability has not been determined (Mani et al., 1985). 
Firing frequencies in corticotrophs are therefore maintained by intrinsic ion channel 
conductances which are modulated by agonist-induced changes in excitability. There is 
some overlap in the channels involved but it remains uncertain whether intrinsic and 
agonist-induced excitability in corticotrophs act via the same or different mechanisms. 
 
 
1.2.3     AtT20: A Spontaneously Excitable Mouse Anterior Pituitary Corticotroph 
Tumour Cell Line 
For many years, in-vitro models have been used to study corticotroph function as they 
allow the mechanisms of pacemaking and secretion to be studied in more controlled 
conditions that are independent of extrinsic input. AtT20 is a cell line cloned from a 
mouse anterior pituitary corticotroph adenoma (Woods et al., 1992). They readily 
secrete ACTH and, similar to corticotrophs in-vivo, show spontaneous electrical activity 
either as regular tonic firing or in plateau-like bursts with a frequency of ~1.4 Hz at a 
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resting potential of -55 mV without any synaptic input (Adler et al., 1983). CRH has 
been seen to facilitate the secretion of ACTH but, unlike their in-vivo counterparts, 
effects on excitability are not always seen (Surprenant, 1982; Guérineau et al., 1991). 
These properties, along with their simple culture conditions, have made them ideal for 
various studies into the mechanisms of secretion and spontaneous activity in 
corticotrophs and their associated diseases. 
Pacemaking in AtT20's was found to be Na+ and Ca2+ dependent, with the removal of 
either ion from the external medium leading to cessation of firing. Block of NaV 
channels with TTX revealed underlying Ca2+ waves that were suspected to be 
generating pacemaking. Depolarising pulses evoked a Ca2+ current during an action 
potential followed by the subsequent repolarisation of the membrane. Block of L-type 
VGCCs prevents rhythmic bursting, causes a membrane depolarisation and eliminates 
Ca2+ oscillations, though holding the membrane potential to resting levels under current 
clamp allows rhythmic firing to continue (Adler et al., 1983). Single channel recordings 
revealed the presence of Ca2+-dependent K+ channels which drive repolarisation in 
response to the Ca2+ influx during the action potential (Adler et al., 1983).  
Various other channels with as yet unknown functions in pacemaking have been 
identified. A Ca2+-dependent Cl- current and two inwardly rectifying potassium 
currents, one voltage-sensitive and one opened in response to the binding of 
isoproterenol, have been identified (Korn et al., 1991; Dousmanis & Pennefather, 1992; 
Weik & Spiess, 1992). RT-PCR has revealed the expression of hyperpolarisation-
activated HCN1 channels (Tian & Shipston, 2000). Ca2+-ATPase and the Na+/Ca2+ 
transporter have been shown to help regulate intracellular [Ca2+] (Korn et al., 1991). 
Various subtypes of VGCCs have been seen in AtT20 cells. VGCC currents are 
primarily L-type, with over 60% of current blocked by the dihydropyridine-specific 
antagonist nifedipine. Other VGCC subtypes such as such as N, P/Q and T-type have 
also been detected by various VGCC blockers (Mackie et al., 1995). 
Several questions remain to be answered over the generation of pacemaking in this cell 
line: Firstly, what do these other identified channel types contribute to the generation of 
pacemaking? Various potassium channels have been seen to control resting membrane 
potential and excitability in-vivo which has yet to be explored in AtT20 cells 
(Dousmanis & Pennefather, 1992). Subtypes of VGCCs have different activation 
properties and have been seen to control excitability in various cell types (Matschke et 
al., 2015) and Hodgkin-Huxley models of corticotroph excitability have suggested roles 
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for T-type channels that have not yet been seen experimentally (LeBeau et al., 1997). 
Secondly, the issue of whether secretion of ACTH is coupled to excitability in this cell 
line needs to be resolved and, if it is uncoupled, why is this the case? 
Answering these questions will provide insight into the dysfunction of pacemaking in 
diseases of ACTH secretion. A summary of the ion channels involved in AtT20 
pacemaking is shown in Figure 1.6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6. - Excitability in AtT20s. Intrinsic excitability is controlled by various ion channels. The 
frequency of NaV-dependent action potentials is regulated by subthreshold membrane potential 
oscillations caused by L-type VGCCs. Action potential repolarisation and duration are regulated by KV, 
VGCCs and Ca2+-activated BK and SK channels. Inwardly rectifying K+ channels, Ca2+-ATPase pumps 
and Na+/Ca2+ transporters maintain ionic concentration gradients. Channels with as yet unknown roles 
include HCN channels, N-type, P/Q-type and T-type VGCCs and Ca2+-dependent Cl- channels. Although 
they are present in AtT20s there is contradictory evidence over whether receptors for the ACTH 
secretagogues CRH and AVP have an effect on excitability (Diagram by M. Euston). 
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1.3     Pacemaking in Dopaminergic Neurons of the Substantia Nigra 
1.3.1     The Role of SNc Dopaminergic Neurons In-Vivo 
The substantia nigra pars compacta (SNc), located in the midbrain, is characterised by 
neurons that tonically release the neurotransmitter dopamine. There are roughly 12,000 
dopaminergic (DA) neurons within the SNc of the adult rat, with each neuron making 
upwards of 100,000 synaptic connections (Francis et al., 2012). Neurons in the 
substantia nigra have two identified phenotypes in rats: large, fusiform cells with 
extensive dendritic trees; and smaller, polar cells with long axons coming from both 
poles that project towards regions of the basal ganglia (Richards et al., 1997) (Figure 
1.7A). 
 
1.3.1.1     SNc Projections to the Basal Ganglia  
Axons from the SNc in rats mainly project along the nigrostriatal pathway to a region of 
the basal ganglia called the dorsal striatum. Projections to and from other regions of the 
basal ganglia including the globus pallidum, pars reticulata, pedunculopontine nucleus 
(PPN) and subthalamic nucleus (STN) have also been identified in mice (Matsuda et al., 
2009; Watabe-Uchida et al., 2012). Projections from the PPN tegmental nuclei to the 
SNc have an excitatory effect on dopamine release. Excitatory postsynaptic potentials 
from this region can be blocked by application of the AMPA/kainate receptor blocker 
CNQX and muscarinic/nicotinic receptor blockers such as atropine and pirenzipine, 
indicating the involvement of glutamate and acetylcholine (Futami et al., 1995). 
GABAergic inputs from regions of the basal ganglia such as the neostriatum, globus 
pallidum and pars reticulata have been seen to act on SNc GABAA receptors to inhibit 
firing in SNc neurons (Petri et al., 2002; Lee & Tepper, 2009). This forms the basis of 
the nigral-striatal-nigral feedback loop, where SNc neurons activate their own 
GABAergic inhibitory neurons to regulate dopamine release. Dual patch clamp 
recordings show that stimulation of one SNc neuron can increase the firing rate of 
adjacent neurons, an effect that is likely caused by local neurotransmitter release 
(Vandecasteele et al., 2005). Application of D2-like receptor agonists decreases 
dopamine release, showing the presence of a dopamine negative feedback loop, with 
release of dopamine from dendrites in the SNc acting on D2-like auto receptors to 
inhibit the release of dopamine (Hooper et al., 1997).  
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1.3.1.2     Dopaminergic Control of Fine Motor Movement 
Lesions of the SNc in animal models lead to motor deficits associated with fine motor 
control, while there is no deficit in cognitive function, memory and mood (which are 
associated with DA neurons in other regions of the basal ganglia). The most common 
symptoms were eyelid closure, bradykinesia, rigidity and postural tremor (Burns et al., 
1983; Pioli et al., 2008). Administration of the dopamine precursor L-DOPA can 
temporarily reverse these effects (Burns et al., 1983). Stimulation of areas containing 
SNc projections can alleviate the symptoms caused by lesions of the SNc and lesions in 
downstream processing areas such as the thalamus can produce motor deficits similar to 
SNc lesions (Kumar et al., 2000; Jeljeli et al., 2003). This provides evidence for their 
role in expansive motor control pathways. These circuits are difficult to dissect due to 
the complex convergence of many pathways onto the basal ganglia, but can generally be 
broken down into two pathways (Figure 1.7B) (Calabresi et al., 2014): 
1.) A direct pathway of SNc input to the dorsal striatum to inhibit the functions of the 
globus pallidum and pars reticulata, preventing their inhibition of the thalamus. This 
pathway contains large numbers of medium spiny neurons (MSNs) that express 
dopamine D1-like receptors (Keeler et al., 2014). The direct pathway has been proposed 
to facilitate the control and timing of motor actions. 
2.) An indirect pathway of SNc input from the dorsal striatum to the external globus 
pallidum, resulting in disinhibition of the internal globus pallidum which in turn allows 
it to freely inhibit the thalamus. This pathway consists of MSNs that express dopamine 
D2-like receptors (Keeler et al., 2014). It has been suggested that this pathway is 
responsible for global inhibition of motor activity.  
The thalamus is a mass of grey matter within the diencephalon that has important 
functions in relaying sensory and motor signals. Projections from the thalamic motor 
area connect to regions of the primary motor cortex, premotor cortex and the 
supplementary motor area (Kurata, 2005).  
MSNs are GABAergic inhibitory neurons that are believed to be the primary site of 
action of DA neuron projections from the SNc. These cells typically form GABAergic 
synapses in-vivo, with the formation of dopamine synapses requiring a mismatch 
between DA pre-synaptic and GABAergic post-synaptic structures that is mediated by 
neuroligin-2 in mice (Uchigashima et al., 2016). 
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Figure 1.7 – The principle components of the nigrostriatal pathway. (A) Projections from the SNc to 
the dorsal striatum result in inhibition or dis-inhibition of the thalamus. (B) The two pathways of the 
nigrostriatal pathway. SNc neurons project onto GABAergic MSNs in the dorsal striatum. MSNs 
expressing D1 receptors make up a direct pathway to the internal globus pallidus (GPi) to prevent its 
inhibition of the thalamus. An indirect pathway involving MSNs expressing D2 receptors inhibits the 
thalamus through disinhibition of the GPi. GABAergic MSNs in the striatum project back to the SNc to 
provide negative feedback (Calabresi et al., 2014. Diagram by M. Euston). 
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Most dopamine receptors are slow-acting g-coupled receptors that produce either 
excitatory or inhibitory effects depending on their specific subtype. Various forms of 
these receptors are expressed throughout the nervous system, with various second 
messenger effects and physiological responses (Missale et al., 1998) (Table 1.1). 
Dopamine receptors can be broken down into two main types: D1-like (D1 and D5) and 
D2-like receptors (D2, D3 and D4). D1 receptors are typically excitatory via 
upregulation adenylate cyclase. This subsequently causes a membrane depolarisation 
via changes in the conductances of pacemaker-associated ion channels such as L-type 
VGCCs, HCN channels and Ca2+ dependent ion channels such as GIRK2. D2-like 
receptors are typically inhibitory via inhibition of adenylate cyclase. This in turn causes 
changes in the conductance states of the aforementioned ion channels and, notably 
through association with GIRK2, causes membrane hyperpolarisation (Missale et al., 
1998). 
These subtypes also differ in their affinities for dopamine, with D2-like receptors 
typically having a higher affinity than D1-like receptors. One such study, by performing 
a displacement assay using radioactive dopamine isotopes, found an IC50 value of 10.16 
µM dopamine for D1-like versus 0.15 µM dopamine for D2-like receptors in the dorsal 
striatum (Marcellino et al., 2012). This can help explain the requirement for constant, 
pacemaker activation of the dorsal striatum by SNc neurons. Low concentrations of 
dopamine will result in a higher degree of activation of the inhibitory D2 pathway, 
while only continuous release of dopamine will result in a high enough concentration to 
activate the excitatory D1 pathway. D2 receptors can also be present in either high or 
low affinity forms depending on the splice variant of the receptor that is expressed. The 
abundance of each variant that is expressed on MSNs will also affect the concentration 
of dopamine required for activation of the D2 pathway (van Wieringen et al.,. 2013). 
Dopamine action on MSNs therefore produces contradictory effects depending on the 
pathway involved. This allows for the inhibition or disinhibition of the thalamus and 
subsequent motor activity. Dopamine release onto MSNs has a concentration-dependent 
excitatory effect for those expressing D1-like receptors in rat striatal neurons, and a 
mainly inhibitory effect for those expressing D2-like receptors which depends upon the 
expression of different splice variants (Surmeier et al., 2007; Marcellino et al., 2012; 
Calabresi et al., 2014). D1- and D2- like receptors on interneurons are also activated to 
cause further inhibitory or excitatory changes in MSN membrane potential. Other 
neurotransmitters have been seen to modulate MSN activity through interneurons such 
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Family Receptor
Transduction 
Mechanism
Expression
D1
AC+
PLC+ 
L-type VGCCs+
Dorsal + ventral striatum, 
thalamus, hypothalamus
D5 AC+
Hippocampus, hypothalamus, 
frontal cortex, cerebellum, 
midbrain
D2
AC-
K
+
 conductance -
Ca2+ conductance -
Dorsal + ventral striatum, 
thalamus, hypothalamus
D3
AC-
MAP Kinase+
Ventral striatum, islands of 
Calleja
D4
AC-
Ca
2+
 conductance-
Frontal cortex, midbrain, 
amygdala, cardiovascular system
D1-like
D2-like
as GABA, acetylcholine, glutamate and neuropeptide Y (Do et al., 2013). It is the 
cumulative effect of all these inputs that decide if dopamine inhibits or excites an MSN 
in the striatum.  
 
 
                       
 
 
  
 
 
 
 
 
Table 1.1 - Dopamine receptor classification. The 5 major subtypes of dopamine receptor, broken down 
according to their signalling pathways and regions of expression within an organism. Adenylate cyclase 
(AC), phospholipase C (PLC), voltage-gated calcium channels (VGCCs), mitogen-activated protein 
kinase (MAP Kinase). Increases and decreases are indicated by + and - symbols respectively. Adapted 
from the Tocris website (https://www.tocris.com/pharmacology/dopamine-receptors) and Missale et al., 
1998. 
 
1.3.2     Pacemaking in SNc Dopaminergic Neurons In-Vivo 
Sustained dopamine release from SNc neurons is required for proper functioning of 
target structures such as the striatum. This is caused by an intrinsic pacemaking activity 
that generates tonic action potential firing. This activity was observed at a rate between 
3-8 Hz in cultures of dissociated rat SNc neurons. This was observed to transition to 
arrhythmic bursting in-vivo in the presence of synaptic input, indicating the role of the 
local synaptic environment in control of their electrical activity (Grace & Bunney, 1984; 
Tepper et al., 1998; Guzman et al., 2009). Control of their excitability, through both 
intrinsic and agonist-induced means, is the central way in which dopamine is regulated 
(Figure 1.8). 
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1.3.2.1     Intrinsic Excitability in SNc Dopaminergic Neurons 
SNc DA neurons have been seen firing in-vivo and in-vitro in animal models in the 
absence of any synaptic input, indicating the presence of intrinsic drivers of pacemaking 
(Grace & Bunney, 1984; Shen et al., 1994; Tepper et al., 1998). Pacemaking is thought 
to mainly be driven by voltage-gated cation channels for Na+, Ca2+ and K+. Block of 
NaV channels in dissociated mouse SNc neurons prevents firing but leaves lower 
amplitude membrane oscillations at close to the pacemaker frequency. These were 
blocked by the removal of Ca2+ from the external medium (Puopolo et al., 2007). Ca2+ 
imaging has revealed this is driven by somatodendritic oscillations in their Ca2+ 
concentration (Guzman et al., 2009). Immunohistochemical analysis of somatodendritic 
ion channel expression in rat models has identified a huge range of channel types 
regulating their excitability including KV channels (KV1.3, KV2.1, KV3.2, KV3.3, 
KV4.3), Ca
2+-activated SK channels (SK1, SK2, SK3), HCN channels (HCN2, HCN4), 
L-type (CaV1.2, CaV1.3) and T-type VGCCs (CaV3.1, CaV3.3) (Dufour et al., 2014). 
Inside-out patch clamp recording has also identified Ca2+-activated BK channels (Su et 
al., 2010). 
K+ channels (KV, SK and BK) appear to control the action potential duration and size of 
the afterhyperpolarisation, though the differing kinetics of these channel types means 
they have different effects. Block of KV2 increases action potential duration and 
decreases the afterhyperpolarisation while block of BK channels increases the amplitude 
of the afterhypolarisation. These contradicting effects are explained by the kinetics of 
both channels: BK channels activate and deactivate much quicker than the slowly 
activating and deactivating KV channels. Block of either BK channels or KV2 resulted in 
an instantaneous increase in the observed current passing through the other channel type 
that allowed pacemaking to continue. This was believed to be due to changes in action 
potential shape and suggests that these channel conductances have a limited ability to 
compensate for each other if one is lost (Kimm et al., 2015). Block of SK channels with 
the specific blocker apamin has been reported to have neuroprotective effects in a model 
of Parkinson's disease (PD), a disease characterised by death of neurons in the SNc 
(Alvarez-Fischer et al., 2013). SK channels also affect the afterhyperpolarisation 
following action potential firing, perhaps in response to an increase in intracellular Ca2+. 
These channels may functionally couple to VGCCs, with the N-type blocker ω-
conotoxin GVIA reducing SK currents by up to 40% (de Vrind et al., 2016).  
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The role of VGCCs in SNc pacemaking has been researched in detail over the last few 
years due to their purported role in the mechanism of SNc cell death in PD. In rats, L-
type VGCC blockers such as nifedipine were reported to block somatodendritic Ca2+ 
oscillations and firing, leading to the conclusion that they generate a slow Ca2+ driven 
pacemaker potential to control pacemaking (Mercuri et al., 1994). SNc DA neurons in 
mice robustly express CaV1.3 mRNA (Chan et al., 2007). This VGCC subtype is rare 
within the brain with their expression only seen in around 10% of neurons. Unlike other 
L-type channels they open at relatively hyperpolarised, subthreshold membrane 
potentials making them ideal for pacemaking (Chan et al., 2007). It has since been 
discovered that the L-type antagonists used in previous experiments were used at such 
high concentrations as to antagonise other VGCC channel types. Subsequent 
experiments using the CaV1.3-selective antagonist isradipine show that this subtype is 
responsible for Ca2+ oscillations in SNc neurons but that their block alone is not enough 
to cause changes in cell excitability (Guzman et al., 2009). This has been backed up by 
CaV1.3-knockout mice which also show no effect on pacemaking (Chan et al., 2007). 
However, the ability for other genes to compensate for the knockout of others during 
development means that knockout models may not give a true indication of the role of 
CaV1.3 in pacemaking (Marschang et al., 2004). Conditional knockouts in adult mice 
would provide a better indicator of the importance of this channel in pacemaking in 
adult neurons. Roles for other VGCC subtypes have also been observed such as P/Q-
type channels which, when blocked, slow the frequency of pacemaking (Puopolo, 
2007). 
Intrinsic pacemaking in SNc DA neurons is therefore a complicated and interconnected 
process. The observed robustness is an amazing example of homeostatic plasticity that 
is likely due to cross-regulation between the vast arrays of channel types involved 
which all have different kinetic properties. The changes in membrane properties caused 
by the loss of one or more channel types can cause alterations in other currents which 
result in a retention of pacemaker activity. It could be hypothesised then that knockout 
or block of several channel types simultaneously that do not affect excitability when 
blocked alone would have an effect on pacemaking. Indeed, this has been seen 
experimentally: Block of either HCN or CaV1.3 channels in mouse brain slices has no 
effect on excitability, yet block of both effectively stops all firing (Chan et al., 2007). 
CaV1.3 -/- mice show a shift in the importance of HCN channels, with them becoming 
critical for pacemaking. This is similar to the pacemaking seen in SNc neurons in 
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juvenile mice, where NaV/HCN channels are critical. As the mice mature, observed 
CaV1.3 currents grow and the contribution of HCN currents diminishes due to a shift in 
its voltage activation. HCN channels are sensitive to allosteric regulation by cAMP. 
SNc DA neurons express the cAMP-producing enzymes adenylate cyclase 5 and 9, both 
of which are inhibited by Ca2+. An increase in intracellular [Ca2+] as a result of CaV1.3 
expression could therefore decrease cAMP synthesis and downregulate HCN channel 
activity. CaV1.3 antagonism in mature SNc neurons does not block pacemaking by itself 
as its removal can increase cAMP synthesis and revert these cells back to a juvenile 
form of NaV/HCN pacemaking (Chan et al., 2007). As previously noted, genetic 
compensation in response to gene knockout has been identified in other systems. 
Therefore another explanation that should be explored is whether developmental 
changes in response to the loss of Cav1.3 can upregulate HCN channel expression. A 
summary of the channels involved in intrinsic excitability is shown in Figure 1.8. 
 
1.3.2.2     Agonist-Induced Excitability in SNc Dopaminergic Neurons 
While intrinsic factors drive tonic firing it is synaptic inputs onto SNc DA neurons, both 
excitatory and inhibitory, that are believed to drive burst firing. Glutamatergic inputs 
from the STN, PPN and from within the SNc have been seen to form synapses onto SNc 
dendrites in mouse brain slices (Pearlstein et al., 2015). Analysis of mRNA expression 
and patch clamp recordings in rodent SNc neurons have identified AMPA-evoked 
currents mediated by GluA2-containing AMPA receptors, Kainate-evoked currents 
mediated by GluK3 and GluK5-containing Kainate receptors and NMDA-evoked 
currents mediated by GluN2B- and GluN2D-containing NMDA receptors (Gotz et al., 
1997; Bischoff et al., 1997; Jones & Gibb, 2005). These are all ionotropic receptors, 
with NMDA receptors primarily passing Ca2+ and AMPA/Kainate receptors primarily 
passing Na+ and K+ (Hille, 2001). NMDA and AMPA receptors are localised to 
subpopulations of synapses within the dendrites of SNc neurons and are often found to 
co-localise (Chatha et al., 2000). The addition of antagonists to block NMDA and 
AMPA glutamate receptors in mice SNc neurons decreased cell activity while the 
addition of glutamate agonists caused high frequency burst activity. In the presence of 
NMDA/AMPA antagonists the afterhyperpolarisation following an action potential is 
decreased, suggesting a mechanism where burst firing is promoted by transiently 
inhibiting the ability of SNc neurons to repolarise (Blythe et al., 2007).  
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Two main types of inhibitory signalling affect SNc activity: A GABAergic feedback 
loop from the striatum and a local dopamine feedback loop. DA neurons form synapses 
with GABAergic neurons in the neostriatum, globus pallidum and pars reticulata which 
project back to the SNc (Lee & Tepper, 2009). Injection of GABA into the rat SNc 
inhibits dopamine levels in the striatum, indicating this feedback is inhibitory in nature 
(Reid et al., 1990). Immunohistochemistry on post-mortem SNc tissue identified a 
population of neurons expressing GABAA receptors (Petru et al., 2002). These are 
ionotropic Cl- channels that produce inhibitory post-synaptic potentials upon receptor 
binding. Activation of GABAA receptors in the rat SNc inhibits burst firing and reverts 
the cells back to an intrinsic tonic modality (Hille et al., 2001; Tepper et al., 2002).  
Whole cell current clamp recording in rat SNc neurons reveals that the application of 
dopamine or dopamine agonists has an inhibitory effect on their firing. This effect was 
reversed by the dopamine receptor antagonist trifluoperazine (Aghajanian & Bunney, 
1977). Release of dopamine in mouse midbrain slices causes a hyperpolarisation of 
nearby neurons resulting in a temporary pause in firing (Beckstead et al., 2004). This 
effect was localised to the action of D2-like receptors within the dendrites and soma 
(Cragg & Greenfield, 1997). These are believed to play a key role in dopamine release 
by providing feedback inhibition that controls cell firing. D2 receptors are g-coupled 
receptors that inhibit adenylate cyclase and cAMP synthesis (Hille, 2001). Aside from 
this, they also activate g-protein activated inward rectifying potassium (GIRK) 
channels. SNc neurons in mice express both GIRK2 and GIRK3, though D2-receptors 
appear to couple specifically to GIRK2 (Davila et al., 2003). These likely form a pre-
coupled complex that, upon dopamine binding, liberates the D2 Gβγ subunit. This 
allows it to bind and cause a conformational change in GIRK2. Activation of this 
channel at resting membrane potentials causes a membrane hyperpolarisation that 
prevents cell firing (Riven et al., 2006).  
Similar to intrinsic excitability, agonist-induced excitability in SNc DA neurons is 
complex. Multiple excitatory and inhibitory systems are in place and it is believed the 
balance of these inputs is an important determinant of cell excitability. For example, 
burst firing in SNc neurons can be induced by the activation of NMDA receptors even 
in the presence of inhibitory GABAergic input. Models of SNc synaptic inputs show 
that it is the cumulative effect of these excitatory and inhibitory inputs that decide 
whether a cell fires, depending on which conductance dominates (Lobb et al., 2010; 
Morozova et al., 2016).  
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Overlap also exists between intrinsic and agonist-induced excitability. Increasing the 
firing rate of SNc neurons from mice causes Ca2+ influx through glutamate receptors to 
increase, increasing their sensitivity to synaptic inputs (Hage & Khaliq, 2015). 
Activation of T-type VGCCs may also be involved in certain SNc populations, acting in 
an excitatory manner in response to D2-activation. These channels open at 
hyperpolarised membrane potentials, hence subthreshold currents generated by D2-
activated hyperpolarisation may open these channels and cause a counter-acting 
depolarisation. This is proposed to be a mechanism by which cells within the SNc can 
transmit dopamine signals differentially based on their ion channel composition (Evans 
et al., 2017). The ion channels involved in agonist-induced excitability are summarised 
in Figure 1.8. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8 - Excitability in animal models of SNc DA neurons. Pacemaking involves the complex 
interaction of many ion channel populations. Subthreshold VGCC dependent Ca2+ waves underlie NaV 
dependent action potentials. Action potential duration and repolarisation are controlled by KV, BK and SK 
channels and VGCCs. HCN channels are believed to be involved in pacemaking in developing SNc 
neurons. Ca2+-ATPase pumps and Na+/Ca2+ transporters maintain ionic concentration gradients. Various 
neurotransmitters also affect pacemaking. These include excitatory inputs through NMDA and AMPA 
receptors, and inhibitory inputs through GABAA and dopamine D2 receptors (which activate a K+ 
conductance through GIRK2 channels) (Diagram by M. Euston). 
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Although the mechanisms of pacemaking in SNc neurons in-vivo are relatively well 
studied, a major problem with current research is the lack of availability of human 
models. The majority of studies have been performed on animals such as primates, rats 
and mice. These have used either brain slices, dissociated cells or in-vivo recordings 
(Blesa & Przedborski, 2014). Differences between human and animal models are 
common across the scientific literature (Shanks et al., 2009), hence by translating data 
from animal models there is a risk of providing an incorrect representation of how SNc 
pacemaking functions in humans. Post-mortem examination of the SNc in PD patients 
has provided some insight into these cells in humans but models for healthy adult 
neurons or for the development of pacemaking are lacking. The requirement for relevant 
human models of SNc DA neurons is a huge bottleneck in this area of research, 
especially given the importance of this cell type in the pathology of PD.  
 
1.3.3     SNc Neurons in Parkinson’s Disease 
Parkinson’s disease (PD) is a neurodegenerative disorder of the central nervous system 
that is second only to Alzheimer’s in terms of prevalence. In industrialised countries 
this is estimated to be 0.3%. Prevalence increases with age, with a huge increase in 
those aged 60 and over, with men slightly more likely to develop PD than women (de 
Lau & Breteler, 2006).  
There are some genetic and environmental risk factors for PD but the majority of cases 
are idiopathic, that is to say, with no known cause. The disease increasingly affects 
quality of life and eventually causes severe disability. This leaves sufferers dependent 
on others for the performance of everyday tasks. Patients have more need for nursing 
home placements, have a greater incidence of hospital visits and a higher mortality rate 
than the general population. The mean duration of death from the onset of the disease is 
estimated at 6.9 to 14.3 years, with age and the co-presence of dementia being the 
highest predictors of mortality (de Lau & Breteler, 2006). 
PD is characterised by the death of DA neurons within the SNc. This is accompanied by 
a reduced signal intensity in MRI scanning (Sasaki et al., 2014; Sveinbjornsdottir, 
2016). Other regions are also affected such as the medulla oblongata, olfactory bulb and 
neocortex. Affected cells typically form abnormal protein aggregates, termed 'Lewy 
Bodies,' which begin to form at defined induction sites. These have been identified by 
histological staining to be comprised of a protein called alpha-synuclein. Lewy bodies 
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form in a predictable topographical sequence with the medulla and olfactory bulb first 
affected. Formation then appears in the midbrain, including the SNc, before finally 
spreading to the neocortex in the later stages of the disease. Neurons affected with Lewy 
bodies eventually degenerate and die, causing the main symptoms of the disease 
(Sveinbjornsdottir, 2016). 
The degeneration of DA SNc neurons with Lewy bodies is regarded as the primary 
neuropathological correlate to PD's symptoms. These are in line with motor symptoms 
seen in animal models with SNc lesions. PD was first described as having 'palsy-like' 
symptoms by James Parkinson in 1817 and is characterised by resting tremor, slowness 
of movement (bradykinesia) and festinating gait (Parkinson, 1817). Symptoms often 
start on one side of the body before the other. Body posture becomes stooped with limb 
rigidity, shuffling gait and lack of arm swing while walking becoming apparent. 
Bradykinesia is common, leading to expressionless face and noticeably smaller hand 
writing (micrographia). Postural instability can occur either early or late in the disease 
and falls in the elderly affected with PD are common. Problems with slurred or hurried 
speech and difficulty swallowing have been identified in 40-80% of patients. Around 
80% of patients have a resting tremor between 4-6 Hz. This is usually noticed in the 
hands but can also affect the legs leading to gait festination, where steps become 
progressively smaller and more rapid. Dystonia, an abnormal sustained muscle 
contraction, is another major symptom which can lead to abnormal movements and 
postural deformities such as forward flexion of the head and neck or scoliosis 
(Sveinbjornsdottir, 2016). 
Non-motor symptoms of the disease are associated with the degeneration of other 
affected brain regions. Dysfunction of the central and peripheral postganglionic 
autonomous nervous system can result in orthostatic hypotension, constipation, lack of 
urinary control and excessive sweating in certain patients. Sleep disturbances are 
common, affecting two thirds of patients. The most common are constant waking, 
daytime sleepiness and obstructive sleep apnoea. Psychotic symptoms are common in 
late stages of the disease, with patients experiencing paranoid visual hallucinations 
associated with deterioration of the hippocampus and amygdala. Associated dementia is 
also common. Sensory symptoms include a loss of sense of smell, tingly sensations and 
neuropathic pain (Sveinbjornsdottir, 2016). 
There is currently no cure for PD, though treatment of the symptoms is possible. L-
dopa, a precursor to dopamine, is the most widely used treatment and is effective at 
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treating the early to mid-stages of the disease. Dopamine receptor agonists and 
glutamate receptor antagonists have similar effects. Monoamine oxidase inhibitors can 
also prevent the breakdown of dopamine. The problem with these treatments is that they 
do not stop nor prevent the pathological course of the disease, hence they become 
ineffective once cell death has progressed past a critical point. Drug targets to halt or 
delay the progression of cell death in PD are being explored, such as enzyme inhibitors 
to prevent the formation of Lewy bodies (SYN-118) and the NaV and T-type VGCC 
blocker Zonisamide. These clinical avenues are promising but so far show limited 
effectiveness (Schapira et al., 2014). 
Transplantation of stem cells or stem cell-derived DA neurons into the SNc has been 
able to improve the motor symptoms of SNc ablated rats. However, these transplanted 
neurons show low levels of tyrosine hydroxylase immunostaining and the survival rate 
for transplanted cells is currently too low to be an effective treatment. iPSC-derived DA 
neurons have shown similar clinical improvements and produce cells that do not form 
Lewy bodies once transplanted. However, it has been suggested that these cells may be 
more susceptible to PD than others due to mutations and epigenetic markers. This field 
is still in its infancy so it remains to be seen whether stem cell transplantation can 
become an effective strategy to prevent or replace cell death in PD (Fu et al., 2015). 
It is clear then that to provide effective strategies for the prevention of cell death in PD 
that the cellular mechanisms underlying specific cell death need to be explored. 
 
1.3.4     The Role of Excitability in Parkinson's Disease 
The predominant theory behind specific cell death in PD is that of mitochondrial 
dysfunction. This has been speculated to lead to the release of mitochondrial Ca2+, 
reactive oxygen species (ROS) and the mishandling of damaged proteins which in 
combination lead to the death of specific subsets of neurons. The causes of 
mitochondrial dysfunction are still under debate but Ca2+ entry through VGCCs, 
specifically Cav1.3, has been proposed as a possible instigator (Surmeier, 2007). 
Various genetic risk factors have been identified in specific cases of PD with those with 
a family history of PD being twice as likely to develop the disease as those without. 
Environmental risk factors such as smoking, obesity and exposure to pesticides are 
linked to an increase in the incidence of PD (de Lau & Breteler, 2006). 
34 
 
The presence of one, or even several, of these genetic and environmental risk factors is 
not indicative of a person developing the disease. Also, current treatments that target the 
suspected mechanism of cell death fail to halt the disease and only slow its progression. 
It is therefore suspected, in most cases of PD, that cell death is due to the innate 
properties of the cell type involved in combination with specific mutations and 
environmental factors. A summary of the information in the following sections is shown 
in Figure 1.9. 
 
 
 
 
 
 
 
 
 
 
Figure 1.9 - Excitability and cell death in PD. SNc pacemaking leads to excessive Ca2+ influx. Ca2+ is 
uptaken by mitochondria, resulting in ROS production. ROS cause numerous effects within the cell, 
including mitochondrial DNA damage, protein phosphorylation, alpha synuclein accumulation and 
promotion of apoptosis. This, in combination with ageing and genetic/environmental risk factors, leads to 
selective death of SNc neurons in PD (From Surmeier, 2007). 
 
 
1.3.4.1     The Role of Mitochondrial Stress 
A role for mitochondrial dysfunction in PD was first identified in opiate addicts in the 
1970s and 1980s. Patients that inadvertently injected 1-methyl-4-phenyl-1,2,5,6-
tetrahydropyridine (MPTP), a by-product of opiate synthesis, showed symptoms 
remarkably similar to PD (Ballard et al., 1985). This was linked to aggregation of the 
active form of MPTP, MPP+, in the mitochondrial matrix leading to inhibition of 
complex I of the electron transport chain (Kopin, 1992). Post-mortem SNc tissue from 
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PD patients also show decreased complex I activity (Schapira et al., 1990) and mouse 
SNc neurons have been seen to selectively die in response to MPTP (Jackson-Lewis et 
al., 1995). 
Cells within the body require mitochondria to produce sufficient ATP to meet their 
energy demands. For neurons in particular, this demand is high due to the energy 
requirement of maintaining the transmembrane ionic gradients that underlie excitability. 
This is carried out by ATP-dependent transmembrane ion pumps, leaving neurons with 
a lower reserve of ATP and increasing the chance of failure of cellular systems through 
ATP shortage (Surmeier & Schumaker, 2013).  
Mitochondrial dysfunction also results in impaired Ca2+ homeostasis. Mitochondria play 
important roles in Ca2+ signalling through the sequestration and release of Ca2+. The 
mitochondrial respiratory chain, through proton pumps in the inner membrane, 
establishes an inner membrane potential difference of around -180 mV. This establishes 
a strong thermodynamic force favouring the sequestration of cations (Murphy, 2009). 
Ca2+ is imported across the outer and inner mitochondrial membrane via various 
transporters: voltage-dependent anion channels in the outer membrane; Ca2+ uniporters 
and H+/Ca2+ or Na+/Ca2+ exchangers in the inner membrane. Failure of the 
mitochondrial membrane potential leads to a massive release of Ca2+, increasing 
cytosolic levels up to 500 µM (Pan et al., 2013). This causes Ca2+-dependent release of 
cytochrome c from the inner mitochondrial membrane, leading to activation of caspases 
which are responsible for protein degradation and apoptosis (Jenner, 2003). 
 
1.3.4.2     The Role of Reactive Oxygen Species 
Mitochondria are known to be a primary source of ROS within cells, producing species 
such as hydrogen peroxide and superoxide in isolated mitochondria as a result of 
complex I and III activity (Jensen, 1966). 
Abnormal levels of oxidative damage to proteins, lipids and DNA has been identified in 
post-mortem samples of PD patients (Floor & Wetzel, 1998). The use of fluorescent 
superoxidase dyes in rat brain has identified increased levels of mitochondrial ROS 
production in response to the addition of rotenone, a complex I inhibitor which 
produces parkinsonian symptoms. ROS production could be further increased by 
hyperpolarisation of the mitochondrial membrane (Votyakova & Reynolds, 2001). All 
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of this suggests that ROS production in PD is linked to the availability of electron 
donors within complex I of the electron transport chain. 
Overproduction of ROS is believed to cause a cascade of biochemical changes that 
eventually lead to the death of DA neurons. ROS-protein interactions have been seen to 
increase levels of lipid hydroperoxidases, malondialdehyde and protein carbonyls in the 
SNc. It is suggested that these oxidised proteins may not be adequately ubiquitinated 
and hence accumulate within cells (Jenner, 2003). 4-hydroxynonenal (HNE), a product 
of lipid peroxidation, shows increased levels in rat models of PD. This protein can cause 
DNA fragmentation and induce apoptosis through the induction of caspases-3, -8 and -9 
(Liu & Kato, 2000).  
Abnormalities in the ubiquitin-proteasome system, responsible for protein degradation, 
have also been identified within the SNc in animal models. This could be due to altered 
coding of the PA28 and PA700 regulatory caps of the 26S proteasome in the SNc, but 
oxidation by free radicals and HNE are more likely (Jenner, 2003). HNE can bind 
directly the 26S proteasome to inhibit protein degradation, and levels of HNE that don't 
inhibit cell viability have been seen to inhibit the processing of ubiquitinated proteins 
(Okada et al., 1999). Treatment of cultured cell lines with HNE causes apoptosis 
through an increase of ubiquitinated proteins leading to mitochondrial stress followed 
by ROS and caspase activation (Hyun et al., 2002). This also provides evidence of a 
positive feedback loop, where the effects of ROS production cause mitochondrial 
dysfunction leading to further ROS production. 
The effects of protein oxidation by ROS in PD are numerous and the extent to which 
individual proteins affect cell death is still mostly speculative. More research needs to 
be carried out to find specific products of oxidation that affect cell survival in PD. 
Evidence also exists for oxidative stress only occurring late in the disease, with patients 
caught early showing little signs of protein oxidation (Jenner, 2003). From this it has 
been speculated that ROS production is an effect, not a cause, of cell death in PD. The 
circular nature of the causes of PD, where mitochondrial dysfunction causes effects that 
lead to further mitochondrial dysfunction, likely means that ROS production is simply 
accelerated in the latter stages of the disease and is not easily detected until this stage. 
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1.3.4.3     The Role of Alpha Synuclein 
Inhibition of protein degradation through the ubiquitin-proteasome system provides a 
link between the mechanisms of cell death and the build-up of alpha-synuclein plaques 
in PD. Immunohistochemical staining of sections from PD patients post-mortem show 
that alpha-synuclein aggregates in clumps called Lewy bodies (Spillantini et al., 1998). 
Triplication of the alpha synuclein gene, SCNA, has been shown to cause a form of PD, 
and single nucleotide polymorphisms in this gene can increase the likelihood of 
developing the disease (Maraganore et al., 2006; Fuchs et al., 2007). It is clear then that 
alpha-synuclein build-up plays an important role in PD. 
Part of the synuclein family, alpha-synuclein is found in association with synaptic 
vesicles on the membrane of neurons. Fluorescent labelling revealed this protein moves 
away from vesicles following action potential firing before rapidly returning. From this 
it is suggested its natural function is to regulate vesicle fusion through aiding the 
formation of the SNARE complex (Fortin et al., 2005). Alpha-synuclein can switch 
from an alpha helix conformation to beta-sheet oligomers in solution (Conway et al., 
2000). Beta sheet aggregation can be induced by oxidation following the addition of 
mitochondrial inhibitors such as HNE and appears to drive its oligomerisation (Qin et 
al., 2007). This promotes the idea that ROS production in PD causes alpha synuclein 
aggregation. 
The effects of alpha-synuclein aggregation are numerous due to its ability to bind to a 
variety of proteins. Through these interactions various pro-apoptotic effects have been 
identified. Alpha-synuclein oligomers have been seen to form pores in cell membranes 
and alter the function of VGCCs, both of which can lead to excessive Ca2+ influx 
(Hettiarachchi et al., 2009). They also inhibit 26S proteasome function during their own 
degradation. This effect is exaggerated in mutant forms of alpha-synuclein, leading to 
proteasomal dysfunction and increased sensitivity to apoptosis (Emmanouilidou et al., 
2010). 
A proportion of alpha-synuclein in wild type and overexpressed mice localises to 
mitochondria. This aggregation causes mitochondrial fragmentation and impaired 
complex I function, hence linking alpha-synuclein aggregation with mitochondrial 
dysfunction in PD. Overexpression of alpha-synuclein increases ROS production, which 
can be protected against through the antioxidant glutathione (Clark et al., 2010).  
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A more worrying aspect of alpha-synuclein in PD is its potential to show prion-like 
effects. Nearby cells can uptake secreted alpha-synuclein which in turn seeds the 
formation of Lewy bodies (Volpicelli-Daley et al., 2011). This ability to migrate to 
other brain regions can help to explain the progression of PD. Advancement from the 
medulla and olfactory bulb to the midbrain and neocortex could potentially be due to 
alpha-synuclein migration and seeding of Lewy bodies in these regions as the disease 
progresses.  
Lowering of alpha-synuclein levels has been explored as a possible avenue for 
protection against PD. However, siRNA down-regulation leads to severe neurotoxicity 
in rats (McCormack et al., 2010). Methods to upregulate endogenous protein 
degradation, such as overexpression of the beclin-1 gene, can lead to protein clearance 
and neuroprotective effects (Spencer et al., 2009).  
 
1.3.4.4     The Role of CaV1.3 Voltage Gated Calcium Channels 
The question remains then: why are DA neurons within the SNc innately susceptible to 
degeneration? The VGCC subtype CaV1.3 has been implicated as a possible cause, 
providing a link between pacemaking and PD. Inhibition of Cav1.3 channels in mice can 
protect against the toxic effects of MPTP, rotenone and 6-hydroxydopamine (6-OHDA) 
at concentrations that would normally cause cell death in DA neurons (Chan et al., 
2007). Use of L-type antagonists for hypertension is associated with a 30% reduction in 
the risk of developing PD and slows the progression of the disease even when initiated 
after diagnosis (Gudala et al., 2015). Due to these effects, clinical trials for CaV1.3-
specific antagonists, such as isradipine, are in progress to determine if there is a clinical 
benefit to their use in PD (Biglan et al., 2017). 
Autonomous pacemaking in SNc neurons uses slow, broad action potentials which 
maximise Ca2+ entry through VGCCs. CaV1.3 channels have faster kinetics and open at 
more hyperpolarised membrane potentials than other L-type VGCCs. Due to the innate 
properties of SNc neurons it is suspected that a proportion of these channels are always 
active during the pacemaking cycle. This results in a sustained elevation of Ca2+ into the 
cell. It is this increase in the intracellular Ca2+ concentration that is suspected to cause 
SNc vulnerability (Surmeier et al., 2017). 
This influx results in elevated Ca2+ uptake by mitochondria at junction sites with the 
endoplasmic reticulum. This has been suggested to stimulate ATP production, ensuring 
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energy demands are met. However, when ATP demand is low it causes a concentration-
dependent hyperpolarisation of the mitochondrial membrane which results in ROS 
production during complex I of the electron transport chain (Votyakova & Reynolds, 
2001; Pacelli et al., 2015).  
Ca2+ can also promote the aggregation of alpha-synuclein through the Ca2+-dependent 
protease calpain. Calpain cleaves the C-terminus region of the protein to promote its 
aggregation. Inhibition of calpain in mice results in a reduction of aggregation and 
neuronal toxicity (Mishizen-Eberz et al., 2003). 
Cav1.3 is therefore suspected to cause SNc vulnerability through sustained elevation of 
Ca2+ in the cytoplasm. This leads to mitochondrial stress, ROS production and 
aggregation of alpha-synuclein. 
 
1.3.4.5     Genetic & Environmental Components 
Although the majority of cases of PD are idiopathic, a proportion (~10%) are familial in 
nature (de Lau & Breteler, 2006). Specific gene mutations have been identified as risk 
factors and these have been used to shed further light on the causes of idiopathic PD.  
Multiplication mutations in the SCNA gene that encodes for alpha synuclein have been 
identified in various cases of familial PD, leading to symptoms similar to the idiopathic 
form of the disease. Mutations in genes involved in the ubiquitin-proteasomal pathway, 
such as Parkin and UCHL1, lead to a slow or late onset form. Recessive mutations in 
mitochondrial function or ROS stress responses, such as PINK1 and DJ-1, have also 
been associated with the disease (de Lau & Breteler, 2006). 
Apart from direct genetic causes in familial PD, a lot of research has gone into 
identifying genetic risk factors in the idiopathic form of the disease. A handful of genes 
are associated with a higher incidence of PD than others. These include those associated 
with dopamine degradation (MAOB) ROS inhibition (GSTT1) and plaque formation 
(APOE and Tau). These studies and meta-analyses have found only a very weak 
correlation between suspected susceptibility genes and PD, likely due to the complex, 
multi-factorial nature of the disease. This means the contribution of any one gene is 
relatively small or requires interaction with other genes and environmental factors (Tan 
et al., 2000; Healy et al., 2004; Huang et al., 2004). 
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Various environmental risk factors have been associated with PD (reviewed in de Lau & 
Breteler, 2006). Exposure to herbicides and pesticides such as paraquat and rotenone are 
suggested to be able to increase the likelihood of developing PD through their complex 
I inhibitory activity. Exposure to heavy metals such as zinc, copper and lead are 
suspected to be a risk factor through the accumulation of metals in SNc neurons leading 
to ROS production. Studies looking at the effects of tobacco and coffee consumption 
have concluded that they are associated with a reduced incidence. Proposed 
neuroprotective mechanisms include stimulation of dopamine production or nicotine 
acting as an antioxidant. Caffeine is known to inhibit adenosine A2 receptors which are 
important for dopamine release and supplementing PD rats with caffeine improves their 
motor deficits. Other Dietary habits are suspected to play a role in susceptibility to PD. 
Antioxidants such as vitamin C and E can reduce ROS damage and studies have found 
an association between vitamin E consumption and reduced risk of PD. It has been 
hypothesised that dietary iron could reduce ROS formation and that fatty acids could 
increase ROS formation through lipid peroxidation. Studies looking at these effects 
have opposing results and no such correlation between dietary iron or fatty acids and the 
incidence of PD has yet been identified (de Lau & Breteler, 2006). 
Most cases of PD are therefore caused by the complex interaction of innate cell 
properties with genetic and environmental risk factors. Ca2+ influx through CaV1.3 
VGCCs leads to uptake of Ca2+ into mitochondria. This can overload the buffering 
capacity of SNc neurons, leading to complex I dysfunction and ROS production. ROS 
production leads to protein damage including those involved in the proteasomal system, 
leading to reduced clearance of defective proteins. Alpha-synuclein, aided by Ca2+ and 
ROS damage, is allowed to aggregate and migrate which causes further damage and 
spread of the disease. These factors eventually lead to cell death. This is aided by 
genetic and environmental factors that cause further susceptibility through reduced 
mitochondrial function or ROS production. Each stage of this mechanism is a possible 
therapeutic target for treatment of the disease. The majority of this research, however, 
has been performed using animal models of the disease. It is clear that for effective 
strategies for the treatment for PD to be developed that more research into human 
models of the disease needs to be performed. 
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1.3.5     hiPSC-Derived Dopaminergic Neurons as a Human Model for Parkinson's 
Disease 
 
1.3.5.1     Animal Models of PD 
The majority of research into PD has been performed in animal models of the disease. 
The most commonly used in-vivo models are neurotoxic lesions caused by DA neuron 
specific toxins. Exposure of primates and mice to MPTP and 6-OHDA causes selective 
SNc death and parkinsonian symptoms, though Lewy body formation that is typical in 
human forms of PD is not present in these animals. To this day, MPTP lesioned 
primates remain the gold-standard for pre-clinical testing of therapeutic strategies for 
PD (Tieu, 2011). 
Genetic models in animals are also a promising strategy. Knockout mouse models with 
mutations in Parkin and PINK1 have been shown to cause SNc degeneration. Two 
specific mutations in SCNA, A53T and A30P, have been used to create transgenic mice 
that show severe motor deficits similar to those seen in PD (Dawson et al., 2010). In the 
last few years a mouse model known as MitoPark has been used to specifically research 
the mechanisms of cell death in the SNc. This model was designed to test the hypothesis 
that mitochondrial dysfunction in the SNc causes parkinsonian symptoms by cell type-
specific inactivation of mitochondrial transcription factor A. MitoPark mice exhibit 
many of the motor symptoms of PD, which can be alleviated by administration of L-
DOPA (Ekstrand & Galter, 2009). 
A major drawback of animal models is that they may not adequately mimic the 
mechanisms occurring in the human form of PD. Post-mortem brain slices have been 
used but these are only able to give insight into very late stages of the disease once 
severe degeneration has already occurred. In-vivo at least, animal models are the best 
we have available. In recent years, however, human induced pluripotent stem cell 
(hiPSC) derived DA neurons have come to the forefront as an in-vitro model of PD.  
 
1.3.5.2     hiPSC-Derived Dopaminergic Neurons 
Induced pluripotent stem cells (iPSCs) were first described in 2006 by Shinya 
Yamanaka and Kazutoshi Takahashi. By introducing certain reprogramming factors 
(Oct3/4, Sox2, c-Myc and Klf4) they were able to re-programme mouse fibroblasts into 
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an embryonic stem cell-like state. When transplanted into mice they were capable of 
differentiating to a wide range of cell types, similar to embryonic stem cells. It was soon 
discovered that these could also be generated from human fibroblasts, opening up a new 
field of possible stem cell therapies and disease models (Takahashi & Yamanaka, 2006; 
Takahashi et al., 2007).  
Over the last few years the ability to differentiate iPSCs into specific cell types has been 
developed, DA neurons among them. iPSCs can be directed down a neural floor plate 
lineage through dual SMAD inhibition, then directed to a midbrain DA neuron fate 
through exposure to the transcription factors SHH and FGF8 (Kriks et al., 2012). This 
method has been used to produce neurons that express tyrosine hydroxylase, the rate-
limiting enzyme in the production of dopamine (Hartfield et al., 2014). When 
transplanted into animal models of PD these neurons can relieve some of the motor 
symptoms of the disease (Wang et al., 2015). However, the discovery that iPSCs retain 
epigenetic markers from their previous lineage has halted most attempts at clinical trials 
in humans (Kim et al., 2010). Instead, human induced pluripotent stem cells (hiPSCs) 
have become important disease models for the study of various aspects of PD.  
The electrical properties of hiPSC-derived DA neurons are relatively under-explored, 
with only one main study being produced that looked at this in any detail. This study 
found that these neurons in culture stain for markers characteristic of SNc DA neurons 
in-vivo. They produced ~10 Hz pacemaker activity in culture, receiving excitatory 
synaptic inputs and firing robust spike trains in response to current injection. These 
properties took 6 weeks to develop and continue to increase in frequency until 10-12 
weeks. Ca2+ imaging revealed Ca2+ waves in both their soma and processes. This study 
also showed these neurons were susceptible to damage by mitochondrial toxins such as 
MPTP (Hartfield et al., 2014). 
Various questions remain to be answered over the electrical excitability of hiPSC-
derived DA neurons. Firstly, whether or not pacemaking is CaV1.3 dependent in these 
cells is unknown and needs to be researched to determine if they are suitable for 
modelling PD. Secondly, is the observed activity truly spontaneous? No study has, as of 
yet, determined whether the activity in these cells is intrinsic or driven by synaptic 
input. Thirdly, cell death in cultures containing hiPSC-derived DA neurons has been 
identified in response to SNc specific toxins, but, considering only up to 20-30% of the 
culture has been identified as being DA neurons in previous studies (Hartfield et al., 
2014), are they more susceptible to death than other neuron types in culture, and does 
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CaV1.3 expression increase their susceptibility to cell death? Answering these questions 
will better inform future studies into PD by providing more information on the 
suitability of hiPSC-derived DA neurons as an in-vitro PD model. 
 
1.4     Conclusion 
Neurons and neuroendocrine cells throughout the nervous system exhibit pacemaker 
activity. This is used to control regular processes such as breathing, repetitive 
movement and consistent hormone release. Pacemaking is controlled by two 
overlapping systems: intrinsic excitability, which involves the balance of ion channel 
populations to produce rhythmic membrane potential changes; and agonist-induced 
excitability, which involves modulation of firing patterns by synaptic inputs. Two 
diseases that occur in cell types that exhibit pacemaker activity are Cushing's disease in 
pituitary corticotrophs and PD in SNc DA neurons.  
Cushing's disease results in HPA-axis dysfunction. Subsequent symptoms including 
osteoporosis, obesity, diabetes and depression. An in-vitro model for this disease is the 
tumour cell line AtT20. These cells show pacemaker activity dependent on L-type 
VGCCs. A role for other VGCCs has been identified in models of their excitability but 
needs to be determined experimentally.  
PD is caused by the selective death of DA neurons in the SNc. This is believed to be 
caused by mitochondrial dysfunction due to Ca2+ influx through CaV1.3 VGCCs. These 
are not critical for the pacemaker process in SNc neurons, with other channel types able 
to compensate for their loss. Human models for the disease are lacking but in the last 
few years hiPSC-derived DA neurons have come to the foreground. They have been 
seen to produce pacemaker activity in-vitro and show susceptibility to the mitochondrial 
toxin MPTP. Apart from this the electrical properties of these neurons are relatively 
underexplored. It is important to know if they have similar activity and synaptic inputs 
to SNc neurons in-vivo and whether or not they express CaV1.3 as this will better inform 
their suitability as a model for PD. 
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1.4.1     Motivation for the Research 
PD and Cushing's disease are conditions that occur in neuronal and neuroendocrine cell 
types that exhibit robust pacemaking. 
Cushing's disease affects around 100 000 people worldwide per year, 70% of which are 
women. The symptoms can cause crippling physical and psychological problems for 
sufferers, including obesity, osteoporosis, diabetes and depression. Treatment is either 
through surgery to remove pituitary tumours or through drugs to target the tumour or 
treat the symptoms. It is an expensive disease to treat, with the cost of one such drug, 
Pasireotide, estimated to cost £50 000 per patient per year (McKeage, 2013). 
PD affects around 1 in 500 people worldwide, with an estimated 127 000 sufferers in 
the UK alone. The disease is more common in the elderly, causing symptoms including 
resting tremor, slowness of movement, shuffling gait and the co-presence of dementia. 
Patients have higher need for nursing home placements, have a greater incidence of 
hospital visits and a higher mortality rate than the general population. The mean 
duration of death from the onset of the disease is estimated at 6.9 to 14.3 years. The 
disease is currently incurable, with a few drugs available to treat or reduce the onset of 
symptoms (de Lau & Breteler, 2006). It is estimated to cost the NHS between £449 
million and £3.3 billion per year, mostly due to the demand for inpatient care and 
nursing home placements (Findley, 2007). 
In-vitro models are often used to study the mechanisms of these diseases, or to test new 
treatments prior to clinical trials. Studying how pacemaking is controlled and how it 
develops in these models will provide information about how similar or different these 
models are to those in-vivo. It is hoped this will inform future studies that use these cell 
types as model disease systems. In turn this will lead to a deeper understanding of 
pacemaking and more targeted, efficient research into the cellular mechanisms behind 
these diseases and any future treatments. 
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1.4.2     Aims of the Research  
The research performed in this thesis has focussed on two in-vitro disease models: 
AtT20 D16v-F2 and hiPSC-derived DA neurons. In both of these models research is 
focused on the electrical properties of pacemaking, how it develops and how these 
properties compare to their in-vivo counterparts. The main questions for each cell type 
are outlined below: 
 
1. AtT20: What are the roles of different VGCC subtypes in pacemaking? 
a. What are the roles of L-type VGCCs? 
b. What are the roles of N-type VGCCs? 
c. What are the roles of T-type VGCCs? 
d. Is the secretion of ACTH coupled to excitability? 
 
2. hiPSC-derived dopaminergic neurons: Are pacemaking properties the same 
or different from SNc dopaminergic neurons in-vivo? 
a. Is spontaneous activity intrinsic or agonist-induced? 
b. What are the main synaptic inputs onto these neurons? 
c. Do they express Cav1.3? 
d. Are they susceptible to 6-OHDA and glutamate toxicity? 
e. When during development do the above properties develop? 
 
In the following chapters I aim to answer these questions using techniques such as 
whole cell electrophysiology, immunostaining and fluorescence imaging. In AtT20 
pituitary corticotrophs this provides a greater understanding of the general mechanisms 
of pacemaking and how its dysfunction could lead to problems of ACTH secretion. In 
hiPSC-derived DA neurons this quantifies any differences in excitability from SNc DA 
neurons in animal models. 
By comparing differences and similarities in pacemaking between these models and 
their in-vivo counterparts it allows for an assessment of their suitability as models of 
their respective diseases that is more informed than any of the previous literature. It also 
allows for a comparison between the two models, giving further insight into the general 
mechanisms of pacemaking in the nervous system. 
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Chapter 2 
 
The Mechanism of Pacemaking in AtT20 
Anterior Pituitary Corticotrophs 
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Abstract 
The murine pituitary tumour cell line AtT20 can be used as a model for normal 
corticotroph function and for related diseases such as Cushing's disease. This chapter 
has focused on the use of electrophysiology and Ca2+ imaging to dissect the roles of 
voltage-gated calcium channel (VGCC) subtypes that were previously unexplored in 
AtT20 pacemaking. Through these techniques I show that AtT20s spontaneously 
produce action potentials in culture. These were driven by underlying rhythmic changes 
in the cytoplasmic Ca2+ concentration, termed “Ca2+ waves,” confirming previous 
literature. Unlike previous literature, however, two modalities of cytoplasmic Ca2+ 
waves were found to underlie AtT20 pacemaking that were able to maintain Ca2+ influx 
at similar levels despite changes in cell excitability: Fast waves that were tetrodotoxin 
(TTX) dependent and slow waves that were TTX-independent. Both modalities were 
found to be blocked by the L-type VGCC antagonist nifedipine. A novel role for T-type 
VGCCs in AtT20 pacemaking was identified, with the T-type antagonist ML218 
blocking all pacemaker activity. N-type VGCCs did not appear to play a role in 
pacemaking. This research improves our understanding of the complex ion channel 
interactions that underlie pacemaking in corticotrophs and their associated diseases.  
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2.1      Introduction 
AtT20 is a mouse anterior pituitary corticotroph tumour cell line that is commonly used 
for the study of exocytosis and hormone secretion due to their robust secretion of 
adrenocorticotropic hormone (ACTH). Similar to corticotrophs in-vivo, AtT20's in-vitro 
have been shown to display pacemaking activity in culture (Adler et al., 1983). This 
provides us with a useful model to study the mechanism of corticotroph pacemaking 
and its relationship to diseases of hormone secretion. 
Research into the mechanisms of AtT20 pacemaking has been limited, mainly focusing 
on the use of ion channel blockers, electrophysiology and fluorescent Ca2+ imaging. 
Both corticotrophs in-vivo and AtT20s in-vitro have shown various rhythmic firing 
patterns with proportions of cells tonically firing single action potentials, firing in 
plateau-like bursts or showing complete quiescence under current clamp (Zemkova et 
al., 2016). The addition of the L-type VGCC antagonist nifedipine abolishes 
pacemaking in AtT20s, indicating these channels are a critical component of their 
pacemaking mechanism. Strengthening this hypothesis, loading of AtT20s with 
fluorescent Ca2+ dyes reveals regular increases in their intracellular Ca2+ concentration 
that are also blocked by nifedipine (Adler, 1983). Antagonists against other VGCC 
subtypes have revealed the presence of small populations of N-type and P/Q-type 
channels in AtT20s (Mackie et al., 1995). Modelling predictions have also suggested a 
role for T-type channels in firing pattern generation (LeBeau et al., 1997). Experimental 
evidence for the involvement of these channel types in pacemaking is lacking, in part 
due to a past lack of specific antagonists for different VGCC subtypes. With specific 
blockers for all major subtypes now available, it affords the opportunity to re-examine 
pacemaking in AtT20s to determine the roles of these other channels. 
The research in this chapter has focused on determining the roles of L-, N- and T-type 
VGCCs in the generation of pacemaking in an AtT20 subtype, D16v-F2. Through the 
use of electrophysiology and fluorescent Ca2+ imaging I show that L-type and T-type 
channels have distinct roles. L-type VGCCs are critical for pacemaking and the 
generation of subthreshold Ca2+ waves. T-type channels are also critical for pacemaking 
and, although not critical for the generation of Ca2+ waves, may be involved in shaping 
their amplitude and duration. N-type channels on the other hand did not appear to be 
involved in pacemaking. This research improves our understanding of the complex ion 
channel interactions that underlie pacemaking in corticotrophs and their associated 
disease models, leading to a better understanding of diseases such as Cushing's disease. 
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2.2     Methods 
2.2.1     Cell Culture 
The AtT-20/D16v-F2 cell line was kindly gifted by Rory Duncan and associates from 
the Life Sciences Interface Laboratory at Heriot-Watt University, Edinburgh. Cells were 
incubated at 37oC and 5% CO2. All media products were obtained from ThermoFisher 
unless stated.  
Murine-derived pituitary corticotroph tumour cells (AtT20) were plated onto sterile 
tissue culture treated 75 cm2 flasks at 40% confluency. Once 80% confluency was 
reached the cells were washed with 5 ml Versene and detached using 5 ml TrypLE 
Express for 5 minutes at room temperature (21oC) before passage. Cell media consisted 
of (v/v): 10% FBS, 1% sodium pyruvate, 1% GlutaMAX, 1% penicillin/streptomycin in 
DMEM lacking glucose and sodium pyruvate supplemented with Phenol Red. Prior to 
experimentation the cells were passaged onto 35 mm coverslips pre-coated with 100 
µg/ml Poly-D-lysine in cell media lacking Phenol Red and incubated for 48-72 hours. 
 
2.2.2     Electrophysiology 
Recordings were performed in the whole cell configuration at room temperature (21oC). 
Data was acquired using Clampex 10 software on an Axopatch 200B patch clamp 
amplifier with a 16 bit Digidata 1440A digital acquisition system (Molecular Devices) 
at 20 kHz with a 10 kHz low pass filter. Microelectrodes were pulled from borosilicate 
glass using a Flaming/Brown P-87 micropipette puller to a resistance of 3-8 MΩ. The 
extracellular solution contained (mM): 140 NaCl, 2.5 KCl, 2 MgCl2, 2 CaCl2, 10 
HEPES, 10 Glucose, 15 D (+)-Saccharose, pH 7.4; 320 mOsm/kg. The intracellular 
solution contained (mM): 100 K-Gluconate, 20 KCl, 1 CaCl2, 1 MgCl2, 10 HEPES, 3 
Phosphocreatine Na2, 11 EGTA, 9 D (+)-Sucrose, 4 ATP-Mg2; pH 7.2; 295 mOsm/kg. 
For calcium current recordings intracellular K-gluconate/KCl was replaced with 120 
mM Cs-Gluconate and 10 mM CaCl2/1 µM TTX were added to the bath prior to 
recording. Cells with more than 100 pA of leak current from a holding potential of -60 
mV were rejected. The liquid junction potential (LJP) was calculated to be -2.4 mV (K 
internal) and -8.9 mV (Cs internal). Recordings were adjusted for these values during 
analysis. Whole cell capacitance was corrected during voltage clamp recording and 
series resistance compensation was applied to a minimum of 60%. The following 
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compounds were added where stated: TTX (1 µM), tetraethylammonium (TEA) (10 
mM) Nifedipine (10µM), ω-conotoxin GVIA (1 µM), ML218 (1 µM), Bay K8644 (1 
mM), corticotropin releasing hormone (CRH) (500 ng/ml). 
The protocols used are outlined below: 
1. Current density and I/V relationships: A holding potential of either -60 mV 
or -80 mV was applied in the voltage clamp configuration. +10 mV steps up to 
+80 mV were applied, with the holding potential being applied between steps. 
Each step lasted 200 milliseconds with 1 second between sweeps. P/4 leak 
subtraction was applied pre-recording. 
2. Firing frequency: Recording was performed gap-free for up to 10 minutes in 
the current clamp configuration. No current was injected during recording and 
no leak subtraction was applied. 
3. Action potential properties: Consecutive current steps of 10 pA were 
applied up to 100 pA from a holding potential of -60 mV. Each step lasted 200 
ms with a 1 second gap between sweeps. No leak subtraction was applied. 
4. Continuous capacitance recording. An estimate of whole cell capacitance 
was recorded using the membrane test feature of Clampfit 10. 4x 500 ms voltage 
steps from -80 to +10 mV were applied mid-recording with 500 ms gaps 
between steps. A full explanation of this approach is described in 
Supplementary 2.1. 
 
2.2.3    Analysis of Recordings 
All data was analysed using Clampfit 10 and Excel. For experiments involving channel 
agonists or antagonists, recordings were performed on the same cell before and after the 
addition of a compound. 
Current Clamp: Firing rate was determined for each cell in each drug condition using 
the ‘Threshold Search’ mode in Clampfit 10. Resting potential, firing threshold, 
amplitude, peak depolarisation, peak hyperpolarisation, time to peak, repolarisation 
time, area under the graph and action potential duration were calculated for each cell in 
each drug condition using the statistics feature of Clampfit 10. Mean values and 
standard errors were calculated using Excel.  
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Voltage Clamp: Recordings were filtered offline using a 3 point lowpass boxcar filter. 
I/V relationships were generated in Clampfit 10 using the Quick-Graph feature. Data 
was exported to Excel and the mean peak current and S.E.M. were calculated for each 
drug condition. Whole cell capacitance was recorded from the membrane test feature in 
Clampex 10 prior to compensation.  
 
2.2.4     Calcium Imaging 
Calcium green-1 AM (ThermoFisher) was loaded into cells to assess changes in 
cytoplasmic Ca2+ concentration. A 1 mg/ml stock solution of Calcium Green-1 AM was 
formulated in loading medium containing 48 µl DMSO (Sigma) and 2 µl 20% w/v 
Pluronic F-127 (Sigma). 2-3 days after passage, AtT20 cells were loaded with a final 
concentration of 5 µg/ml Calcium Green-1 AM for 20 minutes at 37oC in culture 
medium. Cells were washed 5 times with PBS pre-warmed to 37oC and transferred to 35 
mm culture dishes. Recording was performed in extracellular solution (as formulated in 
2.2.2) at room temperature (21oC) using an Olympus IX71 microscope (10x objective, 
NA 0.3) and a 470 nm pE-100 light emitting diode (CoolLED). Fields of cells were 
recorded for 40 seconds using a Qi Click USB camera (QImaging) at 5 frames per 
second with a gain of 20. Data was collected using WinFluor v3.8. To investigate 
calcium spiking in different conditions the following drugs were added where stated: 
TTX (1 µM), Nifedipine (10 µM), ω-conotoxin GVIA (1 µM), ML 218 (1 µM).  
Data Analysis: Manual regions of interest were drawn around cells in ImageJ. Data was 
then imported to Clampfit 10 for the calculation of wave frequency, duration, amplitude 
and time between waves. Graphs were portrayed as the proportional change in 
fluorescence from baseline (ΔF/F). The area under the graph was calculated in Excel 
using the Riemann summing method of numerical integration using ΔF/F values.  For 
all Calcium Green-1 experiments the means from each of 3 experiments were calculated 
from 50 cells in each experiment. These 3 values were then averaged to give an overall 
mean and S.E.M. 
 
2.2.5     Simultaneous Electrophysiology & Fluorescence Imaging 
Simultaneous cell attached recording and fluorescent calcium imaging was performed 
using an Axopatch 200B amplifier at a 10 kHz frequency using an miDAQ USB6002 
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digital acquisition system (Molecular Devices). Data was recorded using WinFluor 
v3.8. The experiment was repeated 6 times. Pipettes and the bath contained extracellular 
solution as described in 2.2.2 and were pulled to a resistance of 2-4 MΩ. Imaging was 
performed as described in 2.2.4. 
Data Analysis: Data was filtered off-line using a 60 Hz low pass filter. Data was 
exported from WinFluor to Excel for analysis. Fluorescence and current clamp data was 
normalised between 0 and 1 to allow for easier comparison. Spikes in membrane 
potential were identified by eye and data points from exactly 1 second before the spike 
to 3 seconds after were averaged to obtain a mean time course for both fluorescence 
intensity and spikes in membrane potential.  
 
2.2.6     Immunofluorescence Staining 
Coverslips containing AtT20 cells were washed in PBS pre-warmed to 37oC before 
fixation in 4% paraformaldehyde for 10 minutes at room temperature (21oC). 3 washes 
with ice cold PBS were performed before permeabilisation with 0.1% Triton X-100 for 
10 minutes at 21oC. Coverslips were washed for 3x 5 minute washes with PBS 
containing 0.1% Tween-20 at 21oC before a 30 minute incubation at 21oC in PBS 
containing 1% BSA and 0.1% Tween-20 to prevent non-specific antibody binding. 
Primary antibody incubation was performed at 21oC for 1 hour in PBS containing 1% 
BSA and 0.1% Tween-20. Coverslips were washed 3x for 5 minutes with PBS 
containing 0.1% Tween-20 at 21oC. Secondary antibody incubation was performed for 1 
hour in the dark at 21oC in PBS containing 1% BSA. All secondary antibodies were 
conjugated with AlexaFluor fluorescent dyes. Coverslips were then washed 3x for 5 
minutes with PBS in the dark at 21oC before mounting on glass microscope slides with 
the mounting medium Mowiol® 4-88 and sealing with nail polish. Slides were stored at 
4oC until analysis. All reagents were acquired from Sigma Aldrich and all antibodies 
were from Abcam unless stated. The antibodies used were: mouse anti-ACTH with a 
rabbit anti-mouse AlexFluor-488 secondary; rabbit anti-CaV1.3 with a goat anti-rabbit 
AlexaFluor-647 secondary. 
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2.2.7     Microscopy 
Light & Fluorescence Microscopy: An IX71 fluorescent microscope (Olympus) was 
used in combination with either a white light or a pE-100 470 nm LED excitation source 
(CoolLED) and a 10x objective lens. Data was acquired using WinFluor v3.8. 
Confocal Microscopy: Fixed coverslips were imaged using a TCS SP5 II confocal 
microscope (Leica) with a 63x oil objective (NA 1.3). Samples were excited using an 
argon or white light laser. Images were collected using a Hamamatsu camera with 3x 
frame averaging at a resolution of 1024x1024 pixels.  
STED Microscopy: Fixed coverslips were imaged using a TCS SP5 II confocal 
microscope (Leica) with a STED module using a 100x objective lens (NA 1.4). An 
Argon laser at 488 nm was depleted using a 592 nm STED depletion laser. Pixel size 
was 19.92 nm. Vesicle diameter calculations were performed in ImageJ using manual 
areas of interest. 
 
2.2.8     Drugs & Compounds 
All drugs were diluted from concentrated stock solutions and pipetted directly into the 
bath solution or culture medium at concentrations determined from the literature. All 
were purchased from Tocris unless otherwise stated. 
 
2.2.9     Graphs & Statistical Analysis 
All graphs and curve fitting were performed using OriginPro 8.5. Statistical analysis 
was performed using an appropriate statistical test in Excel using the XLSTAT plugin 
(t-tests, ANOVAs or KS-tests). The exact test used and their associated significance 
values are reported in the text. Differences were considered statistically significant 
when p <0.05. Asterisks (*) on graphs indicate statistical significance at this p-value. 
Errors bars in all graphs and ± values in the text use the standard error of the mean 
(S.E.M.) which was calculated in Excel. 
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2.3     Results 
 
2.3.1     Characterisation of AtT20 Pacemaking 
2.3.1.1     Confirmation of an AtT20 Phenotype 
To confirm that the cells used during experimentation were functional AtT20s, antibody 
staining against ACTH was performed. Under a light microscope the cells showed a 
morphology typical of AtT20s, being either spindle shaped or triangular with short 
processes extending from each pole (Figure 2.1A). Fluorescent imaging revealed that 
all of the cells in culture stained for ACTH. Staining was primarily localised to a region 
near one pole of the cell (Figure 2.1B). Stimulated Emission Depletion (STED) 
microscopy, a technique to image below the diffraction limit, provided the resolution to 
see ACTH contained within distinct puncta located in regions proximal to the processes, 
analogous to the axon hillock of neurons (Figure 2.1C). The mean diameter of these 
puncta, which were likely to have been ACTH-containing secretory granules, was 
(±S.E.M.) 179 ± 7 nm. A histogram of granule size revealed that their diameter ranged 
from 60-280 nm, with distinct peaks at 80-100 and 160-180 nm (n=108 granules from 1 
cell) (Figure 2.1D). 
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Figure 2.12- ACTH-containing secretory granules in AtT20s. Representative images showing (A) 
AtT20s with a typical spindle or triangular morphology. (B) Cells stained for ACTH showing its 
localisation to a region near one pole of the cell. (C) STED microscopy revealing this region consists of 
small puncta that are likely to be ACTH-containing secretory granules. Image on the right is zoomed-in 
from the blue-outlined region in the left image. The white outline indicates the border of the cell. (D) A 
histogram of vesicle diameter from the STED image from C. Values are binned into 20 nm intervals, i.e. a 
value of 80 nm in the graph includes all vesicles with diameters between 80-99 nm. 
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2.3.1.2     Firing Properties of AtT20s 
To determine the pacemaker properties of AtT20s, cells were analysed under whole cell 
current clamp. 66% of cells spontaneously fired action potentials in culture, with 2 
rhythmic firing patterns being observed. Action potentials were defined as regenerative 
all-or-nothing membrane depolarisations that produced an overshoot beyond 0 mV. 
Cells were either quiescent (n=18), tonic (n=23) or burst firing (n=12) from 53 cells 
tested (Figure 2.2). Quiescent cells generally displayed a more depolarised resting 
membrane potential at -27.89 ± 3.09 mV than tonically firing cells at -38.01 ± 1.37 mV 
(Student's t-test, p=0.0025). Burst firing cells displayed a more hyperpolarised 
membrane potential at -47.2 ± 1.63 mV than tonic cells (Student's t-test, p=0.0002). 
Burst firing, at 0.54 ± 0.16 Hz, was significantly faster than tonic firing, at 0.29 ± 0.06 
Hz (Student's t-test, p=0.02). Hyperpolarisation of quiescent cells could often induce 
firing, though burst firing could not be induced in tonically firing or quiescent cells.  
Current injection elicited single action potentials in all cells tested (n=11) (Figure 2.3A) 
with a mean threshold for firing of -30.43 ± 2.16 mV and a mean peak of +21.18 ± 4.11 
mV before hyperpolarising to -39.8 ± 2.71 mV. Action potentials were slow and broad, 
with the mean time from threshold to repolarisation being 44.7 ± 4.43 ms.  
500 ng/ml of the ACTH stimulant corticotropin releasing hormone (CRH) exhibited no 
effect on membrane potential (Paired t-test, p=0.654) or firing frequency (Paired t-test, 
p=0.646) (n=4) and did not induce firing in quiescent cells up to 10 minutes after 
addition in all cells tested (n=2) (Figure 2.3B, 2.3C). 
Uncertainty remains over whether ACTH secretion is coupled to or uncoupled from 
electrical activity in AtT20s (Surprenant, 1982; Zemkova et al., 2016). In an attempt to 
settle this uncertainty, whole cell capacitance was continuously recorded in whole cell 
voltage clamp from a holding potential of -80 mV. This method can identify secretory 
events via the increase in surface area associated with secretory granule fusion with the 
membrane. The application of 4x 500 ms voltage steps to +10 mV resulted in no change 
in capacitance in any of the cells tested (n=29) (Figure 2.4A). Addition of 1 mM of the 
L-type VGCC agonist Bay K8644, however, caused a response in every cell tested 
(n=5), with a mean increase in capacitance of 0.186 ± 0.058 pF (Figure 2.4B). Given 
the secretory granules were observed to be ~160 nm in diameter, this would indicate the 
fusion of ~231 granules, assuming a specific capacitance of 1 µF/cm2 (Gentet et al., 
2000). 
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Figure 2.23- Spontaneous firing patterns in AtT20s. Representative whole cell current clamp traces 
from (A) quiescent (B) tonic firing and (C) burst firing AtT20 cells in culture. Dotted lines indicate 0 mV. 
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Figure 2.34- Induced Excitability in AtT20s. (A) Representative whole cell current clamp recording 
from a holding potential of -60 mV showing a single action potential upon current injection. 
Representative whole cell current clamp recordings showing the addition of CRH in (B) a firing cell and 
(C) a quiescent cell. Dotted lines indicate 0 mV. 
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Figure 2.45- Capacitance recordings in AtT20s. Representative whole cell voltage clamp recordings 
from a -80 mV holding potential showing changes in membrane capacitance in response to (A) 4x 500ms 
voltage steps to +10 mV and (B) 1 mM BayK 8644.  
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2.3.1.3     Voltage-Gated Ionic Currents in AtT20s 
The voltage gated ionic currents underlying pacemaking were determined using whole 
cell voltage clamp. Mean whole cell capacitance was 14.91 ± 3.24 pF which indicates 
an average cell surface area of 1491 ± 324 µm2 when assuming a specific membrane 
capacitance of 1 µF/cm2 (n=11). All cells tested displayed voltage-gated sodium (NaV) 
and voltage-gated potassium (KV)
 currents in response to positive voltage steps from a 
holding potential of -80 mV (n=11) (Figure 2.5A). These were blocked by the addition 
of 1 µM TTX and 10 mM tetraethylammonium (TEA) respectively (Figure 2.5B, 2.5C, 
2.6A). This revealed the presence of small Ca2+ currents that were blocked by 1 µM of 
the non-specific VGCC blocker CoCl2 (Figure 2.6A, 2.6B).  
To determine the VGCC subtypes that constitute this Ca2+ current density, VGCC 
antagonists were added under whole cell voltage clamp in the presence of 1µM TTX 
(extracellular) and 120 mM Cs-gluconate (intracellular) to block NaV and KV currents 
respectively (Figure 2.6C). Positive voltage steps from holding potentials of -60 and -
80 mV were applied, with the results being analysed via a repeated measures ANOVA 
(n=12). A significant within-subjects difference was observed over the course of the 
experiment, indicating that the drugs were blocking statistically significant proportions 
of the mean peak current, without taking into account the different holding potentials 
(F=97.981, p=0.0001). The Mauchly test indicated that the condition of sphericity was 
not violated (χ2=37.62, p<0.001, ε=0.508). Peak current was denser at -80 mV than -60 
mV though this was not significant (F=0.874, p=0.36). Addition of 10 µM of the L-type 
antagonist nifedipine blocked the majority of the peak current at -60 mV and -80 mV, 
with a significant difference in mean peak current still observed between the two 
(F=12.383, p=0.002). Subsequent co-addition of 1 µM of the N-type antagonist ω-
conotoxin GVIA caused no identifiable difference in current at -60 mV but caused a 
further decrease in current at -80 mV versus nifedipine alone. A difference in peak 
current between -60 mV and -80 mV was still observed under these conditions 
(F=10.394, p=0.004). The I/V relationship at -80 mV was shifted towards a more 
hyperpolarised potential versus nifedipine alone (Figure 2.6D). Further addition of 1 
µM of the T-type antagonist ML218 decreased the peak current at -60 mV and -80 mV 
versus ω-conotoxin and nifedipine combined. A significant difference in peak current 
between -60 and -80 mV was no longer identified (F=4.001, p=0.058). 
A small proportion of the current remained after the addition of all 3 antagonists. This is 
likely comprised of P/Q type channels as these have been previously identified in 
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AtT20s (Figure 2.6C) (Mackie et al., 1995). Figure 2.6E shows the relative proportion 
of the peak current that is blocked by each VGCC antagonist from a -80 mV holding 
potential. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.56- Voltage-gated currents in AtT20s. (A) Representative whole cell voltage clamp recording 
showing voltage-gated currents in AtT20 cells (B) Negative peak current I/V relationship before and after 
the addition of 1 µM TTX. (C) Positive peak current I/V relationship before and after the addition of 10 
mM TEA. N=11. Error bars ± S.E.M. 
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Figure 2.67- VGCC currents in AtT20s. Representative whole cell current clamp recordings from a -80 
mV holding potential from the same cell showing (A) a small inward current in the presence of TTX and 
TEA that (B) was blocked by CoCl2 (C) Mean peak Ca2+ currents from two different holding potentials 
before and after block with various subtype-specific VGCC antagonists (n=12) (D) Mean I/V 
relationships from a -80 mV holding potential before and after addition of each antagonist (n=12) (E) 
Graphical representation of the percentage of peak current blocked by each antagonist from a -80 mV 
holding potential. Error bars ± S.E.M. *indicates statistical significance between subjects using a repeated 
measures ANOVA at p<0.05. 
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2.3.1.4     Calcium Waves in AtT20s 
To determine the role of voltage-gated Ca2+ currents in pacemaking, AtT20 cells were 
loaded with the fluorescent cytoplasmic fluorescent Ca2+ indicator Calcium Green-1 
(Figure 2.7A). During 40 second fluorescence intensity recordings 88 ± 1.8% of cells 
showed regular spikes in their intracellular Ca2+ concentration at a mean frequency of 
0.19 ± 0.02 Hz (Figure 2.7B). This frequency showed no statistical difference from the 
frequency of action potential firing (Student's t-test vs tonically firing cells, p=0.193). 
These were termed "Ca2+ waves." 76 ± 3.6% of cells still produced waves after block of 
NaV channels with 1 µM TTX in the extracellular solution. This addition caused a 
noticeable shift in wave properties (Figure 2.7C). Ca2+ waves decreased in frequency 
(Student's t-test, p=0.012) (Figure 2.8A), increased in amplitude (Student's t-test, 
p=0.045) (Figure 2.8B), increased in duration (Student's t-test, p=0.001) (Figure 2.8C) 
and had a longer inter-wave interval (Figure 2.8D) (Student's t-test, p=0.0004) than 
controls before the addition of TTX (n=3). 
As an estimate of total Ca2+ influx, the area under the Ca2+ waves was calculated (n=3). 
The mean area under individual waves noticeably increased in the presence of 1 µM 
TTX compared to controls (Student's t-test, p=0.003) (Figure 2.9A). This was clearly 
seen after averaging the wave shape in both conditions (n=50 cells from 1 repeat) 
(Figure 2.9B). Interestingly, the mean area under the graph across the whole 40 second 
recording period was not statistically different from controls (Student's t-test, p=0.34) 
(n=3) (Figure 2.9C).   
To determine whether TTX-dependent waves precede or follow an action potential, 
AtT20s were clamped in the cell attached configuration after Calcium Green-1 loading 
(Figure 2.7D). Current clamp revealed brief spikes in membrane potential that were 
followed by longer duration changes in Calcium Green-1 fluorescence. These transients 
started at the onset of a membrane potential spike, with no difference in onset time 
observed between the two (Student's t-test, p=0.28). Ca2+ waves lasted for a mean 
duration of 2.58 ± 0.6 seconds. Peak fluorescence intensity lagged behind the peak in 
membrane potential by a mean of 0.33 ± 0.08 seconds (n=6). The 0.2s frame rate and 
the response time of the dye should be taken into consideration. Despite this it seems 
unlikely that TTX-dependent Ca2+ waves are preceding action potentials, instead 
occurring simultaneously with or after their initiation. 
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Figure 2.78- Intracellular Ca2+ waves in AtT20s. (A) Representative fluorescence images from an 
AtT20 cell loaded with Calcium Green-1 that is producing a Ca2+ wave. Representative bleach corrected 
ΔF/F traces from separate cells (B) before and (C) after the addition of 1µM TTX. (D) Graph showing the 
average shape and onset time of membrane potential changes and Ca2+ waves after Calcium Green-1 
loading (n=6). 
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Figure 2.89- The effect of TTX on Ca2+ waves - I. Graphs from AtT20 cells loaded with Calcium Green-
1 showing means for (A) wave frequency (B) wave amplitude (C) wave duration and (D) the mean 
interval between waves before and after the addition of 1 µM TTX (n=3 for all conditions). Error bars ± 
S.E.M. *indicates statistical significance using two-way Student's t-tests at p=0.05. 
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Figure 2.910- The effect of TTX on Ca2+ waves - II. Graphs from AtT20 cells loaded with Calcium 
Green-1 showing (A) the mean area under individual Ca2+ waves (n=3) (B) the average wave shape from 
1 experiment (50 cells from 1 repeat) and (C) the mean total area under the graph before and after the 
addition of 1 µM TTX (n=3). Error bars ± S.E.M. *indicates statistical significance two-way Student's t-
tests at p=0.05. 
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2.3.2     The Role of L-, N- & T-type Channels in AtT20 Pacemaking 
2.3.2.1     The Role of L-type Channels 
To determine the role of L-type VGCCs in pacemaking, an L-type agonist and 
antagonist were applied to cells during whole cell current clamp recording. Addition of 
10 µM of the L-type antagonist nifedipine caused a membrane hyperpolarisation that 
was found to not be statistically different from controls (Paired t-test, p=0.29) and 
caused action potential firing to cease in all cells tested (n=4) (Figure 2.10A). Addition 
of 1 mM of the L-type agonist Bay K8644 caused an equal and opposite effect. A 17.5 ± 
2.8 mV depolarisation of the membrane occurred that was statistically significant from 
controls (Paired t-test, p=0.024) and action potential firing ceased in all cells (n=3) 
(Figure 2.10C).  
To determine whether NaV and KV currents were affected by the addition of the drug, 
positive voltage steps from a -80 mV holding potential were applied under whole cell 
voltage clamp. The addition of 10 µM nifedipine caused no change in NaV current but 
caused a reduction in KV current (n=4) (Figure 2.10B). No effect on the I/V 
relationships of NaV or KV channels was found upon the addition of 1 mM Bay K8644 
(n=3) (Figure 2.10D).  
To determine whether L-type VGCCs were driving Ca2+ waves, AtT20 cells were 
exposed to nifedipine after Calcium Green-1 loading. Addition of 10 µM nifedipine 
blocked Ca2+ waves observed during 40 second fluorescence intensity recordings in all 
cells tested (Figure 2.11A, 2.11B) and drastically reduced the mean total area under the 
graph (Student's t-test, p<0.001) (n=3) (Figure 2.11C). 
The L-type subtype CaV1.3 is often expressed in pacemaker cell types. To determine 
whether these channels are present in AtT20s, cells were stained using an anti-CaV1.3 
primary antibody (n=3). Fluorescence was identified in all AtT20 cells in culture, 
indicating the presence of CaV1.3 (Figure 2.11D). To ensure the observed fluorescence 
was not due to non-specific staining of either the primary or secondary antibody, 
controls were performed with the primary antibody only, secondary antibody only and 
with both antibodies + an antigen against CaV1.3. No staining was observed in any of 
the controls (Supplementary 2.2). 
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Figure 2.1011- The effect of nifedipine and Bay K8644 on pacemaking. Representative whole cell 
current clamp recordings showing (A) the addition of 10 µM nifedipine and (C) the addition of 1 mM Bay 
K8644. Mean I/V relationships for NaV and KV currents before and after the addition of (B) 10 µM 
nifedipine (n=4) and (C) 1 mM BayK8644 (n=3) Error bars ± S.E.M. 
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Figure 2.1112- Ca2+ waves are L-type dependent. Representative bleach corrected ΔF/F traces from 
AtT20 cells loaded with Calcium Green-1 showing Ca2+ waves in separate cells (A) before and (B) after 
the addition of 10 µM nifedipine. (C) The mean total area under the graph from bleach corrected 
fluorescence traces before and after the addition of 10 µM nifedipine (n=3). (D) Representative confocal 
image of AtT20 cells antibody stained against the L-type VGCC subtype CaV1.3. Error bars ± S.E.M. 
*indicates statistical significance using a two-way Students t-test at p=0.05. 
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2.3.2.2     The Role of N-Type Channels 
The N-type selective VGCC antagonist ω-conotoxin GVIA was applied to AtT20 cells 
under whole cell current clamp to determine the role of N-type VGCCs in pacemaking 
(n=3) (Figure 2.12A). Addition of 1 µM of the drug caused no change in resting 
membrane potential (Paired t-test, p=0.997) or firing rate (Paired t-test, p=0.371) 
(Figure 2.12B). To determine the effect of ω-conotoxin GVIA on NaV and KV currents, 
positive voltage steps from a -80 mV holding potential were applied under whole cell 
voltage clamp. No effects on NaV or KV current density or I/V relationships were 
identified when compared to controls before the addition of the drug (n=3) (Figure 
2.12C, 2.12D). Figure 2.12E and 2.12F show example whole cell voltage clamp 
recordings from a -80mV holding potential before (in the presence of 10 µM nifedipine, 
1 µM TTX and 120 mM Cs-gluconate) and after the addition of 1 µM ω-conotoxin 
GVIA, demonstrating the presence of an N-type current. 
To determine the role of N-type channels in the generation of Ca2+ waves, AtT20 cells 
were loaded with Calcium Green-1. Waves continued in the presence of 1 µM ω-
conotoxin GVIA (Figure 2.13A, 2.13B) with no statistical difference in mean 
frequency (p=0.109) (Figure 2.13C), amplitude (p=0.681) (Figure 2.13D), duration 
(p=0.587) (Figure 2.13E) or inter-wave interval (p=0.408) (Figure 2.13F) when tested 
using a two-way Student's t-test (n=3).  
The area under individual Ca2+ waves upon the addition of 1 µM ω-conotoxin GVIA 
was not statistically different from controls before the addition of the drug (n=3) 
(Student's t-test, p=0.756) (Figure 2.14A), though a slight change in the average wave 
shape did appear to occur (n=50 cells from 1 repeat), which may be due to the slight 
differences in wave amplitude (Figure 2.14B). There was also no statistical difference 
in the mean total area under the graph when compared to controls before the addition of 
the drug (Student's t-test, p=0.97) (n=3) (Figure 2.14C). 
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Figure 2.1213- The effect of ω-conotoxin GVIA on pacemaking. (A) Representative whole cell current 
clamp recording showing the addition of 1 µM ω-conotoxin GVIA. The dotted line indicates 0 mV. (B) 
Graph showing the mean firing frequency from cells before and after the addition of the drug (n=3). Mean 
I/V relationships for (C) NaV currents and (D) KV currents before and after addition of the drug (n=3).  
Representative whole cell voltage clamp recordings from a -80 mV holding potential showing the same 
cell (E) before and (F) after the addition of ω-conotoxin GVIA. Error bars ± S.E.M. 
72 
 
0.00
0.05
0.10
0.15
W
a
v
e
 F
re
q
u
e
n
c
y
 (
H
z
)
Control 1M -CTX GVIA
0.0
0.2
0.4
0.6
1 M -CTX
W
a
v
e
 A
m
p
lit
u
d
e


F
/F
)
Control
E
0
3
6
9
1 M -CTX
W
a
v
e
 D
u
ra
ti
o
n
 (
s
)
Control
0
2
4
1 M -CTX
W
a
v
e
 I
n
te
rv
a
l 
(s
)
Control
0.00
0.05
0.10
0.15
W
a
v
e
 F
re
q
u
e
n
c
y
 (
H
z
)
Control 1M -CTX GVIA
0.0
0.2
0.4
0.6
1 M -CTX
W
a
v
e
 A
m
p
lit
u
d
e


F
/F
)
Control
0
3
6
9
1 M -CTX
W
a
v
e
 D
u
ra
ti
o
n
 (
s
)
Control
F
0
2
4
1 M -CTX
W
a
v
e
 I
n
te
rv
a
l 
(s
)
Control
0.00
0.05
0.10
0.15
W
a
v
e
 F
re
q
u
e
n
c
y
 (
H
z
)
Control 1M -CTX GVIA
C
0.0
0.2
0.4
0.6
1 M -CTXW
a
v
e
 A
m
p
lit
u
d
e


F
/F
)
Control
0
3
6
9
1 M -CTX
W
a
v
e
 D
u
ra
ti
o
n
 (
s
)
Control
0
2
4
1 M -CTX
W
a
v
e
 I
n
te
rv
a
l 
(s
)
Control
0.00
0.05
0.10
0.15
W
a
v
e
 F
re
q
u
e
n
c
y
 (
H
z
)
Control 1M -CTX GVIA
D
0.0
0.2
0.4
0.6
1 M -CTXW
a
v
e
 A
m
p
lit
u
d
e


F
/F
)
Control
0
3
6
9
1 M -CTX
W
a
v
e
 D
u
ra
ti
o
n
 (
s
)
Control
0
2
4
1 M -CTX
W
a
v
e
 I
n
te
rv
a
l 
(s
)
Control
0 20 40
0.0
0.2
0.4

F
/F
Time (s)
A
0 20 40
0.0
0.2
0.4

F
/F
Time (s)
+1M -CTX GVIA
B
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1314- The effect of ω-conotoxin GVIA on Ca2+ waves - I. Representative bleach-corrected 
ΔF/F traces from AtT20 cells after Calcium Green-1 loading (A) before and (B) after the addition of 1 
µM ω-conotoxin GVIA (n=3). Graphs showing mean values for (C) wave frequency (D) wave duration 
(E) wave amplitude and (F) interval between waves before and after the addition of the drug (n=3 
repeats). Error bars ± S.E.M. 
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Figure 2.1415- The effect of ω-conotoxin GVIA on Ca2+ waves - II. Graphs from AtT20 cells loaded 
with Calcium Green-1 before and after the addition of 1 µM ω-conotoxin GVIA showing (A) the mean 
area under individual Ca2+ waves (n=3) (B) the average wave shape before and after addition of the drug 
(n=50 cells from 1 repeat) and (C) the mean total area under the graph (n=3). Error bars ± S.E.M. 
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2.3.2.3     The Role of T-Type Channels 
The T-type antagonist ML218 was added during whole cell current clamp recording to 
determine the role of T-type VGCCs in AtT20 pacemaking (n=4). All action potential 
firing ceased within 2-3 minutes of the addition of 1 µM ML218 (Figure 2.15A). No 
effect on membrane potential was observed when compared to controls before the 
addition of the drug (Paired t-test, p=0.921).  
To determine any effect of ML218 on NaV and KV currents, positive voltage steps from 
a -80 mV holding potential were applied under whole cell voltage clamp (n=4). No 
change in the I/V relationship was seen for NaV or KV currents after the addition of the 
drug. (Figure 2.15B, 2.15C). 
As T-type currents have not previously been identified in AtT20s, attempts were made 
to isolate this current. NaV and KV currents were blocked with TTX (1 µM) and Cs-
gluconate (120 mM in the intracellular solution) respectively. After block of L-type 
channels with nifedipine (10 µM) and N-type channels with ω-conotoxin GVIA (1 µM) 
the addition of ML218 (1 µM) caused a reduction in the remaining current, indicating 
the presence of T-type channels (Figure 2.15D, 2.15E). 
To determine the role of T-type channels in the generation of Ca2+ waves, AtT20 cells 
were loaded with Calcium Green-1 AM (n=3). A shift in wave modality similar to the 
addition of TTX was seen upon the addition of 1 µM ML218 (Figure 2.16A, 2.16B). A 
decrease in the mean wave frequency compared to controls was observed (Figure 
2.17A) while no clear change was observed in mean wave amplitude (Figure 2.17B), 
duration (Figure 2.17C) or interval between waves (Figure 2.17D) compared to 
controls before the addition of the drug.  
Since blocking T-type channels prevented action potential firing it was hypothesised 
that block of NaV channels would no longer have an effect on Ca
2+ waves. Surprisingly, 
the co-addition of 1 µM TTX and 1 µM ML218 caused another shift in modality, with 
waves becoming disordered and smaller in amplitude (Figure 2.16C). One-way 
ANOVAs between controls and each drug condition showed a significant effect of drug 
condition on wave frequency (F=13.391, p=0.006), wave amplitude (F=7.475, 
p=0.023), wave duration (F=7.578, p=0.023) and time between waves (F=8.907, 
p=0.016). Performance of a Tukey comparison test showed a significant decrease in 
wave frequency between the controls and ML218 as well as controls and co-addition, 
but no significant difference between ML218 alone and co-addition (Control/ML218, 
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p=0.006; control/ML218+TTX, p=0.025; ML218/ML218+TTX, p=0.42) (Figure 
2.17A). Mean wave amplitude was not significantly different between controls and 
ML218 nor between ML218 and co-addition, but was significantly decreased between 
controls and co-addition (control/ML218, p=0.381; control/ML218+TTX, p=0.02; 
ML218/ML218+TTX, p=0.112) (Figure 2.17B). Mean wave duration was significantly 
decreased between controls and ML218 as well as controls and co-addition, but no 
significant difference was seen between ML218 and co-addition (controls/ML218, 
p=0.049; controls/ML218+TTX, p=0.026; ML218/ML218+TTX, p=0.865) (Figure 
2.17C) Mean time between waves was not significantly different between controls and 
ML218, but was significantly increased between controls and co-addition and ML218 
and co-addition (controls/ML218, p=0.862; controls/ML218+TTX, p=0.019; 
ML218/ML218+TTX, p=0.035) (Figure 2.17D) compared to ML218 alone was 
observed (n=3). 
One-way ANOVAs were performed to determine the effect of drug condition on Ca2+ 
wave area. A statistically significant effect of drug condition was seen for both single 
wave area and mean total area under the graph (single wave area, F=4.376, p=0.015; 
total area, F=7.459, p=0.024). Performance of a Tukey comparison test showed that 
single wave area was not significantly different between controls and ML218 nor 
ML218 and co-addition, but was significantly decreased between controls and co-
addition (controls/ML218, p=0.886; controls/ML218+TTX, p=0.06; 
ML218/ML218+TTX, p=0.018) (Figure 2.18A) (n=3). The mean total area under the 
graph was significantly decreased between controls and ML218, controls and co-
addition and between ML218 and co-addition (controls/ML218, p=0.016; 
controls/ML218+TTX, p=0.002; ML218/ML218+TTX, p=0.043) (Figure 2.18C) 
(n=3).  Averaging the Ca2+ wave shape in all conditions showed a slight decrease in 
amplitude in the presence of ML218 and a much larger decrease in amplitude upon the 
addition of both drugs (n=50 cells from 1 repeat) (Figure 2.18B). 
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Figure 2.1516- The effect of ML218 on pacemaking. (A) Representative whole cell current clamp 
recording showing the cessation of pacemaking after the addition of 1 µM ML218. Dotted line indicates 0 
mV. Mean I/V relationships before and after the addition of ML218 for (B) KV currents and (C) NaV 
currents (n=4). Error bars ± S.E.M. Representative whole cell voltage clamp recordings from a -80 mV 
holding potential showing Ca2+ currents from the same cell (D) before and (E) after the addition of 
ML218. 
 
 
77 
 
0 20 40
0.0
0.2
0.4

F
/F
T im e (s )
0 20 40
0.0
0.2
0.4

F
/F
T im e (s)
+ 1M  M L218
0 20 40
0.0
0.2
0.4

F
/F
Tim e (s )
+1M  M L218
+1M  TT X
A
B
C
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1617- The effect of ML218 on Ca2+ waves. Representative fluorescence recordings showing 
different cells (A) before and (B) after the addition of ML218, and (C) after the addition of ML218 and 
TTX.  
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Figure 2.1718- The effect of ML218 on Ca2+ wave properties - I. Graphs showing mean values for (A) 
wave frequency (B) wave amplitude (C) wave duration and (D) interval between waves for AtT20 cells 
before and after the addition of ML218 alone or the co-addition of ML218 and TTX (n=3). Error bars ± 
S.E.M. *indicates statistical significance using a Tukey comparison test at p=0.05. 
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Figure 2.1819- The effect of ML218 on Ca2+ wave properties - II. Graphs showing (A) the mean area 
under individual Ca2+ waves (n=3) (B) the average wave shape (n=50 cells from 1 repeat) and (C) mean 
total area under the graph for AtT20 cells loaded with Calcium Green-1 (n=3 repeats for each condition). 
All graphs show cells before and after the addition of ML218 alone or the co-addition of ML218 and 
TTX. Error bars ± S.E.M. *indicates statistical significance using a Tukey comparison test at p=0.05. 
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2.4     Discussion 
The experiments described here examined the role of various VGCC subtypes in 
generating pacemaking in AtT20 anterior pituitary corticotrophs. Through the data 
presented, I show that many AtT20s displayed spontaneous action potentials which 
were TTX and nifedipine sensitive, as has been previously described in the literature 
(Adler et al., 1983). The ACTH secretagogue CRH did not cause membrane potential 
changes, unlike the changes seen in corticotrophs in-vivo. This supports previous 
evidence suggesting that secretion is uncoupled from electrical activity in AtT20s 
(Surprenant, 1982). This is backed here by capacitance recordings which suggest that 
secretion is instead instigated by a general increase in intracellular Ca2+.  
Here I show that rhythmic increases in the cytoplasmic Ca2+ concentration, termed "Ca2+ 
waves," underlie pacemaking. Previous literature has suggested that these waves were 
not affected by the addition of TTX, hence the waves are action potential independent 
and occur below the threshold for firing (Fiekers & Konopka, 1996). My data dispute 
this, with TTX causing a shift in wave properties, increasing their amplitude and 
duration while decreasing their frequency. The finding that both modalities were 
nifedipine sensitive confirms previous studies that suggest pacemaking is L-type 
channel dependent.  
Both N-type and T-type VGCCs were identified here in whole cell voltage clamp 
experiments. N-type and P/Q-type channels have previously been identified using a 
similar approach (Mackie et al., 1995), though the presence of T-type channels had only 
been suggested through simulations (LeBeau et al., 1997). Whether or not these 
subtypes are involved in AtT20 pacemaking had not been investigated. Here I identify a 
novel role for T-type VGCCs in AtT20 pacemaking, with them being critical for the 
generation of action potentials. Considering the voltage-activation properties of T-type 
channels are shifted towards hyperpolarised potentials, similar to CaV1.3 they are ideal 
for subthreshold activation (Perez-Reyes et al., 1998). Although T-type channels are not 
instigating Ca2+ waves in AtT20s (as block of L-type VGCCs completely eliminates 
them) they nevertheless have a small but critical role in their shaping as seen by the 
changes in wave shape and area upon the addition of ML218. In AtT20s these channels 
are likely opening close to the firing threshold, providing enough of a change in 
membrane potential to allow NaV channel activation. In support, they have been 
identified in corticotrophs in-vivo and in other pacemaking cell types performing just 
this purpose (Guérineau et al., 1991; Matschke et al., 2015). A role for NaV channels in 
81 
 
the subthreshold shaping of Ca2+ waves was also identified, as seen by the change in 
mean total area under the graph upon the co-addition of ML218 and TTX. N-type 
channels appeared to play no role in pacemaking. This subtype is rarely seen to 
contribute to pacemaking in other cell types and is most often associated with the 
process of exocytosis in neuronal cell types (Lévêque et al., 1994). 
 
 
2.4.1     Characterisation of AtT20 Pacemaking 
2.4.1.1     Confirmation of an AtT20 Phenotype 
Before detailed characterisation of pacemaking could occur it was important to validate 
that the cell line being used displayed the correct phenotype. Antibody staining for 
ACTH was selected to determine this as corticotrophs (and AtT20's) are characterised 
by its expression. AtT20s have previously been shown to stain for ACTH at their poles 
and in the cell body near the start of processes (Baldini et al., 1998). The same 
observation was made here, indicating cells of the same phenotype. STED microscopy 
provided the resolution to see individual puncta, which were likely to be ACTH-
containing secretory granules. This can be taken as an indicator that the cells are 
functional, as the production of ACTH along with the packaging, transportation and 
docking of a readily releasable pool of secretory granules requires a range of cellular 
processes to be in order.  
Granule diameter appeared to be distributed into two main peaks at 80-100 nm and 160-
180 nm. This could indicate the presence of two populations of "small" and "large" 
granules. Corticotrophs are known to contain large, dense-core granules that contain 
ACTH (Kurosumi et al., 1966). Pituitary cells also secrete other molecules such as beta-
endorphin and beta-lipotropin (Gumbiner & Kelly, 1981). The granule sizes identified 
here may therefore represent different secretory cargoes. Another explanation for the 
peak at 80-100 nm is that vesicles below the STED diffraction limit (which is 30-50 nm 
in theory though is often higher in practice) are being diffraction-limited to a size of 80 
nm, hence artificially inflating the number of 80-100 nm granules. No previous 
literature has demonstrated secretory granules in this cell type at STED resolution. 
Previous studies using electron microscopy have stated the presence of large, dense core 
secretory granules ranging in size from 500-1000 nm in primary corticotrophs 
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(Kurosumi & Kobayashi, 1996). The results here therefore provide new information on 
the size, number and location of secretory granules in AtT20s. 
 
2.4.1.2     Firing Properties of AtT20s 
Two modalities of AtT20 pacemaking, tonic firing and burst firing, have been 
previously described in the literature (Adler et al., 1983). The results here confirm that 
finding. These different modalities could also be identified by their resting potential, 
with quiescent cells having a more depolarised membrane than tonic cells and bursting 
cells having a more hyperpolarised membrane than tonic cells. Hyperpolarising 
quiescent cells could often induce firing, though tonic cells could not be made to burst 
fire. This indicates that membrane potential isn't the only determinant of firing 
modality. Complex variations in ion channel expression are a likely explanation, which 
is backed by computer-based models of excitability (LeBeau et al., 1997). The resting 
potentials described here are somewhat lower than those described in the literature, 
which has stated a resting potential of -55 mV. Bursting cells described here had a 
resting potential close to this at -47 mV. These discrepancies could be due to cell-cell 
variability, differences in temperature or differences in liquid junction potentials. 
A previous study observed CRH-induced changes in membrane potential and firing rate 
in AtT20s (Zemkova et al., 2016). Here I found that CRH had no effect on pacemaking. 
It is worth noting that CRH has both long and short term effects in primary 
corticotrophs, stimulating the release and production of ACTH over minutes to hours. 
The 10 minute recording period used here may not have been enough to determine long 
term effects. A disconnect between excitability and hormone secretion in AtT20s has 
also been described in the literature, perhaps explaining the lack of effect of CRH 
(Surprenant, 1982). Capacitance recording was used to attempt to determine whether 
secretion of ACTH is coupled to electrical activity. Capacitance is a measure of 
membrane surface area, with membrane having a specific capacitance of between 0.8 
and 1 µF/cm2 (Gentet et al., 2000). Fusion of a number of small secretory granules can 
therefore be detected as an increase in capacitance. No capacitance changes were 
observed here in response to membrane depolarisation indicating that secretion is likely 
disconnected from electrical activity. BayK 8644, a VGCC agonist, did induce a change 
in capacitance. This has previously been reported in the literature (Heisler, 1985) and 
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indicates that secretion is likely coupled to the intracellular Ca2+ concentration rather 
than directly to pacemaking. 
 
2.4.1.3     Voltage-Gated Ionic Currents in AtT20s 
Here I show the presence of TTX-sensitive NaV and TEA-sensitive KV
 currents that 
underlie pacemaking. Various subtypes of VGCCs were also identified, such as L-type, 
N-type channels. These are of the same proportions of the total current to those seen in a 
similar study using channel antagonists (Mackie et al., 1995). A small T-type current 
was also identified in AtT20s, which although identified in primary corticotrophs has 
previously only been suggested through computer-based modelling (LeBeau et al., 
1997; Matschke et al., 2015).  
When determining the presence of VGCC subtypes it was important to take into account 
the selectivity of channel antagonists for other subtypes. ω-conotoxin GVIA for 
example, apart from selectivity for N-type channels, has a moderate selectivity for L-
type channels (Mcleskey et al., 1987) and some T-type antagonists can have effects on 
NaV channels (Strege et al., 2005). The concentrations of the antagonists used and the 
order they were applied were carefully selected in an attempt to minimise non-specific 
channel block, though its occurrence should not be discounted. KV, NaV and VGCC I/V 
relationships are shown in many figures in an to attempt to show transparency over this 
potential issue. 
Two holding potentials were used in Figure 2.5C as further confirmation that the 
correct channel types were being blocked. N-type and T-type channels are activated 
from lower holding potentials than L-type channels (Nowycky et al., 1985; Perez-Reyes 
et al., 1998). Hence it was hypothesised that ω-conotoxin GVIA and ML218 should 
block a larger proportion of the current at -80 mV than at -60 mV, an effect that was 
observed in the results. 
 
2.4.1.4     Calcium Spiking in AtT20s 
Here I show that AtT20s exhibited high frequency spikes in their cytoplasmic Ca2+ 
concentration that decreased in frequency but increased in amplitude and duration upon 
the addition of TTX. This likely indicates that Ca2+ waves are entrained by the rate of 
action potential firing. This hypothesis is strengthened by simultaneous cell attached 
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recording and fluorescence imaging that showed the peak fluorescence intensity after 
loading with Calcium Green-1 started at the onset of a membrane potential spike and 
lasted for several seconds afterwards. This contradicts a previous study that showed 
TTX having no effect on Ca2+ waves (Fiekers & Konopka, 1996). The response time of 
the fluorescent dye could provide inaccuracies in this result. Calcium Green-1 has a 
relatively high affinity with a KD of 190 nM (Thomas et al., 2000), indicating a 
relatively fast response time in the 10's of milliseconds at 37oC. However the 
experiments here were performed at 21oC. The expected response time would therefore 
be expected to increase. This, along with the 200 ms frame rate used, means this result 
should be looked at with caution as with a delay in fluorescence peak of 330 ms it may 
lie within the combined response time of the dye and frame rate in the conditions used. 
Given these potential errors it still seems unlikely that Ca2+ waves are occurring a long 
time before an action potential. What is more likely is that the peaks in membrane 
potential and fluorescence intensity lie in much closer proximity than has been 
identified here, with Ca2+ waves occurring simultaneously with or slightly after/before 
an action potential. 
The fact that Ca2+ waves continued in the presence of TTX and were blocked by 
nifedipine indicates that rhythmic L-type waves underlie action potential firing. These 
are likely to be driving rhythmic firing as indicated by the block of pacemaking upon 
the addition of nifedipine. 
Although Calcium Green-1 is not a ratiometric dye and cannot be used to determine an 
exact concentration, its fluorescence increases relatively linearly with Ca2+ binding at 
biological concentrations (Thomas et al., 2000). Hence by calculating the area under the 
graph any changes in the total influx of Ca2+ through VGCCs can be approximated. The 
surprising lack of change in the total area under the graph upon the addition of TTX 
despite a drop in wave frequency can be explained by a compensatory increase in single 
wave area, amplitude and duration. The reason for this change is likely related to the 
uncoupling of Ca2+ entry from action potential firing. The membrane hyperpolarisation 
caused by opening of KV channels during an action potential would normally act to 
inactivate VGCCs, providing a tight window for Ca2+ influx. As this no longer occurs in 
the presence of TTX it means that Ca2+ influx is no longer restricted to entry during this 
window. This could lead to longer duration Ca2+ influx. It could also perhaps lead to 
Ca2+-dependent Ca2+ release from intracellular stores, further increasing the size of 
intracellular Ca2+ waves. Ryanodine receptors have been implicated in secretion in 
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AtT20s, providing some evidence for this possibility (Yamamori et al., 2004). Block of 
VGCCs has previously been shown to reduce AtT20 viability in culture, suggesting that 
Ca2+ influx through these channels is important for cell survival (Loechner et al., 2009). 
Data here suggests the reason for this, where VGCCs are involved in a feedback 
mechanism that retains Ca2+ influx at a set physiological level despite changes in cell 
excitability. Considering that L-type VGCCs are the predominant component of the 
Ca2+ current in AtT20s and block of this channel type prevents all Ca2+ waves it is likely 
that these channels play a major role in this mechanism. 
 
 
2.4.2     The Role of L-, N- & T-type Channels in AtT20 Pacemaking 
2.4.2.1     The Role of L-type Channels 
Data here shows that L-type VGCCs are critical for pacemaking, with their block 
completely abolishing all action potentials and Ca2+ waves. They are also involved in 
the maintenance of the resting membrane potential, shown through the corroborating 
effects of nifedipine (hyperpolarisation) and Bay K8644 (depolarisation). This could 
either be through low-level, persistent activation of L-type channels keeping the Ca2+ 
equilibrium at a point that results in a more depolarised membrane potential; or through 
an indirect effect on the activity of Ca2+-activated K+ channels. K+ channels are known 
to be involved in maintaining the resting membrane potential in the majority of, if not 
all, excitable cells (Peterson & Maruyama, 1984) and Ca2+ dependent K+ channels have 
previously been identified in corticotrophs and AtT20s (Adler et al., 1983; Duncan et 
al., 2015). A reduction in KV current was noticed upon the addition of nifedipine, 
providing some evidence for an effect on Ca2+-dependent K+ channels. L-type channels 
have a major effect on total Ca2+ influx as seen via the area under the graph of the 
fluorescence traces. A decreased concentration of cytoplasmic Ca2+ could be reducing 
K+ channel activity, resulting in membrane hyperpolarisation. However, nifedipine is 
also known to block K+ channels, such as KV and inwardly rectifying K
+ channels, with 
one study citing an effect at ~40 µM (Li et al., 2015). Whether the concentration used 
here, 10 µM, is high enough to affect K+ channels is not known and may be difficult to 
separate from effects on Ca2+ activated K+ channels. The membrane depolarisation seen 
upon the addition of Bay K8644 provides some evidence for the effect of nifedipine 
being due to an effect of Ca2+ channels as opposed to direct block of K+ channels. 
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L-type channels in cardiac cells have been seen to display a 'window current' between -
30 and 0 mV, i.e. voltages at which channels open but do not inactivate completely, 
therefore providing a constant current.  This is suggested to be important for 
maintaining intracellular Ca2+ levels (Hirano et al., 1992). This could provide an 
explanation for their ability to generate Ca2+ waves in AtT20's, with a proportion of 
channels always in an activated state, driving subthreshold membrane potential changes 
to generate rhythmic electrical activity. 
The expression of CaV1.3 in these cells has previously been seen in culture (Loechner et 
al., 2009). This subtype is considered ideal for pacemaking due to their activation 
occurring at potentials that are more hyperpolarised than other L-type VGCCs, making 
them ideal for subthreshold activation. They are found in other pacemaker cells, perhaps 
indicating a conserved feature across many pacemaker types.  
 
2.4.2.2     The Role of N-type Channels 
N-type channels had no statistically significant effects on action potential frequency, 
membrane potential or Ca2+ wave dynamics in the experiments performed here. This 
could be due to the relatively small proportion of the current density that they represent 
(13.99%). It also suggests that no coupling between N-type VGCCs and BK channels is 
occurring as has been identified in other cell types (Loane et al., 2007), as no effect on 
KV current was observed. At this point the role of N-type channels in AtT20s is 
unknown. N-type channels have important roles in exocytosis in other neuronal cell 
types (Millán & Sánchez-Prieto, 2002), a possibility that could also be explored here. 
Performing capacitance measurements in combination with N-type antagonists would 
determine whether N-type VGCCs are involved in secretion in AtT20s. 
 
2.4.2.3     The Role of T-type Channels 
A role for T-type channels in pacemaking had previously been suggested in the 
literature (LeBeau et al., 1997) but had not been experimentally proven. Here I present 
direct evidence of a role for T-type channels in excitability in AtT20s. T-type channels 
have been observed to drive firing in corticotrophs in-vivo and in other cell types such 
as thalamic reticular neurons (Guérineau et al., 1991; Huguenard & Prince, 1992). The 
T-type specific antagonist ML218 prevented action potential firing without affecting the 
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membrane potential. T-type channels have different activation properties than the other 
subtypes described here, being fast activating/inactivating and having an opening 
probability shifted more towards hyperpolarised membrane potentials (Perez-Reyes et 
al., 1997). It is possible, but seems unlikely, that T-type channels are required for the 
generation of action potentials. What is more likely is that they simply enhance and 
shape Ca2+ waves when close to the threshold for firing. This, either by providing a 
larger depolarisation or by increasing dV/dt, acts to push the cell past threshold to cause 
NaV channel activation and hence action potential firing. T-type VGCCs, similar to L-
type, have been observed to produce a window current at hyperpolarised membrane 
potentials (Bijlenga et al., 2000). At resting membrane potentials the majority of 
channels are closed with a small number chronically activated. Slight depolarisations 
can result in massive activation that drives a cell to fire. This chronic activation, if 
present in AtT20s, would also produce a constant subthreshold current and could 
explain how they aid in shaping subthreshold Ca2+ waves. Performing current injection 
would have determined whether action potentials could still be induced in the presence 
of ML218, confirming or refuting a direct involvement of T-type channels in action 
potential generation. 
Block of T-type channels caused changes in Ca2+ wave properties that were similar to 
the addition of TTX, with spiking able to continue at a reduced frequency. Unlike the 
addition of TTX alone, ML218 did not cause an increase in wave amplitude. Block of 
T-type channels would prevent their contribution to Ca2+ influx, perhaps offsetting this 
increase. The co-addition of TTX and ML218 did not cause a further decrease in 
frequency, further indicating that block of T-type channels prevents pacemaking. 
Combined addition did, however, reduce the amplitude, time between waves and the 
total area under the graph from ML218 alone. From this it can be postulated that 
subthreshold NaV channel activation is helping to shape Ca
2+ waves even when the cell 
is not firing. Persistent, subthreshold NaV currents are present in cell types such as 
cerebellar Purkinje neurons, providing some evidence to back this possibility (Carter et 
al., 2012). 
 
2.4.3     Conclusions  
Data here allows for the roles of VGCCs in pacemaking in AtT20s to be described in 
greater detail than is currently in the literature. The likely mechanism is as follows: 
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In the absence of firing, L-type VGCCs, aided by T-type VGCCs and perhaps some 
subthreshold NaV channel activation, produce rhythmic subthreshold Ca
2+ waves. These 
waves retain cytoplasmic Ca2+ concentrations to within a set physiological level that 
promotes cell survival. They also generate membrane potential changes that bring the 
cell close to the firing threshold. When close to this threshold, T-type VGCCs activate. 
This increases the rate of change of membrane potential (dV/dt), allowing for the fast 
activation of TTX-sensitive NaV channels and the generation of an action potential. The 
depolarisation during an action potential acts to open VGCCs, allowing further Ca2+ 
influx. This is followed by their rapid inactivation due to the action potential 
hyperpolarisation. This is caused in part by the Ca2+ influx itself, which may activate 
Ca2+ dependent BK and SK channels. This hyperpolarisation acts to decrease the time 
between Ca2+ waves by rapidly driving the membrane potential back to subthreshold 
values. NaV and Ca
2+ channels are therefore dependent on each other, with VGCCs 
required to maintain an underlying frequency, while NaV channels then entrain Ca
2+ 
waves to the rate of action potential firing to increase this frequency and maintain 
consistent, rhythmic firing. This mechanism also creates a tight window for Ca2+ entry 
into the cell during an action potential, which could also explain the observed 
disconnect between electrical activity and secretion. Since the levels of Ca2+ entering 
the cytoplasm remain relatively consistent whether a cell is active or inactive (due to 
changes in the shape and frequency of NaV entrained vs non-entrained Ca
2+ waves) 
there will be no large increase in Ca2+ to drive Ca2+-dependent exocytosis, which is 
known to be required as shown by the effect of the VGCC agonist BayK 8644 on 
membrane capacitance. This proposed mechanism therefore encapsulates all of the 
results observed within this chapter and is summarised in Figure 2.19. 
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Figure 2.1920- The mechanism of pacemaking in AtT20s. Subthreshold Ca2+ waves generated by L-type 
VGCCs drive membrane potential changes close to the firing threshold. Near the threshold for NaV 
channel opening, T-type VGCCs activate to drive the membrane past the threshold for NaV channel 
opening, generating an action potential. This results in a fast after-hyperpolarisation generated primarily 
by K+ channels that prevents further Ca2+ influx. This acts to decrease the time between Ca2+ waves, 
allowing consistent and rhythmic firing.  
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The Development of Pacemaking in hiPSC-
Derived Dopaminergic Neurons 
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Abstract 
Dopaminergic (DA) neurons of the substantia nigra pars compacta display intrinsic 
pacemaking in-vivo which is believed to be an important factor in their selective death 
in Parkinson’s disease (PD). Human induced pluripotent stem cell (hiPSC)-derived DA 
neurons are a human model of the disease that have previously been shown to display 
pacemaking in-vitro, though the early development of this activity and whether it is 
truly intrinsic rather than synaptically driven has not been determined. Here I have used 
electrophysiology and Ca2+ imaging in combination with pharmacological block of ion 
channels to follow the early development of pacemaking in hiPSC-derived DA neurons 
up to 6 weeks after the onset of differentiation from neural progenitors. The results 
show that pacemaker-like activity developed from 2 weeks post-differentiation, though 
after 6 weeks their electrical properties remained relatively immature. Firing could be 
blocked by glutamate and dopamine D2 receptor antagonists indicating it is driven by 
synaptic input rather than their intrinsic electrical properties. hiPSC-derived DA 
neurons did, however, display a more excitable phenotype than the non-DA cells in the 
same culture, being more likely to fire action potentials and producing spike trains that 
were dependent upon L-type voltage-gated calcium channels (VGCCs). Cultures 
containing hiPSC-derived DA neurons developed regular spikes in their intracellular 
Ca2+ concentration that were sensitive to the voltage-gated sodium channel antagonist 
tetrodotoxin (TTX). These data provide a deeper understanding of pacemaking in this 
disease model, hopefully leading to more targeted, efficient research into the cellular 
mechanisms of PD and any future treatments. 
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3.1     Introduction 
A bottleneck in PD research has been the lack of human models of the disease. 
Although decades of research using rodent and primate models has occurred, we still 
know little about human DA neurons. With the discovery of hiPSCs and their ability to 
be differentiated into various lineages, hiPSC-derived DA neurons have become a 
promising in-vitro model (Takahashi et al., 2007). Performing a detailed 
electrophysiological characterisation of these neurons will potentially provide valuable 
information into the mechanisms of in-vivo cell death in human forms of PD. 
Substantia nigra pars compacta (SNc) DA neurons are characterised by their pacemaker 
activity. This is primarily tonic in nature, with regular single action potentials at 3-8 Hz 
being seen in rat neurons in-vitro. Their activity also appears to be modulated by 
synaptic input, with phasic burst firing seen in the presence of a large quantity of 
synaptic inputs (Grace & Bunney, 1984; Tepper et al., 1998; Guzman et al., 2009). 
These neurons also produce multiple slow, oscillatory action potentials, termed "spike 
trains," in response to current injection in rat models (Grace & Onn, 1989). 
A wide range of ion channels have been implicated in controlling their excitability in rat 
models. This includes voltage-gated sodium (NaV) channels, voltage-gated potassium 
(KV) channels (KV1.3, KV2.1, KV3.2, KV3.3, KV4.3), Ca
2+-activated SK channels (SK1, 
SK2, SK3), BK channels, HCN channels (HCN2, HCN4), L-type (CaV1.3) and T-type 
(CaV3.1, CaV3.3) VGCCs (Dufour et al., 2014). Subthreshold cytoplasmic Ca
2+ waves 
are suspected to act as a driver for this intrinsic excitability (Guzman et al., 2009). 
Inputs onto these cells in rat and guinea pig brain slices are a mix of excitatory 
glutamatergic and inhibitory GABAergic transmission, with D2 autoreceptors allowing 
local negative feedback (Cragg & Greenfield, 1997; Gotz et al., 1997; Lee & Tepper, 
2009). 
Characterisation of pacemaking in hiPSC-derived DA neurons is limited to one major 
study (Hartfield et al., 2014). This study found that these neurons displayed pacemaker 
activity In-vitro that appeared to be spontaneous. They also produced trains of action 
potentials in response to current injection within 6- 12 weeks of differentiation. This 
was accompanied by the development of Ca2+ waves and excitatory spontaneous 
postsynaptic currents (ESPSCs) within the same period. It was suggested by the authors 
that the observed activity is intrinsic, though whether it is instead driven by synaptic 
input was not investigated. Study of these cells from 0-6 weeks post differentiation has 
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also not been performed. It is unknown, for example, when voltage-gated ion channel 
populations characteristic of DA neurons develop or what the synaptic inputs onto these 
neurons are in culture and at what stage they appear and mature. Whether the observed 
activity was specific to DA neurons and not all of the neurons in culture was also not 
considered in this previous study. 
This chapter focuses on how hiPSC-derived DA neurons develop into excitable cells 
capable of pacemaking. Characterisation of electrical activity, Ca2+ spiking, voltage-
gated ion channel currents and synaptic inputs was performed on DA neurons that were 
positively identified as expressing tyrosine hydroxylase (TH). TH is the rate limiting 
enzyme in the production of dopamine, being responsible for the hydroxylation of 
tyrosine into the dopamine precursor L-DOPA. This can then be converted to dopamine 
via aromatic amino acid decarboxylase (Daubner et al., 2011). This experiment was 
performed weekly from 0- 6 weeks post-differentiation from hiPSC-derived neural 
progenitor cells (hNPCs) to produce a time course of their early electrical development.  
My results show that spontaneous firing that is characteristic of SNc DA neurons began 
to develop from 1- 2 weeks post-differentiation. Underlying this excitability was the 
development of voltage gated Ca2+ currents and Ca2+ waves. These waves were found to 
be TTX-sensitive and therefore action potential dependent rather than the subthreshold 
waves that have been reported in primary DA neurons (Puopolo et al., 2007). Firing was 
found to be dependent upon glutamate receptors and dopamine D2 receptors. Excitatory 
spontaneous postsynaptic currents (ESPSCs) were identified from week 2 and were 
blocked by glutamate receptor antagonists. All of this indicates that electrical activity 
during the first 6 weeks of development was not being intrinsically driven. All of the 
above traits showed a clear shift in maturity at week 6, perhaps indicating the 
development of mature synaptic networks at this time point. 
By assessing any differences from DA neurons In-vivo this chapter provides 
information on the strengths and limitations of hiPSC-derived DA neurons as a model 
for PD. It also acts to improve our understanding of pacemaking in human DA neurons, 
leading to more targeted, efficient research into the cellular mechanisms of PD and any 
future treatments. 
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3.2     Methods 
 
3.2.1     Culture & Expansion of Human Neural Progenitors 
The protocols for culture and expansion followed the product description guidelines 
from Axol Bioscience, detailed below. Cells and reagents were from Axol unless 
otherwise stated. Human iPSC-derived neural progenitor cells (hNPCs) originating from 
female new-born cord blood were expanded on sterile 12 well tissue culture plates 
(Corning) pre-coated with SureBond-XF at a density of 80 000/cm2 in plating-XF 
medium. 24 hours after plating, media was replaced with neural expansion-XF medium 
supplemented with 20 ng/ml FGF2 and 20 ng/ml EGF. Cells were passaged every 5 
days and expanded until an optimal quantity were obtained for differentiation. Cells 
were incubated at 37oC and 5% CO2. 
 
3.2.2     Differentiation of hNPCs to Dopaminergic Neurons 
hNPCs were passaged in expansion-XF medium and plated at a density of 30 000/cm2 
onto coverslips pre-coated with SureBond-XF. 24 hours after passage, media was 
changed to STEMdiffTM dopaminergic neuron differentiation medium (STEMcell) 
supplemented with 200ng/ml sonic hedgehog (SHH) (Millipore). Media was changed 
daily for 14 days. The cells were then passaged and plated at a density of 20 000/cm2 
onto glass coverslips pre-coated with SureBond-XF. Media was changed to 
STEMdiffTM dopaminergic neuron maturation medium 1 (STEMcell). Full media 
changes were performed every 48 hours for 5 days. Media was then changed to 
maturation medium 2 (STEMcell) and replaced every 48 hours up to a total culture time 
of 6 weeks. Cells were incubated at 37oC and 5% CO2. Figure 3.1 shows a graphical 
representation of the steps involved in differentiation and the theory behind this 
approach. 
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Figure 3.121- Directed differentiation of NPCs to DA neurons via a neural floor plate lineage. DA 
neurons within the SNc express the floor plate marker LMX1A and roof plate marker FOXA2. hiPSC-
derived NPCs, which are equivalent to cells of the neural tube during embryonic development, can be 
differentiated into DA neurons via the addition of sonic hedgehog (SHH). This promotes expression of 
LMX1A. Subsequent addition of FGF8b induces the co-expression of FOXA2, leading to the generation 
of a DA lineage. Factors such as BDNF, GDNF and cAMP are added to support cell growth and survival. 
(Kriks et al., 2012).  
 
3.2.3     Electrophysiology 
Recordings were performed on 0- 6 week differentiated neurons in the whole cell 
configuration at room temperature (21oC). Data were acquired using Clampex 10 
software on an Axopatch 200B patch clamp amplifier with a 16 bit Digidata 1440A 
digital acquisition system (Molecular Devices) at 20 kHz with a 5 kHz low pass filter. 
Microelectrodes were pulled from borosilicate glass using a Flaming/Brown P-87 
micropipette puller to a resistance of 3-8 MΩ. Extracellular and intracellular solutions 
were formulated identically to those used previously in the literature (Hartfield et al., 
2014): Extracellular (mM): 129 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 30 Glucose, 25 
HEPES, pH 7.4, 310 Osm/kg. Intracellular (mM): 120 K-Gluconate, 25 KCl, 4 MgATP, 
2 NaGTP, 10 EGTA, 1 CaCl2 and 10 HEPES, 295 Osm/kg, pH 7.2. For calcium current 
recordings KCl/Gluconate was replaced with 145 mM Cs-gluconate in the intracellular 
solution and carried out in the presence of 1 µM TTX (Tocris) and 10 mM CaCl2. 1 
mg/ml Lucifer Yellow (Sigma) was added to the intracellular solution immediately prior 
to recording to mark neurons for later cytochemical characterisation. An image of each 
Lucifer Yellow filled cell was taken using an Olympus IX71 microscope with a 470 nm 
LED (CoolLED), with data collection using WinFluor v3.8 with a QiClick USB camera 
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(QImaging). This allowed recordings to be sorted into TH-positive and TH-negative 
categories after immunostaining. Cells with more than 50 pA of leak current were 
rejected. P/4 leak subtraction was applied pre-recording to compensate for leak current 
in all accepted cells during voltage clamp recordings. Whole cell capacitance 
compensation was applied prior to recording in voltage clamp recordings and series 
resistance was compensated to a minimum of 60%. The liquid junction potentials were 
found to be +1.1 mV (K-Gluconate internal) and -6.1 mV (Cs-Gluconate internal) and 
were corrected after recording. To determine which neurotransmitters and receptors 
were involved in driving electrical activity, various agonists and antagonists were added 
directly to the bath. A full list of compounds and the concentrations used can be found 
in 3.2.8.  
Four protocols were used to acquire relevant data: 
1.) Voltage clamp recording from a holding potential of -80 mV to +60 mV in 200 
millisecond +10 mV steps. This was used to acquire current-voltage (I/V) 
relationships and current densities for NaV, KV and Ca
2+ channels. 
2.) Continuous voltage clamp recording from a holding potential of -80 mV. This 
was used to detect the presence of synaptic inputs.  
3.) Continuous current clamp recording without current injection. This was used to 
determine the presence of spontaneous action potentials, subthreshold potentials 
and the resting membrane potential. 
4.) Current clamp recording from a holding potential of -80 mV, with a 20 pA 
current step. This was used to determine the ability of a cell to fire action 
potentials upon current injection. Steps were 1 second in duration. 
Data Analysis: Firing frequency, membrane potential, peak current and area under the 
graph (for ESPSCs) were calculated in Clampfit 10.  
 
3.2.4     Immunofluorescence Staining 
Coverslips were washed in PBS pre-warmed to 37oC before fixation in 4% 
paraformaldehyde for 10 minutes at room temperature (21oC). 3 washes with ice cold 
PBS were performed and cells were permeabilised with 0.1% Triton X-100 for 10 
minutes at 21oC. Coverslips were washed for 3x 5 minute washes with PBS containing 
0.1% Tween-20 at 21oC before a 30 minute incubation at 21oC in PBS containing 1% 
BSA and 0.1% Tween-20 to prevent non-specific antibody binding. Primary antibody 
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incubation was performed at 21oC for 1 hour in PBS containing 1% BSA and 0.1% 
Tween-20. Coverslips were washed 3x for 5 minutes with PBS containing 0.1% Tween-
20 at 21oC. Secondary antibody incubation was performed for 1 hour in the dark at 21oC 
in PBS containing 1% BSA. All secondary antibodies were conjugated with AlexaFluor 
fluorescent dyes. Coverslips were then washed 3x for 5 minutes with PBS in the dark at 
21oC before mounting on glass microscope slides with the mounting medium Mowiol® 
4-88 and sealing with nail polish. Slides were stored at 4oC until analysis. All reagents 
were acquired from Sigma Aldrich and all antibodies were from Abcam unless stated. A 
full list of the antibodies used and their dilutions can be found in Table 3.1. 
 
Table 3.12- Primary and secondary antibodies. Table illustrating the antibodies used during 
experimentation, their uses and the dilutions used. 
 
 
Antibody Description 
Concentration 
 Used 
Secondary 
Concentration 
Used 
Anti-NeuN 
Species: Mouse. 
Antibody against 
Neuronal Nuclei 
 1:50 
Donkey anti 
Mouse 
AlexaFluor-
488 
 1:500 
Anti-PSD95 
Species: Mouse. 
Antibody against 
a human 
postsynaptic 
marker 
associated with 
NMDA receptors 
 1:1000 
Donkey anti 
Mouse 
AlexaFluor-
488 
 1:500 
Anti- 
Synaptophysin 
Species: Rabbit. 
Antibody against 
a ubiquitously 
expressed 
presynaptic 
marker 
 1:1000 
Goat anti 
Rabbit 
AlexaFluor-
647 
 1:500 
Anti-TH 
Species: Rabbit, 
Chicken. 
Antibody against 
a  dopaminergic 
neuron marker, 
Tyrosine 
Hydroxylase 
 1:500 
Goat anti 
Rabbit 
AlexaFluor-
647 
 
Goat anti 
Chicken 
AlexaFluor 
568 
 1:500 
 
 
 1:500 
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3.2.5     Confocal Microscopy 
Fixed coverslips were imaged using a TCS SP5 II confocal microscope (Leica) with a 
63x oil objective (NA 1.3). Samples were excited using an argon or white light laser. 
Images were collected using a Hamamatsu camera with 3x frame averaging at an image 
resolution of 1024x1024 pixels. 
Data Analysis: Images were analysed in ImageJ. Percentages of stained cells was 
performed semi-automatically using the Analyse Particle function in ImageJ. 
Colocalisation of synaptic markers was performed using the NeuronJ and SynapCountJ 
plugins for ImageJ. Cells identified after confocal microscopy as TH -positive and -
negative were manually matched to their corresponding Lucifer Yellow images from 
electrophysiological recordings based on their morphology. 
  
3.2.6     Calcium Imaging 
Calcium green-1 AM (ThermoFisher) was loaded into cells to assess changes in 
cytoplasmic Ca2+ concentration. A 1 mg/ml stock solution of Calcium Green-1 AM was 
formulated in loading medium containing 48 µl DMSO and 2 µl 20% w/v Pluronic F-
127 (Sigma). 0- 6 week differentiated neurons were loaded with a final concentration of 
5 µg/ml Calcium Green-1 AM for 20 minutes at 37oC in culture medium. The cells were 
washed 5 times with PBS pre-warmed to 37oC and the coverslips were transferred to 35 
mm culture dishes. Recording was performed in dopaminergic neuron external solution 
(as formulated in 3.2.3) at 21oC using an Olympus IX71 microscope (10x objective, NA 
0.3) and a 470 nm pE-100 light emitting diode (CoolLED). Fields of cells were 
recorded for 40 seconds using a Qi Click USB camera (QImaging) at 5 frames per 
second with a gain of 20.  
Data Analysis: Regions of interest were drawn manually around cells in ImageJ. 
Fluorescence data was then imported into Clampfit 10 for the calculation of wave 
frequency using the threshold and template search features. Area under the graph was 
calculated manually in Excel using the Riemann summing method of numerical 
integration. Recordings were manually bleach corrected in Clampfit 10. For all graphs, 
changes in fluorescence were expressed as the proportional change in fluorescence from 
baseline (ΔF/F). For all Calcium Green-1 experiments the means from each of 3 
experiments were calculated from 50 cells in each experiment. These 3 values were then 
averaged to give an overall mean and S.E.M. 
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3.2.7     Drugs & Compounds 
In various experiments ion channel agonists/antagonists and other solutions were 
applied to the cells. All drugs were diluted from concentrated stock solutions and 
pipetted directly into the bath at concentrations determined from the literature. All were 
purchased from Tocris unless otherwise stated. The compounds used and their 
concentrations are: TTX (1 µM), TEA (10 mM, Sigma), nifedipine (1 µM), CoCl2 (1 
µM, Sigma), CNQX (5 µM), D-AP5 (50 µM), picrotoxin (1 µM), L-glutamic acid (1 
mM, Sigma), CaCl2 (10 mM), SCH23390 (10 nM), nemonapride (10 nM).  
 
3.2.8     Graphs & Statistical Analysis 
All graphs and curve fitting were performed using OriginPro 8.5. Statistical analysis 
was performed using an appropriate statistical test in Excel using the XLSTAT plugin 
(t-tests, ANOVAs or KS-tests). The exact test used and their associated significance 
values are reported in the text. Differences were considered statistically significant 
when p <0.05. Asterisks (*) on graphs indicate statistical significance at this p-value. 
Errors bars in all graphs and ± values in the text use the standard error of the mean 
(S.E.M.) which was calculated in Excel. 
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3.3     Results 
 
3.3.1     Confirmation of a Dopaminergic Neuronal Phenotype 
DA neurons in culture and in-vivo express tyrosine hydroxylase (TH), the rate limiting 
enzyme in the dopamine production pathway. To determine whether the differentiation 
protocol used was producing hiPSC-derived DA neurons from hNPCs, co-staining using 
antibodies against the neuron-specific marker NeuN and against TH was performed 
from 0 weeks (hNPCs) to 6 weeks post-differentiation (n=4). TH-positive neurons were 
identified from 1 week, with the number of positive neurons increasing as a percentage 
of the total population each week until reaching a steady level of ~25% at 4-6 weeks 
post-differentiation (Figure 3.2A, 3.2B). Counterstaining with the nuclei stain DAPI 
revealed NeuN staining in over 80% of counterstained nuclei at all weeks tested (Figure 
3.2C). This finding was surprising as NeuN was only expected to be present in mature 
neurons in later weeks of development. NeuN staining did, however, become more 
prominent in later weeks, clearly staining the cell bodies and processes of neurons as 
they matured in culture (Figure 3.2A). Almost 100% of TH-positive cells were NeuN-
positive at all weeks tested (Figure 3.2C). Control experiments performed with only the 
secondary antibodies used during the TH and NeuN staining confirmed that the 
observed staining was not due to non-specific binding of the secondary antibody 
(Supplementary 3.1). Non-specific binding of the primary antibody, though unlikely 
due to the presence of NeuN negative cells within the cultures, should not be discounted 
as a possible reason for this unexpected NeuN staining. 
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Figure 3.222- TH-positive neurons develop in culture. (A) Cultured neurons at 0, 1 and 6 weeks post-
differentiation that were immunostained for the neuron-specific marker NeuN (green) and the DA marker 
TH (red). Graphs showing the mean percentages of the total cell population that were (B) TH-positive and 
(C) NeuN-positive up to 6 weeks post-differentiation  (n=4). Error bars ± S.E.M. 
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3.3.2    The Development of Excitability 
SNc DA neurons in-vivo and in-vitro are characterised by their ability to produce 
spontaneous pacemaker activity (Shen et al., 1994; Guzman et al., 2009). To determine 
whether hiPSC-derived DA neurons become excitable and at what stage in development 
this occurs, whole cell current clamp recording was performed from 0 to 6 weeks post-
differentiation with 1 mg/ml Lucifer Yellow added to the intracellular solution to mark 
cells for later cytochemical identification (n=3 to 8 TH-positive or TH-negative cells 
per time point) (Figure 3.3). Action potentials were defined as regenerative all-or-
nothing membrane potential depolarisations that produced an overshoot beyond 0 mV. 
Recordings from human neural progenitor cells (hNPCs) prior to differentiation 
revealed no action potential firing in any cells tested (n=18). Lucifer Yellow 
identification first revealed spontaneous action potential firing in TH-positive cells from 
2 weeks post-differentiation. The percentage of 4-6 week TH-positive cells that were 
firing was significantly higher than in week 4-6 TH-negative cells (n=3) (Figure 3.4A) 
Two modalities of spontaneous firing were observed: tonic firing (Figure 3.4B) and 
burst firing (Figure 3.4C). 
From 0-6 weeks post-differentiation several changes in excitability occurred. The mean 
resting membrane potential in all cells became increasingly hyperpolarised (Figure 
3.4D). The performance of one-way ANOVAs revealed that there was a significant 
effect of time in culture on the resting membrane potential (TH-positive, F=9.947 
p=0.0001; TH-negative, F=3.203, p=0.011). The mean resting potential of TH-positive 
cells was more hyperpolarised than TH-negative cells from weeks 3 to 6, though no 
statistical difference was identified between the two groups (F=4.112, p=0.115). A two-
sided Dunnett test showed that the resting potential statistically differed from controls 
from week 2 in both TH-positive cells and TH-negative cells (TH-positive: week 1, 
p=0.643; week 2, p=0.04; week 3-5, p<0.0001) (TH-negative: week 1, p=0.646; week 2, 
p=0.02; week 3-5, p<0.05).  
The frequency of spontaneous firing remained similar in all cells until week 6, when a 
large increase in firing frequency was observed in both TH-positive and TH-negative 
cells (Figure 3.4E). The performance of one-way ANOVAs showed a statistically 
significant effect of time in culture on firing frequency (TH-positive, F=9.453, 
p<0.0001; TH-negative, F=6.851, p<0.0001). No statistical difference was observed 
between TH-positive and TH-negative cells (F=8.322, p=0.292). A two-sided Dunnett 
test showed that firing frequency was statistically difference from week 0 at week 6 but 
103 
 
not at prior weeks for both TH-positive and TH-negative cells (TH-negative: week 1-5, 
p>0.3; week 6, p<0.0001) (TH-positive: week 1-5, p>0.1; week 6, p<0.0001).  
hiPSC-derived DA neurons have previously been shown to produce trains of rhythmic 
action potentials upon current injection once they reach maturity (Hartfield et al., 2014). 
To confirm this, a 20 pA current injection was applied to cells under whole cell current 
clamp from 0 to 6 weeks post-differentiation. At Week 0, 6 of 18 hNPCs produced 
single action potentials upon current injection with the remaining cells showing no 
ability to fire. Early signs of spike train development were seen from week 2. Spikes 
became more pronounced and the number of spikes per train increased from 2 to 6 
weeks post-differentiation (Figure 3.5A). The percentage of TH-positive cells 
producing these trains at weeks 4-6 was significantly higher than in TH-negative cells 
during the same time period (n=3) (Figure 3.5B).  
Pacemaking in the SNc neurons of animal models has been found to be L-type VGCC 
dependent (Guzman et al., 2009). To determine whether pacemaking in hiPSC-derived 
DA neurons was also L-type dependent, the L-type VGCC antagonist nifedipine was 
applied to week 4-6 cells under whole cell current clamp. Unfortunately, only one week 
5 TH-positive cell survived through the antibody staining and identification process. 
The addition of 10 µM nifedipine to this cell abolished all action potential firing within 
1 minute of addition (Figure 3.6A). Firing could still be induced via current injection, 
though membrane potential depolarisations no longer crossed the threshold of 0 mV 
required to be defined as an action potential. This cell, which was able to produce spike 
trains prior to the addition of nifedipine, could only produce single spikes after the 
addition of the drug (Figure 3.6B). 
Neurotransmitters such as glutamate, GABA and dopamine have been implicated in the 
regulation of pacemaking in SNc DA neurons in-vivo (Blythe et al., 2007). To 
determine their involvement in hiPSC-derived DA neurons, the effect of various 
receptor antagonists on action potential firing was determined in week 4-6 TH-positive 
cells. The general glutamate receptor antagonist Kynurenic acid blocked action potential 
firing in 3 out of 5 cells (Figure 3.7A, 3.7E), with the remaining 2 cells capable of 
firing action potentials in its presence. The GABAA receptor antagonist Picrotoxin (n=3) 
caused a slight decrease in firing frequency that was not found to be statistically 
significant (Paired t-test, p=0.373) (Figure 3.7B, 3.7E). The dopamine D1 receptor 
antagonist SCH 23390 (n=3) had no effect on firing frequency (Paired t-test, p=0.267) 
(Figure 3.7C, 3.7E) while the D2/D3 receptor antagonist Nemonapride (n=4) caused a 
104 
 
membrane depolarisation of 11.32 ± 4.2 mV and a decrease in firing frequency that was 
statistically significant from controls (Paired t-test, p=0.022) (Figure 3.7D, 3.7E). 
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Figure 3.323- Lucifer Yellow identification of neurons. Representative confocal images of cells 5 weeks 
post-differentiation that were pipette-loaded with the fixable fluorescent dye Lucifer Yellow during whole 
cell recording. Images were taken before and after immunostaining for the DA-specific marker TH and 
show TH-positive (upper) and TH-negative (lower) cells in culture. 
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Figure 3.424- TH-positive neurons fire action potentials in culture. (A) Pooled data from weeks 4-6 
showing the percentage of TH-positive and TH-negative cells that fired spontaneous action potentials. 
Representative whole cell voltage clamp recordings showing the two modalities of firing that were 
identified: (B) rhythmic tonic firing and (C) arrhythmic burst firing. Dotted lines indicate 0 mV. Graphs 
showing (D) mean membrane potential and (E) mean firing frequency in TH-positive and TH-negative 
cells from 0 to 6 weeks post-differentiation. Error bars ± S.E.M. *indicates statistical significance using a 
one-way ANOVA at p=0.05.  
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Figure 3.525- TH-positive neurons develop spike trains in culture. (A) Representative whole cell 
current clamp recordings from week 0, week 2 and week 6 showing TH-positive cells developing the 
ability to fire multiple action potentials in response to a 20 pA current step. (B) Pooled data from weeks 
4-6 showing the percentage of TH-positive and TH-negative cells that were able to produce more than 
one action potential upon current injection. Error bars ± S.E.M.*indicates statistical significance using a 
two-way Student's t-test at p=0.05. 
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Figure 3.626- The effect of nifedipine on pacemaking in a TH-positive neuron. Representative whole 
cell current clamp recordings from a week 5 TH-positive cell showing the effect of nifedipine on (A) 
action potential firing and the ability to produce spike trains (B) before and (C) after the addition of the 
drug from a -80 mV holding potential. 
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Figure 3.727- Action potential firing is dependent on synaptic input. Representative whole cell current 
clamp recordings from week 4-6 TH-positive cells showing the effect of extracellular addition of (A) 
Kynurenic acid (B) Picrotoxin (C) SCH23390 and (D) Nemonapride. (E) Graph showing the mean firing 
frequency before and after the addition of each antagonist (n=3-5). Error bars ± S.E.M. *indicates 
statistical significance using a two-way paired t-test at p=0.05. 
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3.3.3     The Development of Ion Channel Populations 
To characterise changes in ion channel expression that accompany the development of 
excitability, whole cell voltage clamp was performed using the fixable fluorescent dye 
Lucifer Yellow (n=3 to 8 TH-positive or TH-negative cells per time point). Whole cell 
capacitance increased from 0-6 weeks post-differentiation in TH-positive and TH-
negative cells, likely indicating an increase in cell size and complexity (Figure 3.8A). 
Performance of one-way ANOVAs revealed that these increases were statistically 
significant across the 6 week time course (TH-positive: F=12.794, p<0.0001; TH-
negative: F=11.714, p<0.0001). No statistical difference was observed between TH-
positive and TH-negative cells (F=0.881, p=0.32). A two-sided Dunnett test against 
week 0 showed that whole cell capacitance first statistically differed from week 0 at 
week 3 for TH-positive cells (week 1-2, p>0.5; week 3, p=0.02, week 4-6, p<0.001) and 
week 4 for TH-negative cells (week 1-3, p>0.1; week 4, p=0.022; week 5-6, p<0.0001).  
The mean access resistance showed a decrease in TH-positive cells but remained 
consistent in TH-negative cells (Figure 3.8B). Performance of one-way ANOVAs 
showed that no statistical change occurred over the 6 week time course for either group 
(TH-positive: F=0.727, p=0.63; TH-negative, F=0.072, p=0.998). No statistical 
difference was found between TH-positive and TH-negative cells (F=2.107, p=0.177). 
Voltage-sensitive currents were identified in all cells from week 0 to week 6 (Figure 
3.9A, 3.9B). These were blocked by the addition of 1 µM TTX and 10 mM 
tetraethylammonium (TEA) to the extracellular solution (Figure 3.9C). When corrected 
for whole cell capacitance these currents increased in density from weeks 0-6, with TH-
positive cells developing larger peak currents than TH-negative cells (Figure 3.10A, 
3.10C). The performance of one-way ANOVAs revealed that for voltage-gated sodium 
(NaV) currents the effect of time in culture on current density was not significant for 
TH-negative but was significant for TH-positive cells (TH-negative: F=0.819, p=0.563; 
TH-positive: F=4.821, p<0.0001). No statistical difference was observed between TH-
positive and TH-negative cells at week 6 (F=1.186 p=0.326).  A two-sided Dunnett test 
showed that, for positive cells, they statistically differed from week 0 at weeks 5 and 6 
(week 5, p=0.008; week 6, p=0.002; other weeks, p>0.1).  
For voltage-gated potassium (KV) currents, one-way ANOVAs revealed that the effect 
of time in culture on current density was also not significant for TH-negative but was 
significant for TH-positive cells (TH-negative, F=1.897, p=0.11; TH-positive, F=4.141, 
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p=0.003). No statistical difference was observed between TH-positive and TH-negative 
cells (F=1.679, p=0.252). A two-sided Dunnett test showed that, for TH-positive cells, 
current density statistically differed from week 0 only at week 6 (p=0.029). 
No shift in the IV relationship for either current was observed between TH-positive 
(n=4) and TH-negative cells at week 6 (n=3) (Figure 3.10B, 3.10D).  
Since VGCCs are believed to be involved in the selective death of SNc DA neurons in 
PD, the development of Ca2+ currents was investigated. After the addition of 1 µM TTX 
and 10 mM CaCl2 to the extracellular solution and 120 mM Cs-gluconate to the 
intracellular solution, no currents were observed in hNPCs at week 0 (n=11) (Figure 
3.11A).  
Capacitance-corrected currents increased weekly up to 4 weeks post-differentiation 
before reaching a plateau (Figure 3.11B, 3.11D). These were blocked by 1 µM of the 
non-specific VGCC blocker CoCl2 (Figure 3.11C). The performance of one-way 
ANOVAs showed there was a statistically significant effect of time in culture on current 
density for both TH-negative and TH-positive cells (TH-negative, F=3.335, p=0.013; 
TH-positive, F=8.122, p<0.0001). TH-positive and TH-negative cells were found to 
statistically differ from each other (F=7.049, p=0.033). A two-sided Dunnett test 
showed that for TH-negative cells current density statistically differed from week 0 at 
weeks 4 and 5 (week 4, p=0014; week 5, p=0.027; week 6, p=0.085; other weeks, 
p>0.05) while it statistically differed at all weeks except week 2 in TH-positive cells 
(week 1, p= 0.017; week 2, p=0147, other weeks, p<0.001).  
The I/V relationship for these currents was slightly shifted towards negative potentials 
for TH-positive compared with TH-negative cells at week 6 (n= 3 to 5 TH-positive or 
TH-negative cells per week) (Figure 3.11E). 
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Figure 3.828- Time-dependent changes in passive membrane properties. Graphs showing changes in 
(A) whole cell capacitance and (B) input resistance in TH-positive and TH-negative cells from 0 to 6 
weeks post-differentiation. Error bars ± S.E.M. *indicates statistical significance using a one-way 
ANOVA at p=0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.929- Voltage-dependent currents in hiPSC-derived dopaminergic neurons. Representative 
whole cell voltage clamp recordings showing voltage-dependent currents at (A) 0 weeks and (B) 6 weeks 
(TH-positive) post-differentiation. (C) Representative whole cell voltage clamp recording after the 
addition of TTX and TEA. The experimental protocol used is shown in the bottom panel. 
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Figure 3.1030- NaV and KV current properties in hiPSC-derived dopaminergic neurons. Graphs 
showing (A) mean current densities for NaV currents for TH-positive and TH-negative cells from 0-6 
weeks post-differentiation and (B) NaV I/V relationships for week 0 and week 6 TH-positive/TH-negative 
cells. Graphs showing (C) mean current densities for KV currents for TH-positive and TH-negative cells 
from 0-6 weeks post-differentiation and (D) KV I/V relationships for week 0 and week 6 TH-positive/TH-
negative cells. Error bars ± S.E.M. *indicates significance using a one-way ANOVA at p=0.05. 
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Figure 3.1131- Voltage-dependent Ca2+ currents in hiPSC-derived dopaminergic neurons. 
Representative whole cell voltage clamp recordings from a -80 mV holding potential for neurons (A) 0 
weeks and (B) 4 weeks (TH-positive) post-differentiation. (C) Same cell from B in the presence of CoCl2. 
The experimental protocol used is shown in the bottom panel. Graphs showing (D) the mean current 
density from weeks 0-6 (n=3-5 per time point) and (E) The mean Ca2+ I/V relationships for TH-positive 
(n=3) and TH-negative cells (n=5) at week 6. Error bars ± S.E.M. * indicates statistical significance using 
a one-way ANOVA at p=0.05. 
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3.3.4     The Development of Synaptic Inputs 
Synaptic input plays a role in the regulation of firing rate in SNc DA neurons in-vivo 
(Blythe et al., 2007). To determine whether hiPSC-derived DA neurons form synapses 
in-vitro, cells were co-stained for the presynaptic marker synaptophysin, the NMDA 
receptor associated protein PSD-95 and the DA marker TH at 6 weeks post-
differentiation. Staining was seen for both PSD-95 and Synaptophysin in TH-positive 
cells (Figure 3.12A). Regions of co-localisation between PSD-95 and Synaptophysin 
could be identified, indicating the formation of synapses in culture (Figure 3.12B). The 
mean number of synapses per TH-positive cell was estimated to be 31.9 ± 4.2 (n=12) 
using the ImageJ plugin SynapCountJ. 
To determine the presence of synaptic currents, cells were held at a -80 mV holding 
potential in the whole cell voltage clamp configuration from 0-6 weeks post-
differentiation. Lucifer Yellow was added to the internal solution to allow cytochemical 
identification of TH-positive cells (n=3-8 TH-positive or TH-negative cells per time 
point). From Week 2 onwards, excitatory spontaneous postsynaptic currents (ESPSCs) 
were identified in the majority of cells, including those that were TH-positive (Figure 
3.13A, 3.13B). As an estimate of total ion flux during these ESPSCs the area under the 
graph was calculated for 60 second recordings. The mean total area under the graph 
remained consistent until week 6, when a drastic increase in area was observed for both 
TH-negative and TH-positive cells (Figure 3.13C). The performance of one-way 
ANOVAs showed that there was a statistically significant effect of time in culture on 
area under the graph for both TH-positive and TH-negative cells (TH-negative, 
F=11.346, p<0.0001; TH-positive, F=11.771, p<0.0001). No statistical difference was 
observed between TH-negative and TH-positive cells at any time point (F=8.434, 
p=0.233). A two-sided Dunnett test showed that, for both TH-negative and TH-positive 
cells, area under the graph statistically differed from week 0 only at week 6 (p<0.0001 
for both).  
To determine which neurotransmitters and receptors were producing these currents, 
various post-synaptic receptor antagonists were added to the extracellular solution 
during whole cell voltage clamp recording from a -80 mV holding potential. The results 
below are only from TH-positive cells that are between 4-6 weeks post-differentiation, 
as identified by Lucifer Yellow staining. Addition of 1 mM of the general glutamate 
receptor antagonist kynurenic acid blocked ESPSCs in TH-positive cells within 10 
minutes of addition (Figure 3.14A) and reduced the area under the graph during 60 
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second recordings when compared to controls before the addition of the drug (n=5) 
(Figure 3.14F). This reduction in area was found to be statistically significant (paired t-
test, p=0.01). 50 µM of the NMDA receptor antagonist D-AP5 (n=4) or 5 µM of the 
AMPA/Kainate receptor antagonist CNQX (n=4) both partially blocked ESPSCs 
(Figure 3.14B, 3.14C) and reduced the mean total area under the graph (Figure 3.14F). 
These changes in area were not statistically significant when compared to controls 
(paired t-test, CNQX: p=0.066, D-AP5: p=0.063). The addition of both antagonists 
blocked ESPSCs similar to the addition of kynurenic acid (n=5) (Figure 3.14D, 3.14F). 
The decrease in total area under the graph that was observed upon the addition of both 
antagonists was found to be statistically significant compared to controls (paired t-test, 
p=0.009). Averaging the shape of ESPSCs from before (n=332 ESPSCs from 4 cells) 
and after the addition of 50 µM D-AP5 (n=227 ESPSCs from 4 cells) revealed a 
reduction in ESPSC duration after the addition of the drug (Figure 3.14E). 
Small amplitude ESPSCs remained in the presence of kynurenic acid or D-AP5/CNQX. 
Calculation of the equilibrium potential for Cl- for the extracellular and intracellular 
solutions used gave a value of -42.12 mV. This is more depolarised than the typical Cl- 
equilibrium potential for neurons which lies around -80 to -90 mV. From the holding 
potential of -80 mV used, Cl- currents would therefore appear as excitatory currents 
rather than the inhibitory currents typically carried by Cl-. The remaining ESPSCs could 
therefore represent GABAergic outward currents, though time constraints meant this 
was not tested experimentally. 
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Figure 3.1232- TH-positive neurons form synapses in culture. (A) Representative confocal images of 
the same field of week 6 cells stained for (top to bottom) TH, PSD-95 (postsynaptic marker) and 
Synaptophysin (presynaptic marker). (B) A composite image of the PSD-95 and Synaptophysin staining 
from A. Regions of co-localisation are shown in yellow. 
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Figure 3.1333- Synaptic currents in hiPSC-derived neurons. (A) Representative whole cell voltage 
clamp recordings from a holding potential of -80 mV in week 0 and week 6 cells showing the 
development of ESPSCs. Graphs showing (B) the percentage of TH-positive and TH-negative cells that 
displayed synaptic currents and (C) the mean total area under ESPSCs during 60 second recordings from 
0-6 weeks post-differentiation (n=3-8 per week). Error bars ± S.E.M. *indicates statistical significance 
using a one-way ANOVA at p=0.05. 
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Figure 3.1434- Synaptic inputs in TH-positive neurons. (A) Representative whole cell voltage clamp 
recordings from a -80 mV holding potential showing the effects of (A) kynurenic acid (B) CNQX (C) D-
AP5 and (D) CNQX + D-AP5 on ESPSCs in TH-positive cells from 4-6 weeks post-differentiation. (E) 
The average ESPSC shape in TH-positive cells before and after the addition of D-AP5. Current values 
were normalised to allow for easier comparison (F) Graph showing the mean total area under the graph 
during 60 second recordings before and after the addition of the receptor antagonists listed above. Error 
bars ± S.E.M. *indicates significance using a two-way paired t-test at p=0.05. 
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3.3.5     The Development of Calcium Waves 
SNc DA neurons control pacemaking partially via Ca2+ influx through VGCCs (Chan et 
al., 2007). To determine whether Ca2+ waves develop in hiPSC-derived DA neuron-
containing cultures, cells were loaded with the fluorescent Ca2+ dye Calcium Green-1 
each week from 0-6 weeks post-differentiation (Figure 3.15A). In all experiments the 
results are obtained from 40 second fluorescence intensity recordings (n=3, with 50 
cells tested per repeat). The results here look at the general cell population and therefore 
do not distinguish between TH-positive and TH-negative cells. 
Calcium Green-1 fluorescence was observed in all the cells in the cultures. Fluorescence 
was seen in both the soma and dendrites, with soma being noticeably brighter. Ca2+ 
waves were present from week 0 in a small percentage of cells, with the percentage 
exhibiting waves increasing from week 0 to week 6 (Figure 3.15B, 3.15C). Waves were 
initially disordered but became regular in frequency between week 0 and week 6, with 
week 6 cells often displaying waves in regularly spaced bursts (Figure 3.15B, 3.16). 
The frequency of Ca2+ waves initially increased, between weeks 0 and 1, then remained 
consistent until week 6 (Figure 3.15D). The performance of a one-way ANOVA 
showed a statistically significant effect of time in culture on Ca2+ wave frequency 
(F=6.303, p=0.002). A Tukey comparison showed that frequency was statistically 
different from week 0 at week 1, then did not statistically differ from the previous week 
at each subsequent week (week 0 vs 1, p=0.007; week 1 vs 2, p=0.933, week 2 vs 3, 
p=0.845; week 3 vs 4, p=0.66; week 4 vs 5, p=0.551; week 5 vs 6, p=0.487). 
Since Ca2+ influx is implicated in the pathology of PD, the mean total area under the 
graph was calculated as an estimate of total Ca2+ influx. The mean total area under the 
graph remained consistent from weeks 0 to 5, with a massive increase being observed at 
week 6 (Figure 3.15E). The performance of a one-way ANOVA showed there was a 
statistically significant effect of time in culture on the mean total area under Ca2+ waves 
(F=5.502, p=0.004). A two-sided Dunnett test showed that mean total area only differed 
from week 0 at week 6 (weeks 1-5, p>0.9; week 6, p=0.002). These data suggest that a 
large increase in Ca2+ influx was occurring at week 6. This ties in with the observed 
increases in action potential firing frequency and area under synaptic events, likely 
indicating that a shift in maturity is occurring at week 6 in culture. 
Ca2+ waves can be dependent on or occur independently of action potential firing 
(Moreno-Juan et al., 2017; Stellwagen et al., 1999). To determine whether Ca2+ waves 
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in hiPSC-derived DA neurons are action potential dependent, recordings were taken 
before and after the addition of the NaV antagonist TTX. Addition of 1 µM TTX to the 
extracellular solution prevented Ca2+ waves in the majority of week 4-6 cells (Figure 
3.17A). Isolated waves still occurred in a small percentage of cells (Figure 3.17B). It 
was hypothesised that spontaneous synaptic events could be producing these TTX-
insensitive waves. To determine whether glutamate receptor activation could cause Ca2+ 
waves, 1 mM L-glutamic acid was added to cells during Ca2+ imaging. All cells tested 
displayed a large peak in fluorescence upon L-glutamic acid addition in the presence of 
TTX which was followed by a decrease in fluorescence from baseline (Figure 3.17C). 
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Figure 3.1535- The development of Ca2+ waves in hiPSC-derived dopaminergic neuron-containing 
cultures. (A) Representative false colour fluorescence image of a week 6 cell loaded with Calcium 
Green-1 that is exhibiting a Ca2+ wave (B) Representative fluorescence intensity recording from a week 6 
cell producing Ca2+ waves. Graphs showing (C) the percentage of cells that were producing Ca2+ waves 
(D) the mean wave frequency and (E) the mean total area under the graph for cells from 0-6 weeks post-
differentiation. Error bars ± S.E.M. *indicates statistical significant using a one-way ANOVA at p=0.05. 
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Figure 3.1636- The maturation of Ca2+ waves in cultures containing hiPSC-derived dopaminergic 
neurons. Representative fluorescence intensity recordings from cells loaded with Calcium Green-1 at 0, 3 
and 6 weeks post-differentiation. Changes in fluorescence expressed as ΔF/F.   
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Figure 3.1737- The action potential dependence of Ca2+ waves. (A) Graph showing the mean percentage 
of week 4-6 cells that were producing Ca2+ waves before and after the addition of TTX. Representative 
fluorescence recordings from week 4 Calcium Green-1 loaded cells in the presence of TTX showing (B) 
waves still occurring in the presence of TTX and (C) the addition of L-glutamic acid in the presence of 
TTX. The arrow indicates the addition of 1 mM L-glutamic acid. Error bars ± S.E.M. *indicates statistical 
significance using a two-way Student's t-test at p=0.05. 
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3.4     Discussion 
This chapter has focused on the early electrical development of hiPSC-derived DA 
neurons in culture. A previous study of these neurons found that spontaneous 
pacemaking, synaptic currents and Ca2+ waves developed between 6-12 weeks post-
differentiation from hiPSCs (Hartfield et al., 2014). The results I present here 
compliment that work, looking instead at the early period of development from 0 to 6 
weeks post-differentiation from hiPSC-derived neural progenitors.  
Here I show that many phenotypic traits that are typical of DA neuron 
electrophysiology developed at earlier time points than previously described. 
Spontaneous action potential firing that resembled pacemaker activity was observed, 
though by examining in detail the effects of neurotransmitter receptor blockers on this 
excitability it was revealed that very little, if any, truly intrinsic activity had developed 
after 6 weeks in culture. Instead, activity was seen to be driven by activation of 
ionotropic glutamate receptors and D2 receptors. The presence of other inputs such as 
metabotropic glutamate and GABA receptors also cannot be discounted.  
Despite this lack of intrinsic activity, TH-positive cells in these cultures displayed a 
natural propensity towards excitable states, being significantly more likely to fire action 
potentials and produce spike trains than TH-negative cells. SNc DA neurons in-vivo 
display a similar inclination towards excitability that is thought to be partially due to the 
expression of CaV1.3 VGCCs (Chan et al., 2007; Guzman et al., 2009). Data here 
provide evidence suggesting that excitability in hiPSC-derived DA neurons is also L-
type VGCC dependent, with action potential firing being blocked by the L-type VGCC 
antagonist nifedipine in one TH-positive cell. Since this was performed in only one cell, 
whether this is representative of the general population cannot be concluded.  
TH-positive cells also developed significantly larger voltage-dependent Ca2+ currents 
than TH-negative cells by week 6, possibly explaining their increased excitability. The 
I/V relationship for Ca2+ currents was shifted towards a more negative potential in TH-
positive cells compared to TH-negative cells, perhaps indicating that Ca2+ currents in 
these two populations are comprised of different channel types. CaV1.3 channels are 
known to open at more negative potentials than other L-type channels (Zampini et al., 
2010), which, if they are expressed in these neurons in culture, could explain the shift. 
Whether or not CaV1.3 is expressed in these cells is investigated in Chapter 4. CaV1.3 
channels have previously been described as "ideal for pacemaking" due to their 
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activation and inactivation properties (Chan et al., 2007). They have been shown to be 
responsible for slow, subthreshold Ca2+ waves in SNc neurons that help control 
pacemaker activity (Guzman et al., 2009). Data here shows that Ca2+ waves were seen 
in cells in culture, though these were TTX-dependent and not subthreshold. It is worth 
noting that I investigated Ca2+ waves in the cell body and not in dendrites, hence the 
presence of subthreshold waves increasing cell excitability in these regions in culture 
should not be discounted. A previous study of these neurons in culture identified Ca2+ 
waves in dendrites (Hartfield et al., 2014).  
All of these traits (excitability, VGCC currents, synaptic currents, and Ca2+ waves) 
began developing from roughly 1-2 weeks in culture and clearly showed a major shift in 
maturity between weeks 5 and 6. All in all, there is evidence to suggest that the 
increased excitability of TH-positive cells in these cultures was likely due to the 
development of VGCC currents, a trait that is critical to pacemaking in SNc DA 
neurons in animal models. 
 
3.4.1    Confirmation of a Dopaminergic Neuronal Phenotype 
A previous study and manufacturer data have described differentiated cultures using the 
STEMdiff protocol as containing 15-30% TH-positive neurons, >90% expressing 
neuronal markers, with <10% of the population expressing astrocyte markers (Hartfield 
et al., 2014). Here I confirm this, with ~25% TH-positive neurons and >80% NeuN 
positive cells after 6 weeks in culture. The remaining NeuN-negative cells may 
therefore represent astrocytes present in the cultures. 
The relatively small percentage of the total population that is TH-positive meant that, 
without a method to positively identify cells that had undergone electrophysiological 
characterisation, the majority of cells analysed would likely not be TH-positive and 
would provide an inaccurate analysis. Lucifer Yellow staining was chosen as a method 
to identify cells as TH-positive or TH-negative after immunostaining, allowing them to 
be matched to their corresponding electrical recordings. Even with Lucifer Yellow 
staining, many of the experiments suffer from relatively low N numbers. This is due to 
the random nature of selecting cells for whole cell recording and the loss of ~50% of 
Lucifer Yellow loaded cells during the immunostaining procedure. Cells at later weeks 
(weeks 5-6) were also far more likely to detach from the coverslips during transfer to 
the extracellular solution used for electrophysiological recording. The "hit rate" of TH-
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positive cells could be increased to ~40-50% by selecting cells for whole cell recording 
based on their morphology (See Chapter 4) and the experiments were repeated as many 
times as possible in an attempt to increase numbers. Time constraints have still left 
many of the results relatively statistically underpowered, though in many experiments 
the differences were still clear enough to draw meaningful conclusions.  
It is worth noting that the TH-negative population likely contains a mixture of neuronal 
and non-neuronal cell types, as seen by NeuN staining. Differences in excitability and 
current density may therefore be explained by the presence of non-excitable cells in the 
results. Attempts at NeuN staining to discount non-neuronal cell types were attempted 
but could not be distinguished from Lucifer Yellow staining. 
The neuronal nuclei marker NeuN is not expected to stain neural progenitors as it is 
typically a marker for mature differentiated neurons (Gusel’nikova & Korzhevskiy, 
2015). hNPCs here, however, clearly showed NeuN staining at concentrations lower 
than those previously used in the literature, which have typically used NeuN antibodies 
at concentrations of 1:10 or 1:20 compared to the 1:50 dilution used here (Eriksson et 
al., 1998). This could be a consequence of the differentiation protocol used to derive 
them from hiPSCs, with them being further towards maturation than typical NPCs in-
vivo. It could also possibly be a retention of a phenotype from a previous lineage. The 
cells used here, hiPSC-derived hNPCs, were originally derived from cord blood which 
are unlikely to have been expressing NeuN. The change in staining that was observed in 
later weeks, with the cell body and processes showing NeuN staining, suggests the 
staining of NPCs was not due to non-specific staining. This is backed up by the fact that 
NeuN did not stain all of the nuclei in culture. This finding suggests at a difference 
between the hiPSC-derived NPCs used here and NPCs in-vivo in terms of their 
expression of  typically mature neuronal markers. NeuN antibodies stain for a protein 
called Fox-3, which is downregulated by expression of doublecortin during NPC 
division (Kim et al., 2009). hiPSC-derived NPCs staining for NeuN could suggest that 
they were no longer dividing, perhaps due to the high density of the population at the 
time of staining, or that progenitor formation and cell division in these neurons is 
controlled through other mechanisms that are different from neuronal development in-
vivo. Staining for a second neuronal marker such as beta III tubulin or MAP2 would 
have solved whether this was specific for NeuN or the NeuN antibody or whether these 
NPCs were generally more mature than expected. 
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3.4.2     The Development of Excitability 
Here I show that TH-positive cells began to spontaneously fire action potentials in 
culture from 2 weeks post-differentiation. In-vivo, SNc neurons have been described as 
firing tonically, with burst firing seen in response to a large quantity of synaptic input 
(Grace & Bunney, 1984; Tepper et al., 1998; Guzman et al., 2009). Both of these 
modalities were seen here. TH-positive cells here were more likely to be firing action 
potentials and more likely to produce multiple action potential "trains" in response to 
current injection, indicating an innate inclination towards more excitable states. These 
trains have previously been seen in both animal models and hiPSC-derived DA neurons 
(Bayer et al., 2007; Hartfield et al., 2014). Here I show that the firing frequency and 
resting membrane potential were no different between TH-positive and TH-negative 
cells, though this could be due to low N numbers and a subsequent lack of statistical 
power.  
Spontaneous action potential firing in hiPSC-derived DA neurons has previously been 
described in the literature (Hartfield et al, 2014). However, whether the observed 
activity was intrinsically or synaptically driven was not investigated. Here I show that 
spontaneous firing was not intrinsic, being dependent on glutamatergic and D2/3 DA 
input. Glutamatergic inputs and D2 autoreceptors have been seen regulating firing in the 
SNc neurons of mice and guinea pigs respectively (Cragg & Greenfield, 1997; 
Pearlstein et al., 2015), along with an inhibitory GABAergic feedback loop in rats 
(Grace & Bunney, 1985). Data here represents the first direct evidence for glutamatergic 
and DA input in hiPSC-derived DA neurons. No clear regulation of firing frequency by 
GABAA receptors was identified here in TH-positive cells in culture, though a small 
non-significant decrease in firing frequency compared to controls was observed that 
may or may not become significant with higher statistical power. Considering the 
calculated -42 mV equilibrium potential for Cl-, which is the major ion flowing through 
GABA receptors (Siegel et al., 1999), it is unlikely that any effect of GABA receptors 
would be seen here in whole cell current clamp experiments. This is due to the 
membrane potential of the cells tested often resting around the equilibrium for Cl-, 
meaning there would be little to no driving force through GABA receptors. 
Two TH-positive cells were identified here that fired action potentials in the presence of 
a glutamate receptor antagonist. Several reasons can be proposed for this: incomplete 
block of glutamate receptors was allowing firing to continue; other neurotransmitters 
such as dopamine or GABA were responsible for firing in these cells; or these cells are 
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innately exhibiting pacemaking independently of outside input. Given the identified 
inclination of TH-positive cells towards excitability, it is possible that given more time 
in culture these neurons have the ability to develop intrinsic pacemaker activity. 
Synaptic activity is critical for the correct development of neuronal networks in-vivo 
(Donovan, 1999). It could therefore be the case that synaptic input is required for the 
development of intrinsic pacemaking in hiPSC-derived DA neurons. 
L-type VGCCs are critical for pacemaking in SNc DA neurons in-vivo (Chan et al., 
2007; Guzman et al., 2009). Attempts were made here to determine whether the same is 
true of hiPSC-derived DA neurons. Unfortunately, due to loss of cells during 
immunostaining only one TH-positive cell could be recovered. This cell, however, 
displayed activity that was L-type dependent. Whether this is representative of all the 
DA neurons in culture cannot be determined, yet it still represents some of the first 
direct evidence for L-type VGCC-dependent excitability in hiPSC-derived DA neurons 
in culture. 
All in all, the results presented here point to many similarities (excitability, L-type 
dependence, glutamatergic and dopaminergic input) and differences (little to no intrinsic 
pacemaking, perhaps no GABAergic feedback) between hiPSC-derived DA neurons 
and SNc neurons in animal models. Given the observed differences in excitability and 
synaptic connectivity, care should be taken over the translation of results to in-vivo 
models. Many of these phenotypic properties continued to mature with time in culture 
and, along with the finding that TH-positive cells showed a tendency towards more 
excitable states, there is evidence to suggest that truly intrinsic activity may develop 
with more time in culture. 
 
3.4.3     The Development of Ion Channel Populations 
Voltage-gated ion channels underlie excitability in all neuronal cells, with differential 
expression of channel types responsible for the range of excitable phenotypes seen in 
the body (Prinz et al., 2003). It was important to investigate any changes in voltage-
gated ion channel currents in TH-positive cellss post-differentiation to determine if they 
are the likely cause of TH-positive cells being more inclined towards excitability that 
TH-negative cells in culture.  
It was important, firstly, to identify changes in passive cell properties. Whole cell 
capacitance is a measure of cell surface area, assuming a specific capacitance of 0.8-1.0 
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µF/cm2. It was therefore important to correct for cell capacitance to determine true 
changes in current density. Here I show that input resistance was lower in TH-positive 
cells than TH-negative cells, though this was not significant perhaps due to low 
statistical power. Lower input resistance would indicate a decrease in responsiveness to 
synaptic inputs, since Ohm's law would give lower changes in membrane potential in 
response to current input. It also decreases with an increase in whole cell capacitance 
(due to more open channels and higher membrane leak) and can be explained by the 
slightly higher, though once again not statistically significant, increase in whole cell 
capacitance in TH-positive cells. 
Here I show that NaV and KV current densities increased weekly but showed no 
difference between TH-positive and TH-negative cells, indicating they are likely not 
responsible for the excitability differences between the two. Changes in channel 
distribution were not investigated and cannot be discounted as a possible cause of 
differences in excitability. Space clamp issues could also prevent proper clamping of 
current or voltage within axons and dendrites meaning that large current densities in 
these regions may not be identified. Ca2+ current densities were significantly larger in 
TH-positive cells and, given that CaV1.3 channels underlie excitability in SNc neurons 
in-vivo, could explain the increased excitability of hiPSC-derived TH-positive cells in 
culture. The negative-shifted voltage-activation of CaV1.3 channels is also a likely 
explanation for the negative-shifted IV relationship for VGCC currents identified in 
TH-positive cells here (Zampini et al., 2010) though could also be due to T-type 
channels which are dendritically expressed in SNc DA neurons in rats (Dufour et al., 
2014). CaV1.3 distribution is investigated in Chapter 4. This negative shift allows 
increased Ca2+ influx at subthreshold membrane potentials. This provides subthreshold 
oscillations in membrane potential, heightening sensitivity to other near-threshold 
stimuli. The increased excitability in TH-positive cells may therefore be due to an 
increased VGCC current density that acts to heighten their sensitivity to other stimuli, 
though the observed differences in current density could also be due to the presence of 
non-neuronal cells within the TH-negative population. 
 
3.4.4     The Development of Synaptic Inputs 
Synaptic inputs are an important regulator of pacemaking in the SNc neurons of animal 
models (Blythe et al., 2007). In experiments here, co-localisation of the presynaptic 
131 
 
marker synaptophysin, a protein that is ubiquitously expressed at the presynaptic 
terminal, with the postsynaptic marker PSD-95, an NMDA receptor-associated protein, 
was used to indicate the formation of synapses in TH-positive cells in culture. Regions 
of co-localisation were identified in TH-positive cells, indicating that these cells likely 
form synapses in culture. The co-localisation method used involved creating a mask of 
the TH-positive region before semi-automated co-localisation in SynapCountJ was 
performed. The number of counted synapses was highly dependent upon the intensity of 
staining and the threshold values selected for each channel, therefore rather than being 
used as a definite indicator of the presence of synapses or their numbers it was instead 
used as supporting evidence to justify an electrophysiological characterisation of 
synaptic currents. Despite this, the number of synapses counted roughly correlates to 
those found in a previous study on synapses in cortical neurons that used a similar 
staining method. This previous study suggested a count of 5 synapses per neuron after 1 
week in culture, with the number increasing 30 fold after 3 weeks (Cullen et al., 2010). 
They also found that numbers were highly dependent upon plating density. The plating 
density here (20 000/cm2) was lower than that used in this previous study (50 000/cm2) 
which may explain the lower numbers observed here at later weeks compared to this 
previous study. 
Here I show that excitatory spontaneous postsynaptic currents (ESPSCs) were first 
observed from 2 weeks post-differentiation. The amplitude and frequency of events was 
highly variable and did not give clear indications of differences between weeks. Area 
under the events was selected as an indicator of changes. It has been previously used in 
the literature as it is sensitive to all factors including amplitude, frequency and the 
duration of events, giving an indication of the total ion flux during the measured period 
(Potapenko et al., 2011). A large increase in area at week 6 was identified in all cells, 
possibly due to an increase in the number or strength of synapses or other 
developmental changes that occur at this time. This likely indicates a maturation of the 
synapses in culture. 
NMDA and AMPA/Kainate receptors may be responsible for the observed ESPSCs 
under the conditions tested, with data here showing that the simultaneous addition of 
antagonists for these receptors almost completely abolishing ESPSCs. Small excitatory 
currents remained in the presence of these antagonists, which could be accounted for by 
excitatory GABA currents caused by the -42 mV equilibrium potential. Due to time 
constraints this could not looked at in any depth. Further evidence for the presence of 
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NMDA and AMPA receptors comes from two sources: First, from PSD-95 staining, 
which associates with NMDA receptors in postsynaptic regions. Second, from the 
change in ESPSC shape upon the addition of an NMDA receptor antagonist. AMPA and 
NMDA receptors have different kinetic properties with AMPA-associated ESPSCs 
being of shorter duration than the extended decay time seen with NMDA-associated 
currents (which are often AMPA-dependent) (Jeun et al., 2009). This effect was 
identified here, with the addition of the NMDA receptor antagonist D-AP5 reducing the 
duration of ESPSCs. 
Given that cells begin to fire action potentials from 2 weeks in culture and this activity 
is largely dependent on glutamate receptors, it is likely that the development of ESPSCs 
is an instigator of this activity. Cultures here likely began to form mature networks at 
week 6, as seen by the large increase in the area under synaptic events that occurred at 
this time point. This correlates with the large increase in action potential firing 
frequency that occurred after the same time in culture. 
Co-expression of AMPA and NMDA receptors is common throughout the nervous 
system and is critical to processes such as synaptic plasticity (Shi et al., 1999). Since 
NMDA receptors are ligand and voltage-gated while AMPA receptors are simply 
ligand-gated, NMDA receptors require a depolarisation for their activation (Bliss & 
Lomo, 1973). Therefore, they are often co-localised AMPA receptors and the two 
receptor types are able to alter the electrical response of a neuron based on their 
expression. Evidence has shown that block of NMDA receptors can increase firing 
frequency in spinal neurons by reducing background NMDA activity 
(Thaweerattanasinp et al., 2016). It has also been shown that block of AMPA receptors 
can have a similar effect in models of DA neurons depending on which other currents 
are present (Zakharov & Kuznetsov, 2015). These differing roles are backed by their 
kinetic properties. AMPA receptors typically allow the flow of Na+/K+ over Ca2+ 
(though this differs based on subunit composition), are fast activating and inactivating, 
and have a large unitary conductance. NMDA receptors are typically slower to 
inactivate and have a smaller unitary conductance (Hille, 2001). The balance of these 
receptor currents therefore appears to be important for determining the electrical 
response of a synapse and/or neuron. AMPA and NMDA receptors have long been 
known to shift their numbers and localisation in response to electrical activity, 
providing the basis for synaptic plasticity. This allows the strengthening or weakening 
of specific synapses (Lau & Zukin, 2007; Malinow & Malenka, 2002). AMPA receptors 
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are believed to be responsible for short term changes in synaptic strength while NMDA 
receptors, through Ca2+ dependent processes, control changes in long term potentiation 
(Rao & Finkbeiner, 2007). Synaptic plasticity is known to be critical during the 
development of mature neuronal networks (Shi et al., 1999), therefore the increase in 
firing frequency and synaptic currents observed in this thesis is likely to be due to 
increases in the expression of AMPA and NMDA receptors as these neurons mature. 
Ca2+ influx through NMDA receptors is known to be critical for synaptic plasticity (Rao 
& Finkbeiner, 2007). The increase in Ca2+ influx seen via Ca2+ imaging at week 6 
provides further evidence for synaptic activity occurring due to increased expression 
and/or localisation of NMDA receptors. 
 
3.4.5     The Development of Calcium Waves 
Somatodendritic Ca2+ waves have been identified in rat SNc neurons in-vivo and in 
hiPSC-derived TH-positive cells in culture. These are believed be an underlying driver 
for pacemaker activity (Guzman et al., 2009; Hartfield et al., 2014). Here I confirm 
these previous studies, with hiPSC-derived DA neuron-containing cultures producing 
Ca2+ waves in their soma that increase in definition and rhythmicity up to 6 weeks post-
differentiation. Once again, I use the area under the graph as a measure of changes in 
total ion flux. A large increase in Ca2+ influx at week 6 was observed and, since an 
increase in ion flux due to synaptic events was also observed at this time point, is likely 
to be due to synaptic activity. This provides further evidence for the formation of 
mature neuronal networks at this time point. 
These waves have previously been described as subthreshold, i.e., occurring below the 
threshold for action potential firing. Here, in all cultures tested, Ca2+ waves were TTX-
sensitive in all but a small proportion of cells. This indicates that the majority of Ca2+ 
influx was not sub-threshold and was dependent upon action potential firing. It was 
hypothesised that the remaining cells were producing waves innately or due to 
spontaneous neurotransmitter release. The addition of glutamate and dopamine receptor 
antagonists would have determined whether the remaining cells produced Ca2+ waves 
intrinsically, but due to time constraints this experiment has not yet been performed. 
Addition of L-glutamic acid caused an increase in intracellular Ca2+ and, although a 
crude manipulation, demonstrates that Ca2+ waves can also be generated by glutamate 
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receptor activation. This also provides further evidence for the presence of glutamate 
receptors, specifically NMDARs, as they pass Ca2+ in response to glutamate activation. 
The results presented here confirm that these cells develop Ca2+ waves in culture as they 
do in-vivo, though they are likely driven by action potential firing and synaptic input. 
The hyperpolarised activation potential of CaV1.3 could be allowing subthreshold 
activation as a cell approaches threshold, increasing the likelihood of a cell reaching the 
threshold for firing. The majority of Ca2+ influx then occurs in a wave-like fashion 
following an action potential. Previous studies in SNc DA neurons have found that Ca2+ 
influx during action potentials acts to control the shape and timing of pacemaking 
(Surmeier et al., 2017). It is important to note that Ca2+ waves here were investigated in 
the soma and not in dendrites. Subthreshold waves in dendrites have been previously 
described in the literature and cannot be discounted. Many classes of voltage-gated ion 
channels are dendritically expressed in rat SNc neurons, hence there are likely 
differences in electrical properties between the soma and the dendrites of these neurons 
(Dufour et al., 2014). It is also possible, given the relatively short time in culture, that 
subthreshold waves begin to develop in more mature differentiated neurons. As such it 
can be concluded that sub-threshold Ca2+ waves did not develop in the soma up to 6 
weeks post-differentiation. 
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Chapter 4 
 
CaV1.3 Expression and Selective Cell Death in 
hiPSC-Derived Dopaminergic Neurons 
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Abstract 
CaV1.3 L-type voltage gated calcium channels (VGCCs) in dopaminergic (DA) neurons 
of the substantia nigra pars compacta (SNc) are believed to contribute towards their 
selective cell death in Parkinson's disease (PD), though whether human induced 
pluripotent stem cell (hiPSC) -derived DA neurons express this channel had not been 
established. In this chapter I have characterised CaV1.3 immunostaining in this cell type 
during the first 6 weeks post-differentiation from hiPSC-derived neural progenitor cells 
(hNPCs). Whether CaV1.3-positive cells were more vulnerable to cell death in response 
to the DA-specific toxin 6-hydroxydopamine (6-OHDA) or in response to glutamate-
induced excitotoxicity was then investigated. The results show that two morphologically 
distinct populations of hiPSC-derived DA neurons could be identified that were either 
CaV1.3-positive or CaV1.3-negative. A novel, single-stain cell death assay was then 
characterised and used to show that 6-OHDA toxicity developed specifically in neurons 
expressing the DA marker tyrosine hydroxylase (TH). All cells in culture displayed a 
resistance to excitoxicity at concentrations of extracellular glutamate that have 
previously been seen to induce cell death in neuronal cell types. No differences in cell 
death between CaV1.3-positive and CaV1.3-negative DA neurons were identified 
indicating that, at least during the 0-6 week development period investigated, the 
presence of CaV1.3 does not increase the susceptibility of hiPSC-derived DA neurons to 
cell death in response to 6-OHDA or extracellular glutamate. Data here provides 
valuable information on the suitability of hiPSC-derived DA neurons for use as an in-
vitro human PD model, hopefully lead to more targeted, efficient design of PD studies 
that use these neurons. 
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4.1     Introduction 
The selective vulnerability of SNc DA neurons in PD is believed to be partially due to 
Ca2+ influx through VGCCs during pacemaking. VGCC-dependent pacemaking in these 
neurons causes excessive Ca2+ influx into the cytosol. This extra Ca2+ is removed by 
mitochondria at special junction sites with the endoplasmic reticulum. This causes a 
concentration-dependent hyperpolarisation of the mitochondrial membrane which 
results in reactive oxygen species (ROS) production during complex I of the electron 
transport chain (Pacelli et al., 2015). This in turn leads to a number of ROS-protein 
interactions that are damaging to the cell, including oxidised protein products such as 4-
Hydroxynonenal (HNE), damage to the ubiquitin-proteasome system leading to alpha-
synuclein aggregation, and promotion of apoptosis through caspase activation (Okada et 
al., 1999; Liu & Kato, 2000; Hyun et al., 2002).  
SNc DA neurons express a relatively rare class of L-type VGCC, known as CaV1.3. The 
negative-shifted voltage-activation of CaV1.3 channels compared to other L-type 
VGCCs has seen them described as "ideal for pacemaking" and they are believed to be 
responsible for subthreshold somatodendritic Ca2+ waves that help sustain SNc 
pacemaking in-vivo (Chan et al., 2007; Guzman et al., 2009). Inhibition of CaV1.3 
channels can protect DA neurons from the toxic effects of the mitochondrial toxins 1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), rotenone and 6-OHDA at 
concentrations that would normally cause cell death (Chan et al., 2007). The use of L-
type antagonists for the treatment of hypertension is associated with a 30% reduction in 
the risk of developing PD and slows the progression of the disease even when initiated 
after diagnosis (Gudala et al., 2015). Due to these effects, clinical trials for CaV1.3-
specific antagonists such as isradipine are in progress to determine if there is a clinical 
benefit to their use in PD (Biglan et al., 2017). 
Studies into the mechanism of selective cell death in PD have used hiPSC-derived DA 
neurons as a model system in recent years (Woodard et al., 2014) but CaV1.3 expression 
in this cell type has not been characterised. Selective susceptibility of hiPSC-derived 
DA neurons to MPTP has been demonstrated through its effects on the mitochondrial 
membrane potential (Hartfield et al., 2014). However, whether susceptibility to these 
toxins results in an increase in cell death, or if the effect is selective for DA neurons 
within a mixed population culture, has only been demonstrated at lower concentrations 
(Nguyen et al., 2011) and no information is available over whether CaV1.3 expression 
affects their susceptibility to 6-OHDA. SNc DA neurons have also shown susceptibility 
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to glutamate excitotoxicity in the presence of MPTP, though whether hiPSC-derived 
DA neurons show a similar susceptibility has not been investigated (Meredith et al., 
2009).  
Research in this chapter has focused on whether hiPSC-derived DA neurons showing 
immunostaining with antibodies specific for CaV1.3 in culture. If and when these 
neurons show selective death in response to the DA specific toxin 6-OHDA or in 
response to extracellular glutamate was then characterised in cells from 0-6 weeks post-
differentiation at the level of the general cell population, in DA neurons and in CaV1.3-
positive DA neurons to determine any differences in susceptibility between these cell 
populations. 
My results show that CaV1.3 staining is ubiquitous across the majority of cells in culture 
from week 0 hNPCs to week 6 differentiated neurons. Morphologically distinct 
populations of CaV1.3-positive and CaV1.3-negative TH-positive neurons were 
identified from week 1 that may correspond to populations of SNc neurons that have 
previously been identified in rat models (Robertson et al., 1991; Richards et al., 1997). 
6-OHDA toxicity was found to be more specific for TH-positive neurons than TH-
negative neurons, with no difference in toxicity between CaV1.3-positive and CaV1.3-
negative phenotypes. In contrast, all neurons in culture from 0-6 weeks post-
differentiation displayed a resistance to glutamate-induced excitotoxicity at 
concentrations that have previously been reported to result in cell death in other 
neuronal cell types in culture (Kritis et al., 2015). 
By performing this characterisation, valuable information on whether early stage (0-6 
week) hiPSC-derived DA neurons are suitable for studying the mechanisms involved in 
selective cell death in PD has been gained. The benefits and limitations of using these 
cells to model PD will be better understood, hopefully lead to more targeted, efficient 
design of PD studies that use hiPSC-derived DA neurons. 
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4.2     Methods 
 
4.2.1     Culture & Expansion of Human Neural Progenitors 
The protocols for culture and expansion followed the product description guidelines 
from Axol Bioscience. Cells and reagents were obtained from Axol unless otherwise 
stated. Human iPSC-derived neural progenitor cells (hNPCs) were expanded on sterile 
12 well tissue culture plates (Corning) pre-coated with SureBond-XF at a density of 80 
000/cm2 in plating-XF medium. 24 hours after plating, media was replaced with neural 
expansion-XF media supplemented with 20 ng/ml FGF2 and 20 ng/ml EGF. Cells were 
passaged every 5 days and expanded until an optimal quantity were obtained for 
differentiation. Cells were incubated at 37oC and 5% CO2. 
 
4.2.2     Differentiation of hNPCs to Dopaminergic Neurons 
hNPCs were passaged in expansion-XF medium and plated at a density of 30 000/cm2 
onto coverslips pre-coated with SureBond-XF. 24 hours after passage, media was 
changed to STEMdiffTM dopaminergic neuron differentiation medium (STEMcell) 
supplemented with 200ng/ml sonic hedgehog (SHH) (Millipore). Media was changed 
daily for 14 days. The cells were then passaged and plated at a density of 20 000/cm2 
onto glass coverslips pre-coated with SureBond-XF. Media was changed to 
STEMdiffTM dopaminergic neuron maturation medium 1 (STEMcell). Full media 
changes were performed every 48 hours for 5 days. Media was then changed to 
maturation medium 2 (STEMcell) and replaced every 48 hours up to a total culture time 
of 6 weeks. Cells were incubated at 37oC and 5% CO2.  
 
4.2.3     Immunofluorescence Staining 
Coverslips were washed in PBS pre-warmed to 37oC before fixation in 4% 
paraformaldehyde for 10 minutes at room temperature (21oC). 3 washes with ice cold 
PBS were performed and cells were permeabilised with 0.1% Triton X-100 for 10 
minutes at 21oC. Coverslips were washed for 3x 5 minute washes with PBS containing 
0.1% Tween-20 at 21oC before a 30 minute incubation at 21oC in PBS containing 1% 
BSA and 0.1% Tween-20 to prevent non-specific antibody binding. Primary antibody 
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incubation was performed at 21oC for 1 hour in PBS containing 1% BSA and 0.1% 
Tween-20. Coverslips were washed 3x for 5 minutes with PBS containing 0.1% Tween-
20 at 21oC. Secondary antibody incubation was performed for 1 hour in the dark at 21oC 
in PBS containing 1% BSA. All secondary antibodies were conjugated with AlexaFluor 
fluorescent dyes. Coverslips were then washed 3x for 5 minutes with PBS in the dark at 
21oC before mounting on glass microscope slides with the mounting medium Mowiol® 
4-88 and sealing with nail polish. Slides were stored at 4oC until analysis. All reagents 
were acquired from Sigma Aldrich and all antibodies were from Abcam unless stated.  
The antibodies used were I.) rabbit anti- CaV1.3 (Alomone Labs, 1:500) with a goat 
anti-rabbit AlexFluor-488 secondary (1:500) and II.) chicken anti-Tyrosine Hydroxylase 
(1:500) with a goat anti-chicken AlexFluor-568 secondary (1:500). 
 
4.2.4     Confocal Microscopy 
Fixed coverslips were imaged using a TCS SP5 II confocal microscope (Leica) with a 
63x oil objective (NA 1.3). Samples were excited using an argon or white light laser. 
Images were collected using a Hamamatsu camera with 3x frame averaging at an image 
resolution of 1024x1024 pixels. 
Data Analysis: Images were analysed in ImageJ. Calculation of the percentages of 
immunostained cells was performed manually using the cell count plugin. Mean values 
are from 5-10 fields of view per experimental repeat. Cell length, area and number of 
projections were calculated from TH-immunostained images. Cell length was calculated 
as a straight line between the two furthest visible points of the cell. Cell area was taken 
as the total 2D surface area (including soma and processes) and was calculated using the 
analyse particle feature. Number of processes was analysed by drawing a circular region 
of interest around the soma of each cell and manually counting the number of processes 
that cross the circle.  
 
4.2.5     Toxicity Assay 
Confirmation of the staining protocol: 0-6 week differentiated neurons were 
incubated at 37oC, 5% CO2 in 24 well plates with 100 µM Etoposide for 1 hour to 
induce cell death. Cells were stained with the live cell nuclei stain Hoechst 33342 (1 
µM). In some experiments the cells were co-stained using the dead cell nuclei stain 
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propidium iodide (1 µM). Staining was performed for 10 minutes at 37oC, 5% CO2. 
Cells were then washed 5 times with PBS pre-warmed to 37oC before imaging at room 
temperature (21oC). This confirmed that dead cells were stained brighter than live cells 
using Hoechst, hence Hoechst alone could be used to indicate the proportion of cell 
death using the bright: total nuclei ratio. This approach was used in the subsequent 
experiments. 
Toxicity Assay: 0-6 week differentiated neurons were taken weekly and incubated at 
37oC, 5% CO2 for 24 hours with varying concentrations of 6-OHDA or L-glutamic acid. 
The cells were then washed 5x using PBS pre-warmed to 37oC before staining with 
Hoechst 33342 (1 µM) for 10 minutes at 37oC, 5% CO2. The cells were then washed 5 
times with PBS pre-warmed to 37oC before imaging. After imaging, cells were 
immunostained for CaV1.3 and TH as described in 4.2.3. Images were once again taken 
after staining. 
Imaging: Images were collected using a FLoid Cell Imaging Station USB microscope 
with a 20x objective (NA 0.45) at room temperature (21oC). Imaging data for cells 0-6 
weeks post-differentiation for Hoechst (Ex: 390 nm, Em: 446 nm) and after 
immunostaining for Hoechst, CaV1.3 (Ex: 482 nm, Em: 532 nm) and TH (Ex: 586 nm, 
Em: 646 nm) were collected from 3-10 fields of view for each concentration of each 
drug and analysed in ImageJ. Each concentration was repeated a minimum of 3 times to 
allow for statistical analysis, with pooling of data from multiple weeks required to 
achieve this where necessary. 
Data Analysis: Semi-automatic nuclei counting for Hoechst and/or Propidium iodide 
was performed using ImageJ. First, images were threshold adjusted to remove artefacts 
within the image. For Hoechst staining the process was repeated separately using two 
different thresholds: I.) one that removed artefacts but left all Hoechst nuclei in the 
image intact; and II.) one that removed artefacts and dim nuclei, leaving only bright 
Hoechst nuclei in the image intact. This allowed for ratiometric counting of live/dead 
nuclei (Supplementary 4.1). The watershed function was used to separate conjoined 
nuclei. The analyse particle function was then used to automatically count nuclei using a 
10 pixel particle exclusion filter. Nuclei on the edges of the images were excluded. 
Nuclei counting from Hoechst images after immunostaining was manually matched to 
the TH and CaV1.3 immunostained images to determine if individual TH or CaV1.3 
positive or negative cells displayed dim/bright nuclei. Calculation of means and S.E.M 
was performed in Excel. The percentage of bright nuclei vs total nuclei for the whole 
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cell population, for TH-positive cells only, for TH-negative cells only and for TH-
positive+CaV1.3 positive cells was used as an indicator of the percentage of cell death in 
each population. 
 
4.2.6     Graphs & Statistical Analysis 
All graphs and curve fitting were performed using OriginPro 8.5. Statistical analysis 
was performed using an appropriate statistical test in Excel using the XLSTAT plugin 
(t-tests, Pearson’s R tests, ANOVAs or KS-tests). The exact test used and their 
associated significance values are reported in the text. Differences were considered 
statistically significant when p <0.05. Asterisks (*) on graphs indicate statistical 
significance at this p-value. Errors bars in all graphs and ± values in the text use the 
standard error of the mean (S.E.M.) which was calculated in Excel. 
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4.3     Results 
4.3.1     CaV1.3 Expression in hiPSC-Derived Dopaminergic Neurons 
SNc DA neurons in-vivo express CaV1.3 L-type VGCCs. This subtype is believed to be 
involved in the selective death of these neurons in PD. To determine whether hiPSC-
derived DA neurons express CaV1.3 in culture, cells were immunostained against the 
DA neuron marker TH and against CaV1.3 from 0-6 weeks post-differentiation. CaV1.3 
staining was seen in all hNPCs at week 0, with near ubiquitous staining seen in both 
TH-positive and TH-negative neurons from 1 to 6 weeks post-differentiation (Figure 
4.1A). Positive and negative controls using human CaV1.3 antigen and lacking 
primary/secondary antibodies confirmed the specificity of the antibody for CaV1.3 and 
proved staining was not due to non-specific antibody binding (Supplementary 4.2).  
From week 1 onwards, a population of TH-positive cells was identified as CaV1.3-
negative. These comprised a small proportion of the TH-positive population (Figure 
4.1B). Interestingly, the presence of CaV1.3 could be predicted based on cell 
morphology. CaV1.3-positive TH-positive cells were typically elongated with spindle 
shaped somas and long processes extending from both poles (Figure 4.2). CaV1.3-
negative cells appeared to have larger somas and a greater number processes (Figure 
4.3). To quantify these observed differences in morphology, the mean cell length, 2D 
surface area and number of processes was calculated for both phenotypes, with data 
pooled from weeks 1-6 to allow for statistical analysis (n=6). The mean whole cell 
surface area was 341.93 ± 42.57 µm2 for CaV1.3-positive versus 341.504 ± 39.6 µm
2 for 
CaV1.3-negative cells. The mean surface area of the soma was 98.16 ± 13.58 µm
2 for 
CaV1.3-positive versus 154.43 ± 21.59 µm
2 for TH-negative cells. No statistical 
difference in surface area was observed between phenotypes (Student's t-test, whole 
cell: p=0.989, soma: p=0.519) (Figure 4.4A). Mean cell length was 150.56 ± 14.72 µm 
for CaV1.3-positive versus 115.53 ± 6.33 µm for CaV1.3-negative cells, with no 
significant difference between the two (Student's t-test, p=0.054) (Figure 4.4B). 
However, the mean number of processes was significantly lower in CaV1.3-positive 
cells at 2.3 ± 0.06 compared to CaV1.3-negative TH-positive cells at 4.42 ± 0.62 
(Student's T-test, p=0.007) (Figure 4.4C). A histogram of the number of processes 
(n=81 CaV1.3-positive, 29 CaV1.3-negative) showed that CaV1.3-negative cells 
displayed greater variance in their number (Figure 4.4D). The Kolmogorov-Smirnov 
test to compare differences between distributions showed there was a significant 
difference between the distributions of the two groups (D=0.558, p<0.0001). 
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Figure 4.138- CaV1.3 immunostaining in cultures containing hiPSC-derived DA neurons. (A) 
Representative confocal images from neurons 0, 1 and 6 weeks post-differentiation that were 
immunostained for TH (red) and CaV1.3 (green). (B) Graph showing the percentage of TH-positive 
neurons that are CaV1.3-positive (green) and CaV1.3-negative (black). Data is pooled from 1-6 weeks 
post-differentiation (n=6). Error bars ± S.E.M. 
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Figure 4.239- CaV1.3 positive hiPSC-derived dopaminergic neurons. Representative confocal images 
from 5 TH-positive neurons from 1-6 weeks post-differentiation that were immunostained for TH (red) 
and CaV1.3 (green). 
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Figure 4.340- CaV1.3 negative hiPSC-derived dopaminergic neurons. Representative confocal images 
of 5 TH-positive neurons from 1-6 weeks post-differentiation that were immunostained for TH (red) and 
CaV1.3 (green). 
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Figure 4.441- Morphological characterisation of CaV1.3-positive and CaV1.3-negative hiPSC-derived 
DA neurons. Graphs from week 1-6 TH-positive neurons showing (A) the mean 2D surface area from the 
whole cell and soma (n=6). (B) The mean cell length between the two furthest poles (n=6). (C) The mean 
number of processes originating from the soma (n=6). (D) Histogram of data showing the percentage of 
cells that have each number of processes (CaV1.3+, n=81. CaV1.3-, n=29). Error bars ± S.E.M. *indicates 
statistical significance at p=0.05 using a two-way Student’s t-test (A) (B) (C) or a Kolmogorov-Smirnov 
test (D). 
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4.3.2     Selective 6-OHDA Susceptibility in hiPSC-Derived Dopaminergic Neurons 
DA neurons in-vivo are selectively killed by 6-OHDA, a toxin that causes oxidative 
damage and dysfunction of mitochondrial metabolism after uptake through dopamine 
reuptake transporters. This susceptibility is often exploited to model PD in-vivo using 
lesioned animal models (Schwarting & Huston, 1996). If hiPSC-derived DA neurons 
are to be used as a human model of PD then they must be able to show a similar 
susceptibility to 6-OHDA. To determine whether this susceptibility exists and whether 
it is specific to TH-positive neurons in culture, cells were exposed to various 
concentrations of 6-OHDA for 24 hours from 0-6 weeks post-differentiation.  
To act as a cell death assay, cells were co-stained with the live cell nuclei stain Hoechst 
33342 and the dead cell nuclei stain Propidium iodide (PI). To validate this method, 
week 4-6 differentiated neurons were incubated with Etoposide, a toxin which induces 
cell death through DNA breaks. More PI staining was identifiable in toxin-incubated 
cells compared to controls (Figure 4.5A). An unexpected result was that Hoechst 
staining was at least 3 fold brighter in PI stained cells than non-PI stained cells (n=3) 
(Student's t-test, p=0.016) (Figure 4.5A, 4.5B). This effect persisted when cells were 
stained for Hoechst alone, with identifiable 'bright' nuclei and 'dim' nuclei (n=3) 
(Student's t-test, p=0.015) (Figure 4.6A, 4.6B). This effect was also able to survive 
through fixation and permeabilization, though with a reduced intensity (n=3) (Student's 
t-test, p=0.007) (Figure 4.6A, 4.6C). Staining was seen in nuclei stained for PI alone, 
confirming that the PI staining seen while co-staining with Hoechst was due to cell 
death and not an artefact due to fluorescence bleed through from high intensity Hoechst-
stained nuclei (Figure 4.6B). 
To determine whether Hoechst alone could be used to calculate the percentage of cell 
death in a culture (and hence allow the PI excitation channel to be used for antibody 
staining), co-localisation analysis of Hoechst-stained 'bright' nuclei and PI-stained 
nuclei was performed. Little co-localisation was seen between PI and Hoechst when 
comparing whole fields of cells, with a mean Pearson's R-value of 0.42 ± 0.11 (n=3) 
(Figure 4.7A). When co-localisation analysis was restricted to only 'bright' Hoechst 
nuclei a higher degree of linear correlation was seen, with a mean Pearson's R-value of 
0.83 ± 0.07 (n=3) (Figure 4.7B).  
No difference in the mean percentage of cell death in neurons incubated with Etoposide 
or in controls was identified when using either the PI:total Hoechst nuclei ratio or the 
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'bright' Hoechst:total Hoechst nuclei ratio (Student's t-test, Etoposide: p=0.899, control: 
p=0.605) (n=5) (Figure 4.7B). From this it was concluded that Hoechst staining alone 
can be used to determine the percentage of dead cells in a culture and was at least as 
accurate as co-staining with PI and Hoechst. This single staining method was used in all 
subsequent cell death assays. 
To determine whether selective cell death occurs in response to DA toxins, neurons 
were incubated with varying concentrations of 6-OHDA from 0-6 weeks post 
differentiation to generate dose-response curves based on percentage of cell death (n=3 
to 4 per concentration). More Hoechst staining was seen in week 1-6 neurons compared 
to week 0 neurons at high concentrations of 6-OHDA (Figure 4.8A). Pooled data from 
weeks 1-6 could be fitted with a Boltzmann function and the concentration at which 
50% of the population displayed cell death (LD50) was shifted towards lower 
concentrations compared to week 0 (Figure 4.8B). Cell death was still seen in week 0 
neurons though higher concentrations were required to elicit an effect, perhaps 
indicating a general toxicity of 6-OHDA at higher concentrations (Figure 4.8B). 
Performance of one-way ANOVAs showed a significant effect of concentration on % 
cell death (F=23.695, p<0.0001) and a Tukey comparison test showed a significant 
statistical difference between week 0 and week 1-6 cells (p<0.0001). The percentage of 
cell death in controls incubated without 6-OHDA remained consistently below 15% and 
dropped between weeks 0 and 6 (Figure 4.8C). Cell death in week 1-6 neurons 
appeared to plateau at ~60% of the general population (Figure 4.8B), suggesting that 6-
OHDA was selective for a subpopulation of neurons. 
To determine whether TH-positive neurons were being selectively destroyed, week 1-6 
6-OHDA incubated neurons were immunostained against TH and CaV1.3 after Hoechst 
staining (Figure 4.9A). TH-positive neurons were selectively destroyed, with almost 
100% cell death at 100-200 µM 6-OHDA compared to ~60% for TH-negative cells at 
200 µM (Figure 4.9B). 6-OHDA incubated TH-positive neurons typically displayed 
small, condensed nuclei typical of apoptosis/necrosis which were seen in fewer TH-
negative neurons. The performance of one-way ANOVAs showed a statistically 
significant effect of concentration on % cell death for both conditions (TH-positive: 
F=117.863, p<0.0001; TH-negative: F=55.973, p<0.0001). A significant effect was 
found between TH-positive and TH-negative cells (F=11.181, p<0.0001).  
Both CaV1.3-positive and CaV1.3-negative TH-positive neurons were affected by 6-
OHDA, with one-way ANOVAs showing a statistically significant effect of 
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concentration on % cell death (CaV1.3+: F=37.411, p<0.0001; CaV1.3-: F=10.221, 
p<0.0001) (Figure 4.9C). The dose-response curves for CaV1.3-positive and CaV1.3-
negative TH-positive neurons displayed little difference, and a one-way ANOVA 
showed no statistical difference between subjects (F=0.106 p=0.751), indicating that 
CaV1.3 expression does not increase the susceptibility of week 1-6 TH-positive neurons 
to cell death in response to 6-OHDA. 
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Figure 4.542- Hoechst 33342 as a differential live/dead cell dye. (A) Representative false-colour 
fluorescence images from Hoechst/PI-stained week 4 neurons before and after 1-hour incubation with 100 
µM Etoposide. Arrows indicate 'bright' (white arrow) and 'dim' (yellow arrow) nuclei, showing that 
'bright' nuclei also stain for PI. In composite images, magenta indicates regions of overlap between the 
two dyes. (B) Graph showing mean fluorescence intensity for Hoechst-stained nuclei that were co-
localised or not co-localised with PI (n=3). Error bars ± S.E.M. *indicates statistical significance using a 
two-way Student's t-test at p=0.05. 
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Figure 4.643- Hoechst 33342 live/dead identification could be performed after fixation. (A) 
Representative fluorescence images from week 4-6 differentiated neurons incubated with Etoposide for 1 
hour showing Hoechst staining (left, left panel) before and (left, right panel) after 
fixation/permeabilization and (B) a separate experiment showing PI staining alone before 
fixation/permeabilization. (C) Graph showing the mean fluorescence intensity of 'bright' and 'dim’ 
Hoechst-stained nuclei before and after fixation and permeabilization (n=3). Error bars ± S.E.M. 
*indicates statistical significance using a two-way Student's t-test at p=0.05. 
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Figure 4.744- Co-localisation of Hoechst 33342 and PI. Representative 2D intensity scatter plots from 
week 1-6 differentiated neurons incubated with 100µM Etoposide showing (A) a whole field of view of 
Hoechst and PI stained cells and (B) a region of interest from A containing only 'bright' Hoechst nuclei. 
(C) Graph comparing the mean percentage of cell death in neurons with and without Etoposide incubation 
when using the 'bright' vs total Hoechst nuclei ratio (blue) or the PI-stained nuclei vs total Hoechst nuclei 
ratio (red) (n=5). Error bars ± S.E.M. 
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Figure 4.845- 6-OHDA toxicity develops in cultures containing hiPSC-derived DA neurons. (A) 
Representative fluorescence images from week 0 and week 6 neurons before and after incubation with 50 
µM 6-OHDA for 24 hours. Graphs showing (B) the mean percentage of cell death after 24 hour 
incubation with 6-OHDA in week 0 and week 3-6 neurons. Dotted lines indicate LD50. Data points are 
fitted using Boltzmann functions. (C) The mean percentage of cell death in controls incubated for 24 
hours without 6-OHDA from weeks 0-6. n=3 to 4 per concentration/time point. Error bars ± S.E.M. 
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Figure 4.946- TH-positive neurons are selectively susceptible to 6-OHDA. (A) Representative 
fluorescence images of neurons 6 weeks post-differentiation that were immunostained for TH (red) and 
CaV1.3 (green) after staining with 1 µM Hoechst 33342. Graphs of the mean percentage of cell death 
using pooled dated from week 1-6 neurons following 24 hours 6-OHDA incubation showing (B) TH-
positive vs TH-negative neurons and (C) CaV1.3-positive vs CaV1.3-negative TH-positive neurons. n=3-5 
per concentration. Dotted lines indicate LD50. Error bars ± S.E.M. 
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4.3.3     Glutamate Excitotoxicity in hiPSC-Derived Dopaminergic Neurons 
It has previously been shown that glutamate excitotoxicity plays a role in the selective 
death of SNc DA neurons in PD. Excessive activation of glutamate receptors, such as 
NMDARs and AMPARs, results in an increased cytosolic Ca2+ concentration which 
results in a cascade of effects that lead to cell death (Gupta et al., 2013). Whether 
hiPSC-derived DA neurons are susceptible to glutamate excitoxicity and whether or not 
there is any difference in susceptibility between TH-positive and TH-negative neurons 
in culture has not been identified. 
To determine whether hiPSC-derived DA neurons display glutamate excitotoxicity, 
cultures were incubated for 24 hours with varying concentrations of L-glutamic acid 
from 0-6 weeks post-differentiation (n=3-6 per concentration). Hoechst staining 
revealed no increase in cell death in week 0 neurons or in pooled data from weeks 3-6 at 
L-glutamic acid concentrations ranging from 100 µM to 10 mM (Figure 4.10A, 4.10B). 
These concentrations have previously been reported as toxic to various neuronal cell 
types in culture (Kritis et al., 2015). Addition of 100 mM L-glutamic acid increased cell 
death in week 3-6 but not week 0 cells (Figure 4.10B). The performance of one-way 
ANOVAs showed no statistical effect of concentration on % cell death for week 0 or 
week 3-6 cells (week 0: F=0.884, p=0.47; weeks 3-6: F=2.189, p=0.129). No statistical 
difference was observed between week 0 and week 3-6 neurons (F=0.18, p=0.683). Cell 
death in controls incubated without L-glutamic acid was high at week 0 (26.36 ± 7.45%) 
but dropped in the following weeks to 4.43 ± 1.89% at week 6 (Figure 4.10C). 
To determine any differences in susceptibility to glutamate excitotoxicity between TH-
positive and TH-negative neurons, cells were immunostained for TH and CaV1.3 
following Hoechst staining (Figure 4.11A, 4.11B). One-way ANOVAs showed a 
significant effect of concentration on % cell death in both TH-positive and TH-negative 
cells (TH+: F=3.87, p=0.041; F=3.641, p=0.048). No difference was observed between 
the dose-response curves for TH-positive and TH-negative neurons (F=0.515, p=0.504).  
Separating TH-positive cells into CaV1.3-positive and CaV1.3 negative cells showed a 
similar trend to previous populations (Figure 4.11B). One-way ANOVAs showed no 
statistically significant effect of concentration on % cell death for CaV1.3-positive nor 
CaV1.3-negative TH-positive neurons (CaV1.3+: F=0.585, p=0.636; CaV1.3-: F=0.089, 
p=0.965). No significant difference was observed between CaV1.3-positive and CaV1.3-
negative cells (F=0.025, p=0.88). 
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Figure 4.1047- Glutamate excitotoxicity in cultures containing hiPSC-derived dopaminergic neurons. 
(A) Representative Hoechst-stained fluorescence images showing neurons 0 and 6 weeks post-
differentiation that have been incubated with 0, 10 or 100 mM L-glutamic acid for 24 hours. (B) Graph 
showing the mean percentage of cell death in week 0 and week 3-6 differentiated neurons after incubation 
with varying concentrations of L-glutamic acid (n=3 to 6 per concentration). (C) Graph showing the mean 
percentage of cell death each week post-differentiation in controls incubated without L-glutamic acid. 
n=3 to 4 per week. Error bars ± S.E.M. 
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Figure 4.1148- TH-positive neurons are not selectively susceptible to glutamate excitotoxicity. Graphs 
showing the mean percentage of cell death in (A) TH-positive vs TH-negative neurons and (B) CaV1.3-
positive vs CaV1.3-negative TH-positive neurons in response to 24 hour incubation with increasing 
concentrations of L-glutamic acid. Data was pooled from 3-6 weeks post-differentiation. Error bars ± 
S.E.M. 
 
 
4.4     Discussion 
The L-type VGCC subtype CaV1.3 is believed to play a role in the selective death of 
SNc DA neurons in-vivo by increasing cytoplasmic Ca2+ levels during pacemaking. This 
in turn leads to accumulation of Ca2+ in mitochondria and, in combination with other 
stressors, leads to a collapse of the mitochondrial membrane potential (Pacelli et al., 
2015). Whether CaV1.3 is expressed in hiPSC-derived DA neurons had not been 
investigated. This chapter has focused on characterising CaV1.3 immunostaining in 
hiPSC-derived TH-positive cells. Here I show that CaV1.3 was identified at all stages of 
development in the majority of cells in culture and that its expression precedes 
differentiation to different phenotypes. It has previously been reported that CaV1.3 is 
expressed in NPCs in mice and may be critical for their development and differentiation 
(Marschallinger et al., 2015). 
Two distinct populations of TH-positive cells were identified here. CaV1.3-positive cells 
made up the majority of TH-positive cells. These were spindle shaped and typically had 
two processes extending from both poles of the cell. CaV1.3-negative cells composed a 
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small proportion of the TH-positive population. These had a more varied number of 
processes and a slight tendency towards larger cell bodies. Rat studies of the SNc in-situ 
have identified long, spindle shaped neurons projecting towards the basal ganglia while 
short, diffuse neurons were seen projecting locally (Richards et al., 1997). Projections to 
other regions of the substantia nigra such as the pars reticulata have also been identified, 
with these cells displaying dendritic release of dopamine (Robertson et al., 1991). The 
two subpopulations of DA neuron I have identified here may therefore correspond to 
some of these previously observed populations. 
Previous studies on hiPSC-derived DA neurons have shown that they are susceptible to 
the effects of mitochondrial toxins such as MPTP and 6-OHDA (Nguyen et al., 2011; 
Hartfield et al., 2014). Whether this susceptibility results in an increased incidence of 
cell death had only previously been investigated at lower concentrations of 6-OHDA 
than those used here (Nguyen et al., 2011). It was also not known whether CaV1.3 
expression increases the susceptibility of TH-positive neurons to 6-OHDA. Here I 
show, by incubating week 0-6 cultures with 6-OHDA, that cell death is selective for 
TH-positive cells, with general toxicity occurring at higher concentrations perhaps due 
to the fact that 6-OHDA auto-oxidises to release free radicals in solution (Padiglia et al., 
1997). This also provides further evidence of the DA phenotype of these cells. No 
increase in cell death in CaV1.3-positive vs CaV1.3 negative TH-positive cells was seen 
over the course of 6 weeks. This does not discount the possibility that an increase in cell 
death would be seen at later stages of maturity when synapses have fully developed or 
that CaV1.3 expression in these neurons increases susceptibility to other mitochondrial 
toxins such as MPTP, as has been seen recently in primary neurons (Wang et al., 2017). 
Glutamate excitotoxicity has been observed in SNc neurons, an effect that is increased 
after exposure to low levels of mitochondrial complex IV inhibitors. This has led to the 
idea that excitotoxicity may be involved in the selective cell death of SNc DA neurons 
in PD (Meredith et al., 2009). The presence of glutamate excitotoxicity in hiPSC-
derived DA neurons had not previously been investigated. Here I show that all of the 
cells in culture, whether week 0 or week 6, showed a remarkable resistance to cell death 
in response to L-glutamic acid. Studies investigating glutamate excitotoxicity in various 
neuronal cell types in culture have reported variable concentrations, from 0.1 to 100 
mM, and variable timescales, from 1 to 72 hours, for death to occur (Kritis et al., 2015). 
The results observed here do not discount several possibilities: that more mature hiPSC-
derived DA neurons develop toxicity to glutamate; that incubation with L-glutamic acid 
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for an extended period may elicit an effect; or that glutamate excitotoxicity in these cell 
types requires other stressors to occur, as has previously been identified in primary SNc 
neurons (Meredith et al., 2015). 
The results from this chapter suggest that hiPSC-derived DA neurons immunostain for 
CaV1.3 in a similar fashion to SNc DA neurons in-vivo, though staining was not 
restricted to TH-positive subpopulations. TH-positive cells, as expected, were 
selectively susceptible to 6-OHDA. hiPSC-derived DA neurons, however, may not be 
suitable for the study of glutamate excitotoxicity in PD as they showed a remarkable 
resistance to its effects. CaV1.3-positive cells did not display an increased susceptibility 
to cell death in response to either toxin, at least during the early development period 
tested. 
 
4.4.1     CaV1.3 Expression in hiPSC-Derived Dopaminergic Neurons 
SNc DA neurons in-vivo express CaV1.3, a relatively rare subtype of L-type VGCC that 
are believed to be involved in the mechanism of selective cell death of SNc neurons in 
PD. This was demonstrated by CaV1.3-/- mice, whose SNc neurons developed 
pacemaking normally via the compensatory effect of HCN channels but developed a 
resistance to mitochondrial toxins when compared to wild type mice (Chan et al., 2007). 
Here I demonstrate that CaV1.3-negative and CaV1.3-positive hiPSC-derived DA 
neurons develop in culture when using the differentiation protocol used here. The 
CaV1.3-positive cells were observed to be elongated with long projections from both 
poles while the CaV1.3-negative cells typically had a more varied number of 
projections. 
A previous study of rat nigral neurons in-vivo found phenotypes similar to those 
identified here, with spindle shaped cells producing long projections to regions of the 
basal ganglia and short, diffuse GABAergic neurons projecting to cells in their local 
environment (Richards et al., 1997). Local SNc projections to other regions of the 
substantia nigra such as the pars reticulata have also been identified, with these cells 
displaying dendritic release of dopamine (Robertson et al., 1991). Other regions of the 
midbrain, such as the ventral tegmental area, contain CaV1.3-negative DA neurons that 
instead rely on NaV channels to control pacemaking (Khaliq & Bean, 2010). Here I 
provide evidence for a potential link between these previous studies, suggesting that the 
morphologically distinct populations seen in these in-vivo studies possibly correspond 
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to cells that are positive or negative for CaV1.3. The spindle shaped cells with long 
projections seen in-vivo projecting to the basal ganglia may correspond to CaV1.3-
positive cells, while the diffuse CaV1.3-negative cells with many projections may 
correspond to neurons that are closer in phenotype to either the locally projecting 
GABAergic neurons, ventral tegmental area neurons or to those that project to the pars 
reticulata. The presence of D2 autoreceptors on SNc neurons in-vivo suggests that local 
release of dopamine may aid in the regulation of pacemaking (Hooper et al., 1997). For 
this to occur, projections from DA neurons to nearby cells must occur. The short, 
diffuse, CaV1.3-negative DA neurons identified here could correspond to the in-vivo 
variants of these cells and suggests that hiPSC-derived DA neuron cultures contain cells 
that correspond to more than one in-vivo phenotype. Co-release of GABA and 
dopamine has also been seen in other neuronal cell types so, although little to no 
GABAergic input was seen in chapter 3 (perhaps due to the solutions used) and GABA 
co-release hasn't been identified in the SNc in-vivo, it is a possibility that is at least 
worth consideration (Richards et al., 1997; Tritsch et al., 2016). 
Another possibility is that these CaV1.3-negative cells may not be neuronal in nature. 
TH has been identified in non-neuronal cell types such as pancreatic islet progenitors, 
though considering the cultures here are differentiated from NPCs it seems unlikely that 
these cell types could be generated (Teitelman et al., 1993). Another suggestion is that 
these cells could be other, non-DA neurons. TH is involved in the production of 
catecholamines other than DA such as adrenaline and noradrenaline so these types of 
neurons could result in false-positive TH-staining. Although rare, adrenergic and 
noradrenergic input has been identified in the SNc so this possibility should perhaps be 
investigated in future studies (Mejías-Aponte et al., 2009). 
The specificity of the antibodies should be considered when interpreting the results. The 
epitope for the CaV1.3 antibody used corresponds to amino acids 859-875 of rat CaV1.3. 
This region lies between the alpha subunit domains II and III and is conserved between 
species such as human, mouse, hamster and chicken. This region is specific to CaV1.3, 
and is not found in other common subtypes such as CaV1.2 (Hui et al., 1991; Soldatov, 
1994) (Alomone labs website, http://www.alomone.com/p/anti-cav1.3/acc-005/1023). 
The antibody used here has previously been used to differentiate between the expression 
of CaV1.2 and CaV1.3 in cell types such as the cultured DA cell line SH-SY5Y, mouse 
cortical astrocytes and mouse spiral ganglion neurons (Lv et al., 2014; Cheli et al., 
2016; Sun et al., 2017). Control experiments were performed here, with no fluorescence 
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being identified when the CaV1.3 primary antibody was first incubated with the CaV1.3 
epitope. Other control experiments confirmed that the primary antibody did not display 
auto-fluorescence and that the secondary antibody did not display non-specific binding. 
Data here, in combination with data from previous studies, demonstrates that the CaV1.3 
antibody used appears to be specific for CaV1.3 over other VGCC subtypes. 
Time constraints meant that an in-depth time course of CaV1.3 immunostaining in 
culture could not be performed. To acquire enough data for statistical analysis, data 
from weeks 1-6 was pooled together. This could have the effect of masking 
morphological differences due to changes in cell length, area and number of processes 
in the general population as the cells mature. Therefore, only gross differences are likely 
to have been identified. Despite this, differences were observed between phenotypes 
and whether a TH-positive neuron stained for CaV1.3 or not could be predicted with a 
reasonably high degree of accuracy based on its morphology.  
The results here confirm that hiPSC-derived DA neurons are suitable for studies into the 
role of CaV1.3 pacemaking in PD, though care must be taken to ensure that CaV1.3-
positive cells and not the CaV1.3-negative variants are being investigated. 
 
4.4.2     Selective 6-OHDA Susceptibility in hiPSC-Derived Dopaminergic Neurons 
SNc neurons in-vivo are selectively destroyed by 6-OHDA, a toxin that produces ROS 
after entering the cell through dopamine reuptake transporters. One study in rats found a 
loss of ~10-15% of TH-positive neurons in the SNc after 7 days of 100 µM 6-OHDA 
incubation (Zhang et al., 2012). Here I confirm the same selective cell death is present 
in hiPSC-derived DA neuron-containing cultures and is specific for TH-positive cells. 
This selectivity has previously been identified in these neurons in-vitro, though only at 
low concentrations that resulted in a low occurrence of cell death in culture (Nguyen et 
al., 2011). This previous study used concentrations from 1-10 µM 6-OHDA, identifying 
~15% of TH-positive neurons expressing the cell death marker Caspase-3 compared to 
~6% of TH-negative cells and ~3-5% of controls incubated without 6-OHDA after 35 
days in culture. Here I confirm this, with a similar selectivity seen in TH-positive 
neurons (~15% compared to ~10% of TH-negative at 10 µM). My data go further, 
showing selectivity of 6-OHDA hiPSC-derived TH-positive cells at concentrations up 
to 200 µM. Data here also shows that this selectivity is not present in hNPCs, instead 
developing after differentiation. 
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The death of TH-negative cells could be attributed to several factors. 6-OHDA is 
rapidly oxidised in solution if not in the presence of an anti-oxidant (Padiglia et al., 
1997). To prevent or slow down oxidation, the anti-oxidant ascorbic acid was added to 
all solutions and cell media containing 6-OHDA. Despite this, oxidation likely still 
occurred at a slower rate, releasing ROS into the media resulting in toxic effects. A 
proportion of "TH-negative" cells may also be expressing low levels of TH that are not 
easily detected through immunostaining and fluorescence imaging. A less likely reason 
is that the TH-negative cells have a limited capability to uptake 6-OHDA, either 
through the expression of dopamine uptake transporters or through other means such as 
endocytosis. A previous study on hiPSC-derived DA neuron-containing cultures found 
that these neurons are susceptible to mitochondrial membrane potential changes in 
response to MPTP, a mitochondrial toxin that is often used in animal models to induce 
Parkinsonian-like symptoms (Tieu, 2011). Though this was not investigated, my data 
provide a link to this study by suggesting that the observed mitochondrial membrane 
potential changes may be the cause of the selective death of TH-positive cells in 
response to exposure to 6-OHDA. 
Block of CaV1.3 channels has previously been found to reduce DA cell death in disease 
models and reduce the incidence of PD in clinical trials (Chan et al., 2007; Gudala et al., 
2015). However, in the experiments performed here, CaV1.3-positive cells were not 
found to be more susceptible to cell death than CaV1.3-negative cells. Since Ca
2+ influx 
due to CaV1.3 VGCCs is linked to pacemaking and a previous study on hiPSC-derived 
DA neurons that looked at their later development (6-12 weeks) found an increased 
frequency and rhythmicity to their pacemaking at later weeks (Hartfield et al., 2014), it 
could be that hiPSC-derived DA neurons at 0-6 weeks in development have not yet 
developed fully mature pacemaking and hence are not yet susceptible to CaV1.3-related 
mitochondrial stress. This is supported by data from Chapter 3 that suggests there is a 
developmental shift at 6 weeks post-differentiation that likely indicates the beginning of 
the formation of mature neuronal networks. 
The use of dedicated live/dead cell dyes to assess cell death was considered, though the 
difference in brightness between live and dead nuclei made it difficult to assess both in 
fluorescent images using the imaging tools that were available. Therefore the common 
two-staining method of using the live nuclei stain Hoechst 33342 and the apoptotic 
nuclei stain PI was used with the idea of using the ratio of the two as an indicator of cell 
death. The finding that Hoechst staining was several fold brighter in dead cells and 
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could therefore distinguish between live/dead nuclei was an unexpected result. Upon 
discovery, this effect was extensively characterised to determine whether it was suitable 
for use as a single-stain cell death marker. The relative difference in brightness between 
live and dead nuclei using this method was much lower (3x compared to 50x) than 
commercially available live/dead cell dyes and therefore allowed analysis of all nuclei 
in a single image without saturation while also allowing immunostaining at the 
excitation wavelength where PI would have been used. If higher concentrations of 
Hoechst or longer incubation times were used no difference in brightness was observed. 
It has been suggested in the literature that Hoechst has a lower rate of diffusion than 
other nuclei stains such as DAPI and, although live cell permeable, it is slow to pass 
through living membranes (Park et al., 1985). All of this suggests that the observed 
effect was highly dependent upon the concentration, incubation time and cell type used. 
Considering that PI is known to stain late apoptotic and necrotic cells rather than early 
apoptotic cells, it was assumed from the results that bright Hoechst nuclei were also late 
apoptotic/necrotic. "Dead" is therefore used as a term that encompasses both apoptotic 
and necrotic as differences between the two were not assessed. It is worth mentioning 
that this Hoechst approach likely does not distinguish between live and early apoptotic 
cells and may therefore miss cells that are starting to undergo apoptosis in response to 
6-OHDA and glutamate incubation. 
The use of a ration method to calculate cell death in Hoechst-stained cells was a novel 
approach I designed during these experiments. By calculating the number of bright 
"dead" nuclei as a percentage of the total number of stained nuclei it gives the 
percentage of dead cells in each condition. This method was relatively robust, with the 
brightness difference in live-stained cells being capable of surviving fixation and 
immunostaining. The effect was, however, very dependent upon the Hoechst 
concentration and time of incubation, with periods longer than 10 minutes at 37oC 
tending to saturate the nuclei, and periods of less than 8 minutes leaving the brightness 
difference too small to accurately quantify. With careful consideration of these facts, 
along with some degree of optimisation for different cell types, I believe this assay can 
be a simple, cheap and effective way of determining late stage cell death in cultures. 
The results here show that hiPSC-derived DA neurons are selectively destroyed by 6-
OHDA similar to SNc neurons in-vivo and primary neurons in culture. CaV1.3 
expressing hiPSC-derived DA neurons were not more susceptible to 6-OHDA than their 
CaV1.3-negative variants during the first 6 weeks post-differentiation. The results also 
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suggest that Hoechst 33342 can be used as a live/dead cell dye depending on the 
concentration, incubation time and cell type studied. 
 
4.4.3     Glutamate Excitotoxicity in hiPSC-Derived Dopaminergic Neurons 
Many neuronal cell types display excitotoxicity where, in the presence of high 
extracellular concentrations of the neurotransmitter glutamate, excessive glutamate 
receptor activation results in increased cytosolic Ca2+ concentrations. This leads to cell 
death either through apoptosis or autophagy (Kritis et al., 2015). Previous studies have 
suggested that SNc DA neurons are vulnerable to glutamate excitotoxicity and become 
increasingly susceptible in the presence of mitochondrial toxins such as MPTP 
(Meredith et al., 2009). Whether hiPSC-derived DA neurons in culture display 
excitotoxicity in response to high concentrations of extracellular glutamate had not been 
investigated.  
Here I have shown that hiPSC-derived DA neurons are resistant to excitotoxicity at 
concentrations that are toxic to various other neuronal cell types in culture. Excitotoxic 
death in PC12 and NT-2 cells has been reported at glutamate concentrations of 10 µM 
to 10 mM respectively at timescales from 0.5 to 72 hours (Kritis et al., 2015). Due to the 
reliance of glutamate excitotoxicity on the expression of glutamate receptors, data from 
weeks 3-6 was pooled as the development of ESPSCs that were blocked by glutamate 
receptor antagonists was first observed at around this time point in culture. No 
difference between week 0 hNPCs and week 3-6 differentiated neurons was observed 
here, neither were TH-positive cells nor CaV1.3-positive/TH-positive cells more 
susceptible.  
NPCs have previously been reported to have a high resistance to glutamate 
excitotoxicity (Suzuki et al., 2006), perhaps due to differences in glutamate receptor 
expression compared to mature neurons. 
Several reasons for the resistance of differentiated neurons to glutamate excitotoxicity 
can be proposed. During these experiments, cultures were incubated with L-glutamic 
acid for 24 hours. In certain cell types toxicity was seen after as long as 72 hours. It 
could be that further incubation is needed to see an effect.  
Astrocytes are known to play an important role in excitotoxicity, being mainly 
responsible for the uptake of released extracellular glutamate in-vivo. They can also 
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promote excitotoxicity through the reversal of their Na+-Glutamate transporters when 
extracellular glutamate concentrations are above a critical level (Schousboe & 
Waagepetersen, 2005). Considering that ~85% of the cells in culture stained for 
neuronal markers (Figure 3.2C) it is possible that astrocytes make up a significant 
proportion of the remaining cells. Astrocytes are also believed to interact directly with 
synapses in what is known as a "tripartite synapse." This close association allows for 
cross-talk between neurons and glia and is believed to be critical for excitotoxicity in-
vivo (Rudy et al., 2015). It could be predicted then that the astrocytes in hiPSC-derived 
DA cultures would promote excitotoxicity. Since excitotoxicity was not seen in culture, 
it could indicate either the lack of formation of these tripartite synapses or that there are 
too few astrocytes present to induce excitotoxicity. An interesting experiment for future 
studies would be to add glia such as astrocytes and oligodendrocytes to these cultures to 
see if excitotoxicity develops. 
Another possibility is that synapses in these cultures have not yet reached full maturity. 
Data from chapter 3 suggests at a shift in synaptic maturity at 6 weeks post-
differentiation, though this may indicate the onset of maturity rather than its completion. 
NMDA receptors are believed to be critical for excitotoxicity in hiPSC-derived neurons 
(Gupta et al., 2013). Changes in NMDA receptor expression, localisation and trafficking 
are associated with synaptic plasticity and maturation (Yashiro & Philpot, 2008). 
Excitotoxicity may therefore develop with more time culture.  
Previous studies have suggested that dopamine can reduce the cytosolic Ca2+ increases 
associated with exposure to high concentrations of extracellular glutamate (Vaarmann et 
al., 2013). The presence of dopamine in the extracellular medium could therefore be 
having a protective effect on all the cells in culture. 
It has previously been shown that neurons with a compromised mitochondrial 
membrane potential are protected against the toxic effects of excessive glutamate 
receptor activation. This is due to their inability to accumulate Ca2+ into mitochondria as 
efficiently as other neurons (Nicholls & Budd, 1998). Since the mitochondrial 
membrane potential is known to be vulnerable in SNc DA neurons (Schapira et al., 
1990) it could be that the vulnerable phenotype associated with these neurons is 
providing a degree of neuroprotection against glutamate excitotoxicity. This theory 
does, however, contradict evidence that suggests SNc DA neurons are more susceptible 
to glutamate excitotoxicity in the presence of mitochondrial toxins (Meredith et al., 
2009). 
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AMPA receptors expressing the GluR2 subunit have been shown to protect against 
excitotoxicity due to their reduced permeability for Ca2+ (Iihara et al., 2001). If this 
subunit is expressed in these cells it could explain the resistance, though this would 
need to be experimentally determined.  
NPCs have also been shown to protect neurons against the toxic effects of glutamate 
through the release of neurotrophic factors (Lladó et al., 2004). The cells in these 
cultures have been differentiated from NPCs. If a proportion of the cells in culture have 
not gone through differentiation, or if they have retained certain phenotypic traits 
typical of NPCs due to their relative immaturity, they may provide neuroprotection to 
neurons in culture.  
Interestingly, resistance to glutamate-induced excitotoxicity has been identified in other 
PD models in-vitro. The human neuroblastoma cell line SH-SY5Y, which displays 
phenotypic traits typical of DA neurons, has been shown to be sensitive only to high 
extracellular glutamate concentrations ranging from 8 to 80 mM (Xie et al., 2010). 
Through the experiments performed here I have shown that hiPSC-derived DA neurons, 
during the first 6 weeks post-differentiation from hNPCs, display a resistance to 
excitoxicity at concentrations of extracellular glutamate that cause death in other 
neuronal cell types. This resistance was not specific to TH-positive cells and the 
presence of CaV1.3 did not influence susceptibility. These neurons may therefore not be 
suitable for the study of excitotoxicity in PD. 
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Chapter 5 
 
General Discussion 
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Abstract 
In this thesis I have presented data that fills in gaps in our knowledge of pacemaking in 
two in-vitro models of human diseases. This allows for a comparison of pacemaking 
between these models and their in-vivo counterparts to be performed and for their 
suitability for modelling the role of excitability in these diseases to be assessed. For 
AtT20s, I show that their intrinsic properties are similar to corticotrophs in-vivo. They 
do, however, appear to be disconnected from agonist-induced effects on excitability and 
from action potential-evoked release of adrenocorticotropic hormone. They are 
therefore suitable for investigating the mechanisms of intrinsic pacemaking but not for 
the study of the role of excitability in hormone release. For human induced pluripotent 
stem cell derived dopaminergic neurons, I show that excitable properties that are 
characteristic of the dopaminergic neurons of the substantia nigra pars compacta that die 
in Parkinson’s disease develop during early maturation in these cultures. Overall, 
however, excitability in these neurons appeared relatively immature. They are therefore 
not suitable or require extended maturation times before they can be used to model 
mature pacemaking and cell death in Parkinson’s disease. 
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5.1     Conclusions 
Pacemaking in neuronal and neuro-endocrine cell types provides a mechanism for the 
entrainment of action potential firing to a particular frequency. This in turn allows for 
the control of rhythmic processes such as breathing, hormonal cycles and fine motor 
control (Pike et al., 1999). 
Two examples of diseases that occur in cell types known for their pacemaker activity 
are Cushing's disease and Parkinson's disease (PD). Cushing's disease is caused by 
corticotroph tumours within the anterior pituitary, resulting in excess secretion of 
adrenocorticotrophic hormone (ACTH) and subsequently cortisol from the adrenal 
cortex (Nelson et al., 1960). PD is caused by the selective death of substantia nigra pars 
compacta (SNc) dopaminergic (DA) neurons, in part due to Ca2+ influx through CaV1.3 
voltage-gated calcium channels (VGCCs) during pacemaking (Chan et al., 2007; 
Sveinbjornsdottir, 2016). 
Both cell types have in-vitro models that can be used to study their relevant diseases. 
AtT20 is a neuroendocrine cell line derived from mouse pituitary tumours and are 
known for their robust secretion of ACTH (Woods et al., 1960). Human induced 
pluripotent stem cell (hiPSC)-derived DA neurons are a promising new in-vitro model 
for PD (Swistowski et al., 2010). However, whether the mechanisms of pacemaking in 
these models truly mimic their respective in-vivo counterparts is not fully known. 
The research in this thesis has focused on gaps in the understanding of pacemaking in 
both models. For AtT20s the role of L-type, N-type and T-type VGCCs was 
investigated. For hiPSC-derived DA neurons the early development of pacemaking and 
selective vulnerability to cell death were investigated. This allows for two types of 
comparison to be made: Differences and similarities between the models and their 
respective in-situ counterparts can be assessed; and differences and similarities between 
the two models can be assessed to compare the mechanisms of pacemaking between cell 
types. 
 
5.1.1     Pacemaking in AtT20s 
Various VGCC subtypes have previously been identified in AtT20s, including L-type, 
N-type, T-type and P/Q-type channels (Mackie et al., 1995). The role of many of these 
in AtT20 pacemaking had not been studied. The results from chapter 2 show that L-type 
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VGCCs are critical for pacemaking in AtT20s, being required for action potential firing 
and the generation of subthreshold Ca2+ waves. This has previously been reported in the 
literature (Adler et al., 1983). One important new finding that I present is the 
relationship of two modalities of Ca2+ waves to pacemaking: TTX-dependent waves and 
slower, larger amplitude TTX-independent waves. It has previously been reported that 
TTX has no effect on Ca2+ waves in this cell type (Fiekers & Konopka, 1996). Here, by 
looking at the form of Ca2+ waves before and after the addition of TTX, I show that 
although they are not abolished by NaV channel block they are significantly altered. 
There was no statistical difference in total nominal Ca2+ influx upon the addition of 
TTX, with the increased duration and amplitude of the waves compensating for their 
significantly reduced frequency. This points to a mechanism whereby L-type VGCCs 
and NaV channels synergistically shape the frequency and amplitude of spontaneous 
Ca2+ waves. During loss of NaV currents, L-type VGCCs compensate for and prevent a 
decrease in cytosolic Ca2+ in quiescent cells that would normally enter the cell during 
pacemaking. L-type VGCCs have previously been reported as critical for proliferation 
and cell survival in AtT20s (Loechner et al., 2009), a role that can be explained by this 
compensatory mechanism.  
The L-type subtype CaV1.3 is often found in pacemaker cells due to its activation 
properties being favourable for subthreshold activation (Zampini et al., 2010). Here I 
show that AtT20s immunostain for CaV1.3, partly confirming the presence of this 
subtype in these cells. This has been previously seen in the literature, with this channel 
type being critical for the proliferation and survival of AtT20s (Loechner et al., 2009). 
No molecular identification of CaV1.3 channels through the detection of, for example, 
CACNA1D RNA transcripts via RT-PCR, has been performed either here or in the 
literature. Although it seems relatively clear that it is present, performing this 
experiment would eliminate any doubt over the presence of CaV1.3 in AtT20s. 
T-type VGCCs have previously been suggested to be involved in AtT20 pacemaking by 
way of computer-based modelling (LeBeau et al., 1997), however direct evidence for 
their presence or involvement was lacking. Here I show that T-type channels are critical 
for pacemaking in AtT20s, though they play a different role to L-type channels. The T-
type antagonist ML218 blocked all pacemaking without affecting the membrane 
potential. It also caused a shift in the modality of Ca2+ waves that was exacerbated by 
the addition of the NaV antagonist TTX. This suggests that T-type channels are required 
for action potential generation and that T-type and NaV channels are synergistically 
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involved in the shaping of but not the generation of subthreshold Ca2+ waves. T-type 
channels are found in many pacemaker cell types due to their negative-shifted activation 
properties being favourable for their subthreshold activation (Perez-Reyes, 2003; 
Matschke et al., 2015). A major difference from CaV1.3 is that T-type channels are fast 
and transiently activated. This makes them ideal for aiding in action potential generation 
by shifting dV/dt when close to the firing threshold. This observed role for T-type 
channels in AtT20s has not previously been described in the literature. 
N-type VGCCs did not appear to be involved in pacemaking in AtT20s, with the N-type 
antagonist ω-conotoxin having no significant effect on action potential firing or Ca2+ 
wave properties. This finding was not surprising considering the lack of N-type channel 
pacemaking in the literature. This channel type is more closely associated with 
exocytosis in neurons, having previously been found to lie close to exocytotic protein 
complexes (Millán & Sánchez-Prieto, 2002). N-type channels may even contain a 
binding site to allow for direct interaction with the exocytotic proteins syntaxin, SNAP-
25 and synaptotagmin (Sheng et al., 1997). 
All in all, the results here allow for the conclusion that VGCCs and NaV channels 
generate pacemaking in this model. L-type VGCCs, with input from other VGCCs 
subtypes and perhaps a degree of subthreshold NaV channel activation, produce 
subthreshold oscillations in membrane potential that bring the cell close to the firing 
threshold. Near threshold, T-type VGCCs increase the rate of change of the membrane 
potential substantially to activate NaV channels, generating an action potential. The 
following hyperpolarisation then acts to quickly inactivate VGCCs, keeping Ca2+ entry 
locked to a tight window during an action potential. 
Data here also provides the first super-resolution analysis of secretory granule size in an 
AtT20 cell, with them likely having a diameter of 160-180 nm. Secretion of these 
granules appeared to be disconnected from their excitability, however, with membrane 
potential changes unable to induce capacitance changes associated with secretion. 
Capacitance could be increased by addition of an L-type agonist, indicating that 
secretion is likely linked to increases in intracellular Ca2+. In addition, no changes in 
excitability were observed upon the addition of the ACTH secretagogue corticotropin 
releasing hormone (CRH). Whether or not excitability is linked to secretion in this cell 
type has remained ambiguous, with contradictory evidence being published on the 
matter. One study identified a membrane depolarisation and increase in firing rate upon 
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the addition of CRH (Zemkova et al., 2016). Another found that changes in excitability 
had no effect on secretion, with it instead being linked to increases in intracellular Ca2+.  
(Surprenant, 1982). The experiments here, along with those in previous studies, require 
the addition of chelators such as EGTA to buffer unwanted changes in intracellular 
Ca2+. This could have undesired effects on Ca2+ increases after CRH addition or during 
action potential firing. The true effect of excitability on secretion is therefore difficult to 
determine under these conditions, with studies that avoid this buffering required to draw 
a more meaningful conclusion. 
Figure 5.1 summarises the ion channels that were investigated during the course of this 
thesis, highlighting those for which new roles in pacemaking in AtT20s were identified. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 – The ion channels investigated in AtT20s. A graph showing the ion channels that were 
(bottom) and weren’t (top) investigated in AtT20s during this research. Green highlights channels that 
were found to be involved in pacemaking in novel ways: NaV channels supported Ca2+ waves in a 
subthreshold manner along with T-type VGCCs; L-type VGCCs maintained intracellular Ca2+ to within 
physiological levels despite changes in activity; K+ channels help shape Ca2+ waves. Red highlights 
channels that were found to not be involved in pacemaking: N-type channels played no role; CRH-1 had 
no role despite having a role in corticotrophs in-vivo. 
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5.1.2     Pacemaking in hiPSC-Derived Dopaminergic Neurons 
By identifying cells as tyrosine hydroxylase (TH)-positive or negative, data presented in 
chapters 3 and 4 shows that hiPSC-derived DA neurons begin to develop an excitable 
phenotype typical of SNc DA neurons from 1-2 weeks post-differentiation from hiPSC-
derived neural progenitor cells (hNPCs). Action potential firing was observed in cells 
from 2 weeks in culture. TH-positive cells had a tendency towards more excitable 
states, being more likely to be firing action potentials and more likely to produce spike 
trains in response to depolarisation than cells that were TH-negative. This result is 
likely confounded by the presence of non-neuronal/non-excitable cell types within the 
TH-negative population, considering that 10-15% of cells in the cultures were identified 
as NeuN-negative. Neurons in culture also developed Ca2+ waves that increased in 
amplitude and rhythmicity up to 6 weeks post-differentiation. All of this has been 
previously described in the only study that has looked at excitability in these neurons in-
depth (Hartfield et al, 2014). This study described the development of action potentials 
and Ca2+ waves from 6-12 weeks post-differentiation from hiPSCs rather than from 
younger hiPSC-derived NPCs as has been performed in this thesis. Considering the 
different starting points, where it takes ~2 weeks to develop hNPCs from hiPSCs, 
excitability and Ca2+ waves developed several weeks earlier than described in this 
previous study, though likely continue to mature past 6 weeks as previously described 
(Hartfield et al., 2014). 
Here I show that action potential firing and spike trains were L-type VGCC dependent, 
though only in one TH-positive cell. This is the first time L-type dependence has been 
investigated and identified in a hiPSC-derived DA neuron. Only a single TH-positive 
cell could be identified due to time constraints and the loss of Lucifer Yellow marked 
cells during immunostaining. This marks a good starting point, however, for further 
analysis of the role of L-type VGCCs in pacemaking in hiPSC-derived DA neurons. 
Although action potential firing in this previous study was described as spontaneous, the 
authors did not investigate whether the observed activity was being driven by synaptic 
activity rather than intrinsic properties (Hartfield et al., 20140. Here I show that firing is 
not intrinsic, instead being driven by synaptic activity. Action potential firing could be 
blocked by glutamate receptor and dopamine D2 receptor antagonists. Excitatory 
spontaneous postsynaptic currents (ESPSCs) developed from 2 weeks post-
differentiation. These were blocked by the co-addition of NMDA and AMPA/Kainate 
receptor antagonists. The addition of extracellular glutamate resulted in increases in the 
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intracellular Ca2+ concentration, providing further evidence for influx through NMDA 
receptors. Another possibility is that glutamate-induced depolarisation is activating low-
voltage activated VGCCs such as T-type channels. These lines of evidence, along with 
the observation that they developed simultaneously alongside action potential firing, 
points to their importance in generating the electrical activity seen in culture. 
Although inhibitory postsynaptic currents were not identified, the presence of 
GABAergic input should not be excluded. Calculation of the equilibrium potential for 
Cl- in the conditions used indicated that the Cl- equilibrium was reversed at the -80 mV 
holding potential used. This indicates that under these conditions they would appear as 
depolarising currents rather than the hyperpolarising currents that are typical of GABA 
receptor activation. Indeed, small ESPSCs remained in the presence of glutamate 
receptor blockers. Given the information above, these could possibly correspond to 
excitatory GABAergic currents, though this would need to be determined 
experimentally to know for sure. 
Although Hartfield et al describe the development of Ca2+ waves, it was not determined 
whether these waves were occurring below the threshold for action potential firing (as 
previously described in SNc neurons in-vivo (Puopolo et al., 2007)). Here I show that 
the addition of TTX blocked Ca2+ waves in the majority of cells. This indicates that they 
were action-potential dependent rather than subthreshold. TH-positive cells developed 
denser Ca2+ currents than TH-negative cells and the majority of TH-positive cells 
(>70%) immunostained against CaV1.3, a channel type that characterises SNc DA 
neurons in-vivo (Chan et al., 2007). The presence of this channel could explain the 
differences in excitability between TH-positive and TH-negative cells as CaV1.3 
expression in SNc DA neurons in-vivo is suspected to underlie their pacemaker activity 
(Chan et al., 2007). However, the finding that CaV1.3 immunostaining was seen in the 
majority of cells in the cultures regardless of whether they were TH-positive along with 
the fact that a proportion of TH-negative cells are likely non-neuronal as seen by NeuN 
staining, it is possible that this result could also be confounded by the presence of non-
neuronal cell types within the TH-negative population or by different channel 
localisation between these two groups. 
It is possible, given the fact that the electrical properties of hiPSC-derived DA neurons 
in the previous study by Hartfield et al continued to mature up to 12 weeks post-
differentiation and that the results here only investigated time points earlier in 
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development, that intrinsic pacemaking and subthreshold Ca2+ waves develop at later 
stages of maturity. Synaptic input and the entrainment of Ca2+ waves to action potential 
firing may be important steps that lead to the development of intrinsic pacemaking in 
these neurons in culture. The requirement of synaptic input for the development of 
intrinsic excitability has been seen in many other systems. Dopamine has been seen to 
induce synaptic plasticity in pyramidal neurons from the CA1 region of the 
hippocampus, resulting in long term changes in their intrinsic firing (Edelmann & 
Lessmann, 2013). Activation of NMDA receptors in cerebellar deep nuclear neurons 
results in changes in their response to current injection (Aizenman & Linden, 2000). 
Purkinje cells in the cerebellar cortex require GABAergic input to develop intrinsic 
excitability during their early development (Watt et al., 2009). "Intrinsic plasticity," 
whereby changes in ion channel expression in mature cells results in long-term changes 
in excitability, has been identified as an important requirement for the development of 
mature neuronal networks and has specifically been implicated in memory formation 
(Zhang & Linden, 2003). 
hiPSC-derived DA neurons have previously been shown to be susceptible to cell death 
in response to incubation with the DA-specific toxin 6-hydroxydopamine (6-OHDA) 
(Nguyen et al., 2011) and show susceptibility to the mitochondrial toxin 1-methyl-4-
phenyl-1,2,3,6-tetrahydropyridine (MPTP) in a similar fashion to SNc DA neurons 
(Hartfield et al., 2014). It was not known whether this susceptibility continued at higher 
concentrations of 6-OHDA or whether they are susceptible to glutamate-induced 
excitotoxicity. The results here confirm that TH-positive cells are selectively susceptible 
to 6-OHDA-induced cell death over TH-negative cells, though at very high 
concentrations general toxicity did occur.  
Many neuronal cell types display excitotoxicity, where excessive activation of 
ionotropic glutamate receptors, such as NMDA receptors, results in excessive Ca2+ 
influx and cell death. Concentrations of extracellular glutamate that have previously 
been reported to induce cell death in neuronal cell types in culture range from 10 µM – 
100 mM (Kritis et al., 2015). The results here show that all of the neurons in culture, 
from hNPCs to differentiated neurons, displayed a resistance to cell death in response to 
24 hour incubation with extracellular glutamate concentrations up to 100 mM, at least 
up to 6 weeks post-differentiation. Reasons I suggest for this include a lack of synaptic 
maturity, the lack of formation of a tripartite synapse (see Rudy et al., 2015), the 
requirement of incubation times longer than 24 hours, the protective effects of 
177 
 
dopamine (Nicholls & Budd, 1998), the protective effects of AMPA receptors (Iihara et 
al., 2001), metabolic susceptibility preventing Ca2+ influx into mitochondria (Schapira 
et al., 1990) or the retention of stem cells or stem cell properties within the population 
having a neuroprotective effect (Lladó et al., 2004). 
Whether CaV1.3 expression, which is suspected to be involved in the mechanism of 
selective cell death in mature SNc neurons in-vivo (Chan et al., 2007), increases the 
susceptibility of hiPSC-derived DA neurons to death in response to 6-OHDA or 
extracellular glutamate was not previously known. In Chapter 4 I show that TH-positive 
cells that immunostained against CaV1.3 are not more susceptible to death than TH-
positive cells that are CaV1.3-negative. This was true for both glutamate and 6-OHDA 
up to 6 weeks post-differentiation from hNPCs. Although the results do not discount the 
possibility that CaV1.3-related susceptibility develops in these cells at later stages of 
maturity, or that susceptibility requires the co-addition of mitochondrial toxins as has 
been seen in primary SNc neurons from mice (Chan et al., 2007), the results do discount 
CaV1.3 as a primary factor in the susceptibility of hiPSC-derived DA neurons to cell 
death in response to extracellular glutamate and 6-OHDA at early stages in their 
development. 
All in all, the data presented here fills in gaps in the literature surrounding the 
mechanisms and development of pacemaking in AtT20 anterior pituitary corticotrophs 
and hiPSC-derived DA neurons. This allows for an assessment of their suitability as 
model systems to study their respective diseases that is more informed than those 
previously in the literature.  
Figure 5.2 summarises the ion channels that were investigated during the course of this 
thesis, highlighting those for which roles in pacemaking in hiPSC-derived DA neurons 
were identified. 
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Figure 5.2 – The ion channels investigated in hiPSC-derived DA neurons. A graph showing the ion 
channels that were (left) and weren’t (right) investigated during this research. Green highlights channels 
that were found to be involved in pacemaking. Red indicates channels that were found to not be involved. 
 
5.2     Similarities & Differences Between AtT20s and Corticotrophs 
In-Vivo 
 
5.2.1     Pacemaking and Control of ACTH Release 
In-situ, pacemaking in corticotrophs is closely associated with the secretion of ACTH, 
controlling the timing of its release (Lee & Tse, 1997). Action potential firing patterns 
that have been observed include tonic firing, burst firing and quiescence all within the 
same population (Zemkova et al., 2016). The two main hormonal regulators of ACTH 
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secretion, CRH and arginine vasopressin (AVP), have been seen to induce firing in both 
active and quiescent cells in-vivo (Kuryshev et al., 1995; Lee et al., 2015). Similar 
activity patterns have been identified in AtT20s (Adler et al., 1983), which is confirmed 
by data here. 
There is contradictory evidence over whether ACTH release is coupled to pacemaking 
in AtT20s. One study observed that membrane depolarisation and secretion occurred 
upon the addition of CRH (Guérineau et al., 1991). Another study found action potential 
firing did not induce secretion, with it instead being linked to increases in their cytosolic 
Ca2+ concentration (Surprenant, 1982). Here I provide evidence for the latter, as CRH 
had no effect on pacemaking. CRH is believed to act short term via activation of TREK-
1 K+ channels and voltage-gated ion channels (Luini et al., 1985; Lee et al., 2015). It 
also acts long term via stimulation ACTH synthesis from its precursor, pro-
opiomelanocortin, through the induction of cAMP pathways (Kageyama & Suda, 2009). 
It is possible that an effect would be seen over longer periods than the 10 minute 
recordings performed here, though the lack of any immediate effect indicates that CRH 
is likely disconnected from direct control of excitability. Data here therefore confirms 
that the outward patterns of intrinsic excitability appear similar between corticotrophs 
and AtT20s, though there is a difference in agonist-induced excitability. 
Ca2+ waves have been seen to underlie pacemaking in corticotrophs, producing Ca2+-
dependent oscillations in membrane potential in the presence of TTX (Zemkova et al., 
2016). Ca2+ waves have also been identified in AtT20s, acting completely 
independently of action potential firing (Fiekers & Konopka, 1996). Here I present data 
that disputes this independence, with action potentials being seen to entrain the 
amplitude and frequency of Ca2+ waves. This dependence acts both ways, with the Ca2+ 
waves then acting to maintain high frequency action potential firing. These waves 
continued in the presence of TTX though at an increased amplitude and a reduced 
frequency. This is backed by simultaneous patch clamp and Calcium Green-1 staining 
which showed Ca2+ influx primarily occurs after an action potential. No in-depth 
analysis of the effects of TTX on Ca2+ waves in corticotrophs has been performed so 
whether this constitutes a similarity or difference between AtT20s and corticotrophs in-
vivo is yet to be seen. In both cell types, Ca2+ waves have been seen to be L-type VGCC 
dependent (Adler et al., 1983; Zemkova et al., 2016). Data here confirms this, with the 
L-type antagonist nifedipine blocking all pacemaking and Ca2+ waves. CaV1.3 staining 
partly confirms the previous finding that CaV1.3 and CaV1.2 are expressed in AtT20s 
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(Loechner et al., 2009). With more time, specific block of CaV1.3 channels with drugs 
such as Isradipine would have confirmed or discounted their involvement in 
pacemaking. It is not yet known which subtypes are involved in corticotrophs in-vivo 
so, as far as current evidence allows us to conclude, Ca2+ waves in AtT20s are produced 
via a similar mechanism to corticotrophs in-vivo. 
 
5.2.2     Ion channels Involved in Intrinsic Pacemaking 
Intrinsic pacemaking in corticotrophs requires the complex interplay of many different 
ion channels to function correctly. Firing appears to mainly be dependent upon NaV 
channels and L-type VGCCs (Zemkova et al., 2016). This is also seen in AtT20s, with 
the removal of Na+ from the extracellular medium preventing action potential firing 
while the antagonism of L-type VGCCs prevents both action potential firing and Ca2+ 
waves (Adler et al., 1983). These observations are backed by data here. I also provide 
evidence to suggest that L-type VGCCs are involved in a compensatory mechanism that 
retains intracellular Ca2+ concentrations at physiological levels despite changes in 
excitability. This is backed up by the finding that L-type VGCCs (CaV1.2 and CaV1.3) 
are critical for proliferation and survival in AtT20s (Loechner et al., 2009). This 
mechanism has not been studied in-vivo and may be worth investigating for its potential 
link to ACTH secretion. 
Maintenance of the resting membrane potential in corticotrophs is performed by a 
variety of channels including KV, BK, TREK-1, HCN and inward rectifying K
+ 
channels (Kuryshev et al., 1995; Liang et al., 2011; Liang, 2012; Kretschmannova et al., 
2012). Quiescent cells have been noted to have a more depolarised membrane potential 
than firing cells, indicating the importance of the regulation of membrane potential in 
pacemaking (Zemkova et al., 2016). Computer modelling of BK channels has also 
indicated they are able to regulate activity patterns in firing cells but are unable to 
transition quiescent cells to a firing state (Fletcher et al., 2017). This effect has also been 
identified in BK channel knockouts (Liang, 2012). K+ channels have also been 
identified in AtT20s, with BK channels suspected to drive membrane repolarisation 
following an action potential (Adler et al., 1983). KV channels and inwardly rectifying 
K+ channels have also been identified though their role in pacemaking has not been 
explored (Dousmanis & Pennefather, 1992). Various other channel types have been 
identified in AtT20s whose role in pacemaking in-vivo is unknown. These include two 
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types of Ca2+ dependent chloride channels, the Ca2+-ATPase pump and the Na+-Ca2+ 
transporter (Korn et al., 1991). TREK-1 channels in corticotrophs have also not yet been 
identified in AtT20s. All in all, there remain many gaps in our knowledge of the ion 
channels involved in corticotrophs in-vivo and in AtT20s. The mechanism of intrinsic 
pacemaking appears to be relatively well conserved between the two, meaning that the 
identification of a pacemaking-associated channel type in one cell type gives a strong 
grounding for investigating its possible role in the other. 
Several VGCC subtypes have been identified in AtT20s and in rat corticotrophs. 
Although the role of L-type VGCCs has been relatively well characterised, many of 
these other subtypes had unknown roles in pacemaking. These subtypes are N-type, T-
type and P/Q-type VGCCs (Mackie et al., 1995).  
T-type VGCCs have been identified in both human and rat corticotrophs. They have 
been suggested to be involved in the generation of Ca2+ waves but not directly in firing 
(Guérineau et al., 1991). In support, computer-based modelling of corticotroph 
excitability suggests that conductances associated with T-type VGCCs can control 
firing patterns but have no role in action potential generation (LeBeau et al., 1997). 
Here I show that T-type channels are required for pacemaking in AtT20s. This could 
suggest either a difference in the mechanism of pacemaking between these two cell 
types or that refinement of these computer-based models is required in response to this 
updated information. The transient opening and closing of T-type channels at negative 
membrane potentials makes them ideal for activation close to the firing threshold, 
explaining their ability to drive NaV-dependent action potentials (Perez-Reyes, 2003). It 
may be worth re-examining the roles of T-type channels in corticotrophs to determine 
whether they play a similar role in-vivo. 
N-type VGCCs have been identified in AtT20s but whether they are expressed in 
corticotrophs in-vivo is unknown (Mackie et al., 1995). Data here suggests they play no 
major role in AtT20 pacemaking. Considering the lack of N-type associated pacemaking 
in the literature they likely play no role in corticotrophs in-vivo, though experimental 
evidence is needed to confirm this. 
 
182 
 
5.2.3     Suitability as a Model for Cushing's Disease 
Corticotrophs in-vivo and the AtT20 pituitary tumour cell line show many similarities in 
their pacemaking properties. They display identical activity patterns with quiescent, 
burst firing and tonic firing cells seen within the same population. Similar complements 
of ion channels drive their excitability with L-type VGCCs playing critical roles. 
Several types and subtypes of ion channels that are involved in pacemaking in AtT20s 
have as of yet unidentified roles in-vivo. These include HCN channels, Ca2+ dependent 
Cl- channels, Ca2+ pumps and, supported by data here, T-type VGCCs. This, coupled 
with the fully intrinsic nature of AtT20 electrical activity, means they serve as a useful 
model for the general mechanisms of pacemaking in corticotrophs. 
Both corticotrophs in Cushing's disease and AtT20s show excessive secretion of ACTH. 
This is due to Cushing's disease being specifically caused by pituitary tumours (Nelson 
et al., 1960). In-vivo, ACTH release is coupled to pacemaking (Guérineau et al., 1991). 
Evidence for a loss of this coupling in AtT20s is contradictory. One study states that 
ACTH-releasing hormones cause membrane potential changes while another, supported 
by data here, provides evidence that no changes occur (Surprenant, 1982; Zemkova et 
al., 2016). This cell type may therefore not be suitable for studying the effects of 
abnormal excitability on ACTH release. They are, however, suitable for studying the 
mechanisms of secretion that are independent of electrical activity and for studying 
possible treatments for Cushing's disease. These include the suppression of growth of 
pituitary tumours and downregulation of ACTH production or secretion. These types of 
studies are already being performed in AtT20s, with the roles of the Brg1 and HDAC2 
genes in ACTH production and the effects of Curcumin and Pasireotide on reducing 
secretion having been investigated (Bilodeau et al., 2006; Bangaru et al., 2010; Castillo 
et al., 2011). 
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5.3     Similarities and Differences Between hiPSC-Derived and SNc 
Dopaminergic Neurons 
 
5.3.1     Properties of Pacemaking 
Mature SNc DA neurons display two main activity patterns in rats: tonic firing at a 
frequency of 3-8 Hz that can occur in the absence of synaptic input and burst firing 
when in the presence of large quantities of synaptic input (Grace & Bunney, 1984; 
Tepper et al., 1998; Guzman et al., 2009). The same patterns of activity have been 
identified in hiPSC-derived DA neurons in a previous study (Hartfield et al., 2014) 
which is backed by data here. Hartfield et al described action potential firing as 
occurring at a similar frequency to SNc neurons in these animal studies, though data 
here found that firing occurred at far lower frequencies (>2 Hz). This is likely explained 
by the earlier developmental time points I investigated and by the fact that experiments 
here were performed at 21oC rather than 37oC as performed by Hartfield et al. Action 
potential firing began to develop from 2 weeks post-differentiation in this study and 
from 6-12 weeks post-differentiation in the study by Hartfield et al (bearing in mind a 
longer differentiation process in this previous study, equivalent to a 4-10 week period in 
the results here). This is roughly equivalent to the development of pacemaking in 
cultured SNc neurons from postnatal rats, which began to develop pacemaking from the 
second postnatal week and showed mature properties from week 4 (Tepper et al., 1990). 
In-vivo recording from the primate SNc has shown that these neurons produce, slow 
rhythmic bursts of action potentials in response to current injection (Bayer et al., 2007). 
These "spike trains" have also been identified in hiPSC-derived DA neurons both here 
and by Hartfield et al. I carry this further, showing that DA neurons in culture are far 
more likely to produce spike trains than non-DA neurons. This finding, however, could 
be due to the presence of non-excitable cell types within the TH-negative population. 
Spike trains here appeared underdeveloped at 6-weeks post-differentiation compared to 
those by Hartfield et al at 12 weeks post-differentiation. This indicates that these 
neurons require extensive time in culture before they develop excitable properties 
similar to mature SNc neurons in-vivo. 
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5.3.2    Intrinsic vs Agonist Induced Excitability 
Action potential firing in SNc DA neurons has been found to be TTX dependent, with 
subthreshold Ca2+-dependent membrane potential oscillations still able to occur in the 
absence of firing (Puopolo et al., 2007). Immunohistochemical analysis of 
somatodendritic ion channel expression has identified a large range of channel types 
including voltage gated potassium channels (KV1.3, KV2.1, KV3.2, KV3.3, KV4.3), Ca
2+-
activated SK channels (SK1, SK2, SK3), HCN channels (HCN2, HCN4), L-type 
(CaV1.2, CaV1.3) and T-type VGCCs (CaV3.1, CaV3.3) (Dufour et al., 2014). Inside-out 
patch clamp recording has also identified Ca2+-activated BK channels (Su et al., 2010). 
The study of postnatal rat SNc neurons revealed that the extent to which these channels 
are expressed in the dendrites increases as the cells mature, meaning that dendritic ion 
channel expression is likely important for the development of pacemaking (Dufour et 
al., 2014).  
Here I show that hiPSC-derived DA neurons display voltage-gated Na+ and K+ currents 
which increase in density as they mature. They also selectively develop denser voltage-
gated Ca2+ currents than non-DA neurons in culture, though this difference may be due 
to non-excitable cells within the cultures. No study has yet looked at whether other ion 
channels identified in-vivo are expressed in hiPSC-derived DA neurons. Doing so 
would provide valuable information on how similar the intrinsic mechanisms of 
pacemaking are between these two cell types.  
Hartfield et al., supported by data here, identified Ca2+ waves in hiPSC-derived DA 
neurons that developed and matured between 6-12 weeks in culture. Here I show that 
these are TTX-dependent and are therefore not subthreshold as seen in mature SNc 
neurons in animal studies, at least up to 6 weeks post-differentiation from hNPCs. This 
does not discount the possibility that subthreshold waves are present in dendrites or that 
action potential dependence is required at early development stages to allow 
subthreshold waves to develop. Whether the observed increases in voltage-gated current 
density in hiPSC-derived DA neurons are due to an increase in dendritic expression has 
not been studied, though doing so would provide valuable information on whether ion 
channel expression in hiPSC-derived DA neurons matches those of SNc neurons in-
vivo. 
SNc DA neurons are characterised by the expression of the L-type VGCC subtype 
CaV1.3. This is thought to underlie both their pacemaking and their selective 
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vulnerability in PD (Chan et al., 2007). Expression of CaV1.3 has been identified in both 
the soma and dendrites of these neurons (Dufour et al., 2014). Data here confirms for 
the first time that hiPSC-derived DA neurons also express CaV1.3 in their soma and 
processes. Staining was identified in the majority of, but not all, TH-positive cells in 
culture. CaV1.3-positive cells are likely to be phenotypically similar to SNc DA neurons 
that project to the basal ganglia as part of the nigrostriatal pathway (Richards et al., 
1997). CaV1.3-negative cells are perhaps phenotypically similar to DA neurons from 
other regions such as glutamatergic neurons within the SNc, locally projecting SNc  
GABAergic neurons or globus pallidus neurons which exhibit NaV1.6 dependent 
pacemaking (Richards et al., 1997; Mercer et al., 2007; Root et al., 2016). Local release 
of dopamine has been identified within the SNc in-vivo (Vandecasteele et al., 2005). 
The TH-negative cells identified here could therefore represent a phenotype similar to 
the cells involved in this local release. Another possibility is that the CaV1.3 negative 
DA neurons represent immature SNc DA neurons. These have been seen to display 
HCN-dependent pacemaking in animal models before an increase in CaV1.3 current at 
later stages of maturity (Chan et al., 2007). Data here therefore shows that hiPSC-
derived DA neurons in culture contain two or more phenotypically different populations 
that may correspond to different DA populations in-vivo or to SNc DA neurons at 
different stages of maturity. 
Here I show that hNPCs stain for CaV1.3. This has been previously identified in the 
literature (Marschallinger et al., 2015) and brings about an interesting contradiction in 
the results. Voltage-gated Ca2+ currents in week 0 NPCs were small or non-existent yet 
they stained positive for CaV1.3. Expression of these channels may just be at a much 
lower density than could be identified in voltage clamp recordings. Another possibility 
is that space clamp issues could mean that Ca2+ currents in NPCs may not be identified 
if VGCCs are expressed in axons and dendrites rather than at the soma. VGCCs have 
been seen to be inactivated or inhibited in certain cell types due to regulation by 
PtdIns(4,5)P2 (Wu et al., 2002), activation in response to mechanical strain in bone cells 
(Walker et al., 2000) and synaptic activity in developing neurons (Magee & Johnston, 
1995). Considering the suggested importance of CaV1.3 in NPC differentiation 
(Marschallinger et al., 2015) it could be that they require specific activation or 
disinhibition in response to e.g. transcription factors related to differentiation.  
Pacemaking in SNc neurons has been shown to be Ca2+ dependent (Grace & Onn, 
1989). Further experiments have narrowed this dependence to the action of L-type 
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VGCCs, in particular the CaV1.3 subtype (Chan et al., 2007; Guzman et al., 2009). Data 
here suggests that L-type VGCCs are also critical for firing in hiPSC-derived DA 
neurons, with action potential firing and spike trains being abolished by the addition of 
the L-type antagonist nifedipine in one TH-positive cell.  
Intrinsic pacemaking has been seen to occur in dissociated rat SNc neurons that lack any 
synaptic input. In these instances, activity is often characterised by the tonic firing of 
action potentials in a rhythmic fashion (Grace & Bunney, 1984; Puopolo et al., 2007). 
SNc neurons in-vivo receive excitatory glutamatergic inputs from regions such as the 
STN, PPN and from within the SNc. Inhibitory inputs are also received from D2 
receptor expressing GABAergic neurons in the neostriatum, globus pallidum and pars 
reticulata, and local dopamine inhibition through D2 autoreceptors (Cragg & 
Greenfield, 1997; Lee & Tepper, 2009; Pearlstein et al., 2015). Firing in hiPSC-derived 
DA neurons has previously been seen to be spontaneous without evidence to back the 
claim that it is intrinsic rather than synaptically driven (Hartfield et al., 2014). Here I 
show that firing during the first 6 weeks post-differentiation from hNPCs is dependent 
almost solely upon synaptic input, with no truly intrinsic pacemaking being identified. 
Action potential firing was dependent upon glutamatergic input and DA input through 
D2/D3 receptors.  
ESPSCs have been seen to develop in hiPSC-derived DA neurons from 6-12 weeks 
post-differentiation by Hartfield et al and 2-6 weeks post-differentiation in this study. 
Data here suggests these currents are passed by NMDA and AMPA/Kainate receptors, 
which have been identified in SNc DA neurons both experimentally (Gotz et al., 1997; 
Jones & Gibb, 2005) and in computer-based models of their activity (Zakharov et al., 
2016).  
Inhibitory postsynaptic currents were not observed here nor were they observed by 
Hartfield et al (2014). Cultures of rat SNc neurons have been seen to develop inhibitory 
postsynaptic currents from postnatal week 2 (Tepper et al., 1990) and populations of 
GABAergic neurons have been identified within the rat SNc (Richards et al., 1997). 
Calculation of the equilibrium potential for Cl- in the solutions used in both studies 
indicates that Cl- flow through GABA receptors would be reversed at the holding 
potential of -80 mV used here for studying the postsynaptic currents. Low amplitude 
excitatory currents remained after the block of glutamate receptors in some cells. The 
possibility remains that these could correspond to excitatory GABA currents. 
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Experimental evidence is required to determine this, through further analysis of GABA 
currents and through identification of GABAergic neurons in the culture (which can be 
identified via expression of glutamate decarboxylase). This could also explain the lack 
of effect of picrotoxin on firing frequency and membrane potential. Since the reversal 
potential of Cl- in these experiments (~ -40 mV) lies close to the resting potential of the 
neurons (-30 to -60 mV depending on the developmental week) it would mean that there 
would be little to no driving force for Cl- flow through GABA receptors at these 
potentials. 
Data here suggest at a major difference between SNc DA neurons and hiPSC-derived 
DA neurons in terms of the development of their synaptic networks. This fact is not 
surprising considering the difference in culture conditions. hiPSC-derived DA neurons 
in culture lack both the spatial conditions and the direct input from other brain regions 
seen in-vivo. Data here also suggests either that hiPSC-derived DA neurons are involved 
in the co-transmission of glutamate and dopamine as has been seen in an optogenetic 
study of midbrain DA neurons (Sulzer et al., 1998), or that there are separate 
populations of glutamatergic and DA neurons in these cultures. This is supported by a 
previous study of hiPSC-derived neuronal cultures (Root et al., 2016) and data here that 
shows that only up ~30% of the neurons in culture were TH-positive. 
Although truly intrinsic activity was not seen in hiPSC-derived DA neurons within the 
first 6 weeks post-differentiation from hNPCs, they did, however, display a tendency 
towards excitable states. Here I show that action potential firing and spike trains were 
identified in statistically higher percentages of DA neurons than non-DA neurons in 
culture. Providing that these differences are not an artefact due to non-excitable cells 
within the TH-negative population, this could be an indicator that the capacity for 
intrinsic pacemaker activity may be developing. Neither this study nor the study by 
Hartfield et al discount the possibility that intrinsic pacemaking independent of synaptic 
activity develops at later stages of maturity. 
 
5.3.3     Susceptibility to 6-OHDA 
6-OHDA is a dopamine analogue that selectively induces cell death in DA neurons. It is 
often used to induce Parkinsonian-like symptoms in animal models (Tieu, 2011). Cell 
death in-vivo has been seen within several weeks in response to low doses (µg/ml) and 
in-vitro within hours or days at 10-100 µM concentrations (Michel & Hefti., 1990; 
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Perez-Rial et al., 2011). Selective death is suspected to be due to internal production of 
reactive oxygen species (ROS) after entry into the cell through dopamine uptake 
transporters (Glinka et al., 1997). Studies using cultured neurons have noted that the 
toxin is less selective in-vitro, causing cell death among non-DA neurons. This is 
suspected to be due to extracellular production of oxidative species such as hydrogen 
peroxide (Hanrott et al., 2006).  
hiPSC-derived DA neurons have shown a similar susceptibility to 6-OHDA and other 
mitochondrial inhibitors to SNc neurons in-vivo. One study found that the mitochondrial 
membrane potential of hiPSC-derived DA neurons is reduced in the presence of the 
mitochondrial toxin MPTP (Hartfield et al., 2014). Another study identified the 
selective death of hiPSC-derived DA neurons over other cell types within the same 
culture at concentrations of 10 µM (Nguyen et al, 2016). Here I confirm these cultures 
are susceptible 6-OHDA induced cell death at concentrations of 10-200 µM, with an 
increase in general toxicity occurring at higher concentrations. It would appear then, 
given current evidence, that hiPSC-derived DA neurons and DA neurons in-vivo show a 
similar susceptibility to 6-OHDA, though a higher degree of non-selective cell death 
occurs in-vitro compared to in-vivo. This also provides further evidence for the DA 
phenotype of these cultures as this toxin is known to be specific to these neurons. 
 
5.3.4    Susceptibility to Glutamate-Induced Excitotoxicity 
Excitotoxicity is believed to play a role in SNc cell death in PD. Loss of DA neurons 
disinhibits the STN which in turn allows more glutamatergic input onto the SNc 
(Johnson et al., 2009). Mitochondrial dysfunction is believed to leave SNc neurons 
susceptible to excitotoxicity. This is believed to be due to the action of NMDA 
receptors, which have been identified in SNc neurons (Jones & Gibb, 2005; Meredith et 
al., 2009). Due to their compromised membrane potential in PD, mitochondria in these 
neurons are unable to adequately sequester the Ca2+ that passes into the cell through 
these channels, resulting in ROS production. This creates a feedback loop where further 
mitochondrial damage leads to an increased susceptibility to excitotoxicity leading to 
further mitochondrial damage. Backing this, cultured DA neurons become more 
susceptible to cell death in response to extracellular glutamate if they are first exposed 
to the mitochondrial toxin MPTP (Meredith et al., 2009). Antioxidants such as 
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resveratrol can protect against glutamate-induced cell death in murine DA neurons in 
culture (Moldzio et al., 2013).  
Here I show that, from 0-6 weeks post-differentiation from hNPCs, hiPSC-derived DA 
neurons in culture show a resistance to glutamate-induced excitotoxicity. Cell death was 
only seen at high concentrations (100 mM+). Resistance to excitotoxicity has been seen 
in another PD model: The human neuroblastoma cell line SH-SY5Y, which displays 
phenotypic traits similar to DA neurons, has been shown to be sensitive only to high 
extracellular glutamate concentrations ranging from 8 to 80 mM (Xie et al., 2010).  
Several reasons can be proposed for the resistance of hiPSC-derived DA neurons to 
excitotoxicity. In-vivo, glutamate is removed from the synaptic cleft and recycled by 
astrocytes. These are glial cells that are believed to interact directly with synapses in 
what is known as a “tripartite synapse.” In situations involving high concentrations of 
glutamate, reversal of glutamate transporters on astrocytes can promote excitotoxity 
(see Rudy et al., 2015). It is not clear whether astrocytes were present in the cultures 
used here. Without the presence of astrocytes (at least in high numbers) the cycle of 
uptake and release of glutamate that promotes excitotoxicity in-vivo may not be 
occurring in these cultures. 
The synaptic cleft in-vivo is relatively closed, with a width no larger than 10’s of 
nanometres (Kandel et al., 1997). Due to the lower cell density and open nature of these 
cultures, it could be that glutamate is simply able to freely diffuse and is unable to 
accumulate to excitotoxic levels at synapses as occurs in the closed in-vivo 
environment. 
Excitotoxicity is believed to be largely NMDA receptor dependent. Data here suggests 
that mature networks begin to form in hiPSC-derived DA neuron cultures at roughly 6 
weeks post-differentiation. If low numbers of NMDA receptors are present before this 
time point then excitotoxicity may not be seen. Longer maturation periods may result in 
the formation of more mature, NMDA receptor dependent synaptic networks and the 
subsequent development of glutamate-induced excitotoxicity.Previous experiments on 
excitotoxicity in culture have used incubation periods up to 72 hours (Kritis et al., 
2015). Incubating these neurons for longer than the 24 hours used here may result in an 
increase in excitotoxic cell death.  
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Dopamine has been seen to protect against excitotoxicity, reducing rises in intracellular 
Ca2+ that are associated with pathological levels of glutamate (Vaarmann et al., 2013). 
Dopamine release from DA neurons could therefore be providing neuroprotection to all 
the cells in culture. 
AMPA receptors expressing the GluR2 subunit have been shown to protect against 
excitotoxicity due to their reduced permeability for Ca2+ (Iihara et al., 2001). This 
subunit, if expressed in hiPSC-derived DA neurons, could have a neuroprotective effect. 
It has previously been shown that neurons with a compromised mitochondrial 
membrane potential are protected against the toxic effects of excessive glutamate 
receptor activation. This is due to their inability to accumulate Ca2+ into mitochondria as 
efficiently as other neurons (Nicholls & Budd, 1998). Since the mitochondrial 
membrane potential is known to be vulnerable in SNc DA neurons (Schapira et al., 
1990) it could be that the vulnerable phenotype associated with these neurons is in itself 
providing a degree of neuroprotection against glutamate excitotoxicity. This theory 
does, however, contradict evidence that suggests SNc DA neurons are more susceptible 
to glutamate excitotoxicity in the presence of mitochondrial toxins (Meredith et al., 
2009).  
NPCs have also been shown to protect neurons against the toxic effects of glutamate 
through the release of neurotrophic factors (Lladó et al., 2004). The cells in these 
cultures have been differentiated from NPCs. If a proportion of the cells in culture have 
not gone through differentiation, or if they have retained certain phenotypic traits 
typical of NPCs due to their relative immaturity, they may provide neuroprotection to 
neurons in culture.  
 
5.3.5     CaV1.3 Expression and Susceptibility 
Expression of CaV1.3 in SNc DA neurons is associated with an increased susceptibility 
to 6-OHDA, with the CaV1.3 selective antagonist Isradipine able to protect against 6-
OHDA induced cell death (Chan et al., 2007). Ca2+ influx during pacemaking has also 
been linked to increased susceptibility to excitotoxicity both in-vivo and in-vitro 
(Schapira et al., 1990; Shimizu et al., 2003). Here I show that hiPSC-derived DA 
neurons that stain for CaV1.3 are not more susceptible to death in response to 6-OHDA 
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or glutamate-induced excitotoxicity, at least during the first 6 weeks post-differentiation 
from hNPCs.  
A likely explanation for this is the lack of mature intrinsic pacemaking in these cells at 
these early stages of development. Ca2+ influx through CaV1.3 channels is associated 
with mature pacemaking in SNc DA neurons in-vivo, with block of CaV1.3 channels 
showing neuroprotective effects. Early developmental pacemaking is seen in animal 
models which instead relies on HCN and NaV channels. As these neurons matured, 
CaV1.3-dependent pacemaking began to dominate (Chan et al., 2007). Without mature 
CaV1.3-dependent pacemaking it is likely that mitochondrial stress due to Ca
2+ 
accumulation in hiPSC-derived DA neurons is not occurring to the same extent, if at all. 
The possibility that CaV1.3 expression is associated with an increased susceptibility to 
6-OHDA and glutamate induced excitotoxicity at later stages of maturity if or when 
intrinsic pacemaking develops should therefore not be discounted. It is also possible that 
the effects of CaV1.3 expression are subtle and require other stressors to be identified. 
One study, for example, has identified an increased susceptibility of cultured DA 
neurons to glutamate-induced excitotoxicity when in the presence of the mitochondrial 
toxin MPTP (Meredith et al., 2009). Data here therefore shows a difference in the 
effects of CaV1.3 expression on susceptibility to cell death between SNc DA neurons in-
vivo and hiPSC-derived DA neurons in-vitro that is likely to be due to the relative 
immaturity of the cultures. 
 
5.3.6     Suitability as a Model for Parkinson's Disease 
Many similarities between hiPSC-derived DA neurons and SNc neurons exist. These 
include similarities in activity patterns, the ability to produce spike trains, the 
development of Ca2+ waves and the receiving of glutamatergic and DA inputs to 
modulate their activity. Both cell types develop a sensitivity to mitochondrial toxins 
such as MPTP and DA-specific toxins such as 6-OHDA (Michel & Hefti., 1990; Perez-
Rial et al., 2011; Hartfield et al., 2014; Nguyen et al, 2016). Both cell types likely 
display L-type dependent pacemaking and express the L-type VGCC subtype CaV1.3 
which is believed to underlie the selective death of SNc neurons in PD (Chan et al., 
2007). This makes hiPSC-derived DA neurons suitable for studying the development of 
phenotypic traits associated with SNc DA neurons in-vivo. This includes the 
development of excitability, synaptic signalling, the role of D2 autoreceptor control of 
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excitability and the roles of CaV1.3 VGCCs. They can also be a useful tool for drug 
testing of new neuroprotective therapies that protect against PD due to their 
susceptibility to 6-OHDA and MPTP. 
Many differences between these cell types also exist.  Data here shows that electrical 
activity up to 6 weeks post-differentiation was found to not be intrinsic, unlike mature 
SNc DA neurons (Guzman et al., 2009). It is instead driven by synaptic activity. 
Inhibitory synaptic currents were not identified in this study nor by Hartfield et al 
though this may be due to the solutions used. hiPSC-derived DA neurons therefore do 
not truly mimic either the pacemaking or the synaptic networks of mature SNc neurons, 
lacking the intrinsic drive for pacemaking and perhaps the inhibitory input seen in-vivo.  
hiPSC-derived DA neurons also display a resistance to excitotoxicity while SNc DA 
neurons in-vivo are suspected to display a selective vulnerability to its effects. hiPSC-
derived DA neurons are therefore not suitable for modelling the role of excitotoxicity in 
PD unless, for example, they are cultured with other cell types such as astrocytes. 
As evidence stands, caution should be taken when using hiPSCs-derived DA neurons to 
model PD as these cells, within the first 6-12 weeks of differentiation, appear to show a 
degree of immaturity in their electrical properties that does not fully mimic those of the 
mature SNc DA neurons that selectively die in PD. In both this study, which looks at 
the first 6 weeks post-differentiation from hiPSC-derived hNPCs, and a previous study 
by Hartfield et al, which looked at the first 12 weeks of differentiation from hiPSCs, the 
electrical properties of these neurons were observed to mature with time in culture, 
showing more and more properties typical of mature SNc DA neurons (Hartfield et al., 
2014). Data here suggests that 6 weeks post-differentiation is a critical point in their 
development, with dramatic increases in synaptic activity, firing frequency and Ca2+ 
influx observed at this time point. Hartfield et al observed further maturation at later 
time points. The suitability of hiPSC-derived DA neurons as a model for PD may 
therefore be determined by the length of time these cells can be kept in culture. 
Extended maturation times past 12 weeks in culture could possibly result in the 
development of intrinsic pacemaking. In this study, time points past 6 weeks were 
associated with an increase in membrane leak and a decrease in cell viability. Hartfield 
et al's previous study, however, was able to maintain cultures for up to 12 weeks. 
Whether longer development periods are possible, along with the cost efficiency and 
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difficulty of maintaining lengthy cultures, may determine the viability of hiPSC-derived 
DA neurons as a model for PD. 
 
 
5.4     Similarities and Differences Between AtT20s and hiPSC-Derived 
Dopaminergic Neurons 
 
Comparing AtT20s and hiPSC-derived DA neurons reveals similarities in their 
pacemaking that are common across many cell types. Data here shows that tonic and 
phasic activity are seen in both models. These patterns are also identified in a variety of 
other pacemaker neurons such as in respiratory rhythm networks and mesencephalic DA 
neurons (Charlety et al., 1991; Smith et al., 2000).  
NaV channels, KV channels and L-type VGCCs (in particular CaV1.3) are common to 
both cell types, with CaV1.3 likely responsible for the production of the observed Ca
2+ 
waves in both models. This ion channel is found in other cell types with pacemaker 
properties such as cardiac cells of the sinoatrial node and adrenal chromaffin cells 
(Mangoni et al., 2003; Marcantoni et al., 2010). The expression of subthreshold-
activated VGCCs likely constitutes a conserved feature between pacemaker cell types.  
Ca2+ influx in both models occurs during action potentials, perhaps acting as a 
mechanism to control the timing of firing. Other conserved ion channel types that have 
been identified in their corresponding in-vivo cell types are HCN channels, Ca2+ 
activated K+ channels such as SK and BK channels and inward rectifier K+ channels, 
indicating that these cells have similar mechanisms that drive their intrinsic pacemaking 
in-vivo (Su et al., 2010; Dufour et al., 2014). 
What is more interesting, however, are the differences in excitability between these two 
models. Despite their similarities in activity patterns and ion channel expression there 
are major differences over what is driving their pacemaking. AtT20 pacemaking is 
entirely intrinsic and appears to no longer be coupled to agonists such as CRH 
(Surprenant, 1982). Pacemaking is instead dependent upon increases in cytosolic Ca2+. 
hiPSC-derived DA neurons, on the other hand, do not appear to show any intrinsic 
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pacemaking during their early development, though the results are confounded by the 
length of time that is required for their electrical properties to reach maturity. Activity is 
instead dependent upon synaptic input from glutamate and dopamine receptors, with 
intrinsic properties providing a mechanism that allows these neurons to be more likely 
to fire than other cell types within the same culture.  
These models also display different responses to current injection. In data here, AtT20 
cells produced single action potentials while hiPSC-derived DA neurons developed the 
ability to produce multiple action potentials in what is known as a "spike train." These 
differences are examples of how subtle changes in ion channel expression, either in 
terms of their density or localisation, can cause major differences in excitability. 
Computer-based modelling of various cell types has previously shown that subtly 
altering the conductances of several voltage-gated ion channel populations can result in 
activity patterns including quiescence, tonic firing and burst firing. This provides a basis 
for the differences in excitability seen between these cell types (Prinz et al., 2003). In  
rat SNc DA neurons, the expression of particular ion channels such as VGCCs and KV 
channels becomes more prominent in dendrites as the cells mature in culture (Dufour et 
al., 2014). AtT20s represent a neuro-endocrine cell type in-vivo rather than a neuronal 
one. Corticotrophs in-vivo are therefore lacking the extensive axons and dendritic trees 
typical of neurons. Ion channel expression is therefore likely to be densely packed into 
the soma of these cells. Differences in the spatial distribution of ion channels likely 
regulates neuronal excitability as much as differences in ion channel expression do. This 
fact is highlighted clearly when comparing excitability in AtT20s and hiPSC-derived 
DA neurons.  
Here I show that Ca2+ waves in AtT20s are still able to occur in the absence of action 
potential firing, acting to both maintain oscillatory changes in membrane potential and 
to maintain cytosolic Ca2+ at physiological concentrations whether a cell is firing or 
quiescent. Ca2+ waves in hiPSC-derived DA neurons were found to be action potential 
dependent, at least during the early development period investigated. This indicates a 
difference in the mechanism of pacemaking between the two. Subthreshold, L-type 
dependent Ca2+ waves are required for pacemaking in AtT20 cells, while hiPSC-derived 
DA neurons produce Ca2+ waves that are dependent upon action potentials and 
postsynaptic receptors. Data here therefore describe models displaying two distinct 
forms of excitability in culture: intrinsic excitability and agonist-induced excitability. 
195 
 
It has been previously found that AtT20s do not show robust pacemaking, with no 
ability to compensate for the loss of L-type VGCCs (Adler et al., 1983). In SNc neurons 
in-vivo, however, it has been shown that loss of L-type channels during development 
results in them reverting to a juvenile HCN-dependent form of pacemaking (Chan et al., 
2007). The lack of subthreshold Ca2+ waves in hiPSC-derived DA neurons identified 
here could be explained by them still being dependent upon this HCN-dependent 
pacemaking during their early development in culture. This identifies a degree of 
robustness that is not present in AtT20s.  
Data in chapter 3 shows that action potentials in hiPSC-derived DA neurons are blocked 
by the L-type antagonist nifedipine with no ability to compensate. This, however, may 
be explained by the relatively high concentration of nifedipine used that is likely to 
affect other channel types. This has previously been seen in dissociated rat SNc 
neurons, with the application of antagonists that are more selective for CaV1.3 showing 
that pacemaking continues after block of CaV1.3. With more time, Isradipine could have 
been applied to hiPSC-derived DA neurons here to confirm or refute the involvement of 
CaV1.3 in their pacemaking and to determine whether they are able to compensate for 
its block.  
By highlighting the differences and similarities between pacemaking in these two cell 
types it allows for the identification of features that are both conserved and those that 
are different across pacemaker cells in the nervous system. By highlighting differences, 
such as intrinsic vs agonist-induced excitability in these two cell types, it allows studies 
that focus on the causes of these differences to be performed. This will in turn lead to 
more information on the general mechanisms of pacemaking in the nervous system and 
any associated diseases. 
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Supplementary 2.1 - Software-Based Calculation of Whole Cell 
Capacitance 
 
The calculation of whole cell capacitance in chapter 2 was performed using the 
membrane test feature of Clampfit 10. This feature uses an exponential fitting algorithm 
in whole cell voltage clamp to determine passive membrane properties in response to 
square-wave voltage steps. In response to a step change in voltage (Figure S2.1, bottom 
panel), membrane currents display a transient increase in current that exponentially 
decays to a steady state (Figure S2.1, top panel).  
 
 
 
 
 
 
 
 
 
 
This49transient is due to the charging of the membrane capacitance, an innate property of 
biological membranes that is dependent upon the surface area of the cell. Capacitance 
can therefore be used as a general indicator of changes in cell size/surface area. 
Capacitance introduces errors into voltage and current clamp recordings if not 
adequately compensated. By leaving it uncompensated, however, it is possible to 
calculate changes in capacitance over time by providing continuous voltage steps at a 
high frequency. Capacitance (Cm) is calculated according to the following equation, 
where Q(t) is the total charge under the capacitive transient and ΔV is the amplitude of 
the voltage pulse applied: 
𝐶𝑚 = 𝑄(𝑡)/𝛥𝑉 
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ΔV is decided by the user while Q(t) is calculated by integrating the area of the 
capacitive transient above the steady state level, as denoted in Figure S2.1 as Q1. 
However, since capacitance causes errors in voltage during the observed transients 
(Figure S2.1, bottom panel, denoted by yellow lines), this means an error is introduced 
into the measurement of Q(t), denoted as Q2 (Figure S2.1, top panel denoted by yellow 
lines). This means that the actual Q(t) is calculated as: 
𝑄(𝑡) = 𝑄1 + 𝑄2 
Q2 is calculated as: 
𝑄2 = 𝛥𝐼 ∗ 𝑇𝑎𝑢 
ΔI is the change in steady state current in response to the voltage step (and is measured 
before and after the capacitive transient at the straight line regions show in red (Figure 
S2.1). Tau is the time constant for the charging of a capacitor to ~63.2% of its 
capacitance and is calculated in-software using an exponential fitting algorithm during 
the capacitive transient, denoted by the curved lines in red (Figure S2.1). All of these 
calculations are performed in-software to provide close to real time measurements of 
whole cell capacitance. Information here was obtained from the molecular devices 
website: 
(http://mdc.custhelp.com/app/answers/detail/a_id/17006/~/membrane-test-algorithms). 
Diagram by M. Euston. 
 
 
The membrane test parameters used during these experiments were: 
 
• Holding potential: -80 mV 
• Voltage step amplitude: +10 mV 
• Step duration: 10 ms 
• Step frequency: 50Hz 
• Point averaging (to reduce noise): 5 
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Supplementary 2.2 - Control Experiments for CaV1.3 Antibody 
Staining of AtT20s 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2.250- CaV1.3 antibody controls for AtT20s. Representative fluorescence images from separate 
experiments showing AtT20 cells stained with the rabbit anti-CaV1.3 primary antibody only (top left), the 
goat anti-rabbit Alexa-647 secondary antibody only (top right), both antibodies (bottom left) and both 
antibodies after the primary antibody was incubated with a CaV1.3 antigen for 1 hour prior to staining. All 
antibodies were used at a dilution of 1:500. 
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Supplementary 3.1 - Secondary Control Experiments for TH and 
NeuN Antibody Staining 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S3.151- Secondary antibody controls for TH and NeuN immunostaining. Antibody controls 
performed with the secondary antibody only for (A) the donkey anti mouse AlexaFluor-488 secondary 
antibody used during NeuN staining and (B) the goat anti rabbit AlexaFluor-647 secondary antibody used 
during TH staining. Experiments were performed at dilutions of 1:500. 
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Supplementary 4.1 - Ratiometric Determination of Percentage Cell 
Death Using Hoechst 33342 
 
After the collection of Hoechst-stained fluorescence images (see Chapter 4 methods), 
the percentage of cell death in each image was calculated using ImageJ.  
Using the threshold feature, nuclei in each image were converted to binary black and 
white, with nuclei above a defined threshold appearing as white particles within the 
image. By changing the threshold, one image could be separated into two separate 
images containing "all nuclei" or "bright nuclei." Figure S4.1B demonstrates the use of 
this threshold approach to produce two separate versions of the fluorescence image in 
Figure S4.1A. For experiments here, the threshold was set manually for each image. 
As clusters of nuclei would introduce errors into the counting due to the difficulty of 
separating them into individual nuclei, the watershed function was performed. This is a 
feature of ImageJ that attempts to separate conjoined particles and, although not perfect, 
likely increases the accuracy of the results. 
Particles were then counted using the analyse particle function. This is a feature that 
automatically counts and produces statistics on all of the particles within an image. A 10 
pixel diameter particle exclusion filter was set, as it was decided that particles below 
this were likely too small to be nuclei, instead being artefacts within the image. An 
example of the output obtained from using this feature is shown in Figure S4.1C.  
The number of total nuclei and the number of bright nuclei were summed from all of the 
images from 1 experimental repeat. The % cell death in this repeat was calculated as: 
 
% 𝐶𝑒𝑙𝑙 𝐷𝑒𝑎𝑡ℎ =  
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑏𝑟𝑖𝑔ℎ𝑡 𝑛𝑢𝑐𝑙𝑒𝑖
𝑇𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑛𝑢𝑐𝑒𝑖
∗ 100 
 
Each experiment was repeated a minimum of 3 times, with the 3 or more values 
obtained used to calculate a mean and S.E.M for each condition. 
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Figure S4.152- Ratiometric determination of % cell death using Hoechst 33342. A Hoechst-stained 
image such as that in (A) was split into images containing "bright" or "all nuclei" using the threshold 
feature, shown in (B). These nuclei were then automatically counted using the analyse particle feature, 
shown in (C). 
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Supplementary 4.2 - Control Experiments for CaV1.3 Antibody 
Staining of hiPSC-Derived Dopaminergic Neurons 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S4.253- CaV1.3 antibody controls for hiPSC-derived dopaminergic neurons. Representative 
fluorescence images from separate experiments showing cells 3 weeks post-differentiation that were 
stained with the rabbit anti-CaV1.3 primary antibody only (top left), the goat anti-rabbit Alexa-488 
secondary antibody only (top right), both antibodies (bottom left) and both antibodies after the primary 
antibody was incubated with a CaV1.3 antigen for 1 hour prior to staining. All antibodies were used at a 
dilution of 1:500. 
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